<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-10-10" version="256">
<accession>P00533</accession>
<accession>O00688</accession>
<accession>O00732</accession>
<accession>P06268</accession>
<accession>Q14225</accession>
<accession>Q68GS5</accession>
<accession>Q92795</accession>
<accession>Q9BZS2</accession>
<accession>Q9GZX1</accession>
<accession>Q9H2C9</accession>
<accession>Q9H3C9</accession>
<accession>Q9UMD7</accession>
<accession>Q9UMD8</accession>
<accession>Q9UMG5</accession>
<name>EGFR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Epidermal growth factor receptor</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene c-ErbB-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor tyrosine-protein kinase erbB-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EGFR</name>
<name type="synonym">ERBB</name>
<name type="synonym">ERBB1</name>
<name type="synonym">HER1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="Nature" volume="309" first="418" last="425">
<title>Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.</title>
<authorList>
<person name="Ullrich A."/>
<person name="Coussens L."/>
<person name="Hayflick J.S."/>
<person name="Dull T.J."/>
<person name="Gray A."/>
<person name="Tam A.W."/>
<person name="Lee J."/>
<person name="Yarden Y."/>
<person name="Libermann T.A."/>
<person name="Schlessinger J."/>
<person name="Downward J."/>
<person name="Mayes E.L.V."/>
<person name="Whittle N."/>
<person name="Waterfield M.D."/>
<person name="Seeburg P.H."/>
</authorList>
<dbReference type="PubMed" id="6328312"/>
<dbReference type="DOI" id="10.1038/309418a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 25-32</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Mol. Reprod. Dev." volume="41" first="149" last="156">
<title>Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Stark B.C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="7654368"/>
<dbReference type="DOI" id="10.1002/mrd.1080410205"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="4050" last="4056">
<title>A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="8918811"/>
<dbReference type="DOI" id="10.1093/nar/24.20.4050"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Gynecol. Oncol." volume="65" first="36" last="41">
<title>Expression of a truncated epidermal growth factor receptor-like protein (TEGFR) in ovarian cancer.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Gariti J."/>
<person name="Niederberger C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="9103388"/>
<dbReference type="DOI" id="10.1006/gyno.1996.4526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Genomics" volume="71" first="1" last="20">
<title>Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Eley G.D."/>
<person name="Strunk K.E."/>
<person name="Danielsen A.J."/>
<person name="Schehl Sinclair C."/>
<person name="Pearsall R.S."/>
<person name="Green P.J."/>
<person name="Yee D."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.D."/>
<person name="Magnuson T.R."/>
<person name="James C.D."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="11161793"/>
<dbReference type="DOI" id="10.1006/geno.2000.6341"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of the cDNA for a short EGF receptor from human placenta.</title>
<authorList>
<person name="Xu L."/>
<person name="Hong A."/>
<person name="He X."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2004-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLN-98; ARG-266; LYS-521; ILE-674; GLY-962 AND PRO-988</scope>
</reference>
<reference key="8">
<citation type="submission" date="1999-02" db="EMBL/GenBank/DDBJ databases">
<title>Human and mouse alternative EGFR transcripts encoding only the extracellular domain of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Danielsen A.J."/>
<person name="Schehl C.M."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.O."/>
<person name="Magnuson T.R."/>
<person name="Maihle N.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 575-687</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1984" name="Science" volume="224" first="843" last="848">
<title>Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.</title>
<authorList>
<person name="Lin C.R."/>
<person name="Chen W.S."/>
<person name="Kruiger W."/>
<person name="Stolarsky L.S."/>
<person name="Weber W."/>
<person name="Evans R.M."/>
<person name="Verma I.M."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="6326261"/>
<dbReference type="DOI" id="10.1126/science.6326261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-924</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1984" name="Nature" volume="309" first="806" last="810">
<title>Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells.</title>
<authorList>
<person name="Xu Y.H."/>
<person name="Ishii S."/>
<person name="Clark A.J.L."/>
<person name="Sullivan M."/>
<person name="Wilson R.K."/>
<person name="Ma D.P."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="6330563"/>
<dbReference type="DOI" id="10.1038/309806a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 150-962</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="124" first="125" last="132">
<title>Isolation of an evolutionarily conserved epidermal growth factor receptor cDNA from human A431 carcinoma cells.</title>
<authorList>
<person name="Simmen F.A."/>
<person name="Gope M.L."/>
<person name="Schulz T.Z."/>
<person name="Wright D.A."/>
<person name="Carpenter G."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="6093780"/>
<dbReference type="DOI" id="10.1016/0006-291X(84)90926-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1028-1210</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1987" name="Oncogene Res." volume="1" first="375" last="396">
<title>The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Whittle N."/>
<person name="Bennett P."/>
<person name="Kinchington D."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="3329716"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="1746" last="1753">
<title>Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="1988448"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="4920" last="4924">
<title>Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.</title>
<authorList>
<person name="Ishii S."/>
<person name="Xu Y.H."/>
<person name="Stratton R.H."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="2991899"/>
<dbReference type="DOI" id="10.1073/pnas.82.15.4920"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1984" name="Science" volume="224" first="294" last="297">
<title>Production of an epidermal growth factor receptor-related protein.</title>
<authorList>
<person name="Weber W."/>
<person name="Gill G.N."/>
<person name="Spiess J."/>
</authorList>
<dbReference type="PubMed" id="6324343"/>
<dbReference type="DOI" id="10.1126/science.6324343"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 25-49</scope>
</reference>
<reference key="16">
<citation type="submission" date="1997-09" db="UniProtKB">
<authorList>
<person name="Kohda D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 540</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="13152" last="13158">
<title>Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo.</title>
<authorList>
<person name="Heisermann G.J."/>
<person name="Gill G.N."/>
</authorList>
<dbReference type="PubMed" id="3138233"/>
</citation>
<scope>PROTEIN SEQUENCE OF 687-705; 986-998; 1000-1023; 1026-1030 AND 1068-1077</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-695; SER-1070 AND SER-1071</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1985" name="J. Biol. Chem." volume="260" first="5205" last="5208">
<title>Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase.</title>
<authorList>
<person name="Russo M.W."/>
<person name="Lukas T.J."/>
<person name="Cohen S."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="2985580"/>
</citation>
<scope>PROTEIN SEQUENCE OF 740-744 AND 746-747</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="737" last="748">
<title>Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.</title>
<authorList>
<person name="Huang F."/>
<person name="Kirkpatrick D."/>
<person name="Jiang X."/>
<person name="Gygi S.P."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="16543144"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.02.018"/>
</citation>
<scope>PROTEIN SEQUENCE OF 861-875 AND 914-932</scope>
<scope>UBIQUITINATION AT LYS-716; LYS-737; LYS-754; LYS-867; LYS-929 AND LYS-970</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="11150" last="11157">
<title>Disulfide bond structure of human epidermal growth factor receptor.</title>
<authorList>
<person name="Abe Y."/>
<person name="Odaka M."/>
<person name="Inagaki F."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="9556602"/>
<dbReference type="DOI" id="10.1074/jbc.273.18.11150"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1984" name="Nature" volume="309" first="270" last="273">
<title>ATP-stimulated interaction between epidermal growth factor receptor and supercoiled DNA.</title>
<authorList>
<person name="Mroczkowski B."/>
<person name="Mosig G."/>
<person name="Cohen S."/>
</authorList>
<dbReference type="PubMed" id="6325948"/>
<dbReference type="DOI" id="10.1038/309270a0"/>
</citation>
<scope>RECEPTOR ACTIVITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1987" name="Annu. Rev. Biochem." volume="56" first="881" last="914">
<title>Receptors for epidermal growth factor and other polypeptide mitogens.</title>
<authorList>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="3039909"/>
<dbReference type="DOI" id="10.1146/annurev.bi.56.070187.004313"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1989" name="Cell" volume="59" first="33" last="43">
<title>Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.</title>
<authorList>
<person name="Chen W.S."/>
<person name="Lazar C.S."/>
<person name="Lund K.A."/>
<person name="Welsh J.B."/>
<person name="Chang C.P."/>
<person name="Walton G.M."/>
<person name="Der C.J."/>
<person name="Wiley H.S."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="2790960"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90867-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>LIGAND-BINDING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="10667" last="10671">
<title>All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.</title>
<authorList>
<person name="Margolis B.L."/>
<person name="Lax I."/>
<person name="Kris R."/>
<person name="Dombalagian M."/>
<person name="Honegger A.M."/>
<person name="Howk R."/>
<person name="Givol D."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="2543678"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1110</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="2924" last="2931">
<title>Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.</title>
<authorList>
<person name="Johnson G.R."/>
<person name="Kannan B."/>
<person name="Shoyab M."/>
<person name="Stromberg K."/>
</authorList>
<dbReference type="PubMed" id="7679104"/>
</citation>
<scope>IDENTIFICATION OF AREG AS LIGAND</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1996" name="Science" volume="272" first="1797" last="1802">
<title>Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.</title>
<authorList>
<person name="Galcheva-Gargova Z."/>
<person name="Konstantinov K.N."/>
<person name="Wu I.-H."/>
<person name="Klier F.G."/>
<person name="Barrett T."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="8650580"/>
<dbReference type="DOI" id="10.1126/science.272.5269.1797"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="143" first="1471" last="1484">
<title>Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells.</title>
<authorList>
<person name="Gangwani L."/>
<person name="Mikrut M."/>
<person name="Galcheva-Gargova Z."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="9852145"/>
<dbReference type="DOI" id="10.1083/jcb.143.6.1471"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="5567" last="5576">
<title>Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor.</title>
<authorList>
<person name="Bagowski C.P."/>
<person name="Stein-Gerlach M."/>
<person name="Choidas A."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="10523301"/>
<dbReference type="DOI" id="10.1093/emboj/18.20.5567"/>
</citation>
<scope>PHOSPHORYLATION AT THR-678 AND THR-693</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="9966" last="9973">
<title>Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.</title>
<authorList>
<person name="Watanabe T."/>
<person name="Shintani A."/>
<person name="Nakata M."/>
<person name="Shing Y."/>
<person name="Folkman J."/>
<person name="Igarashi K."/>
<person name="Sasada R."/>
</authorList>
<dbReference type="PubMed" id="8144591"/>
</citation>
<scope>IDENTIFICATION OF BETACELLULIN/BTC AS LIGAND</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="20242" last="20245">
<title>Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.</title>
<authorList>
<person name="Galisteo M.L."/>
<person name="Dikic I."/>
<person name="Batzer A.G."/>
<person name="Langdon W.Y."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7657591"/>
<dbReference type="DOI" id="10.1074/jbc.270.35.20242"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="Growth Factors" volume="13" first="121" last="132">
<title>Analysis of the glycosylation patterns of the extracellular domain of the epidermal growth factor receptor expressed in Chinese hamster ovary fibroblasts.</title>
<authorList>
<person name="Smith K.D."/>
<person name="Davies M.J."/>
<person name="Bailey D."/>
<person name="Renouf D.V."/>
<person name="Hounsell E.F."/>
</authorList>
<dbReference type="PubMed" id="8962717"/>
<dbReference type="DOI" id="10.3109/08977199609034572"/>
</citation>
<scope>GLYCOSYLATION AT ASN-128; ASN-175; ASN-413; ASN-444 AND ASN-528</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2841" last="2848">
<title>Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.</title>
<authorList>
<person name="Komurasaki T."/>
<person name="Toyoda H."/>
<person name="Uchida D."/>
<person name="Morimoto S."/>
</authorList>
<dbReference type="PubMed" id="9419975"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201458"/>
</citation>
<scope>IDENTIFICATION OF EPIREGULIN/EREG AS LIGAND</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1622" last="1634">
<title>Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.</title>
<authorList>
<person name="Tiganis T."/>
<person name="Bennett A.M."/>
<person name="Ravichandran K.S."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9488479"/>
<dbReference type="DOI" id="10.1128/MCB.18.3.1622"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN1 AND PTPN2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="2489" last="2499">
<title>Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis.</title>
<authorList>
<person name="Nesterov A."/>
<person name="Carter R.E."/>
<person name="Sorkina T."/>
<person name="Gill G.N."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="10228163"/>
<dbReference type="DOI" id="10.1093/emboj/18.9.2489"/>
</citation>
<scope>INTERACTION WITH AP2M1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="5542" last="5549">
<title>Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck.</title>
<authorList>
<person name="Braverman L.E."/>
<person name="Quilliam L.A."/>
</authorList>
<dbReference type="PubMed" id="10026169"/>
<dbReference type="DOI" id="10.1074/jbc.274.9.5542"/>
</citation>
<scope>INTERACTION WITH GRB2; NCK1 AND NCK2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2000" name="J. Biochem." volume="127" first="65" last="72">
<title>Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor.</title>
<authorList>
<person name="Sato C."/>
<person name="Kim J.-H."/>
<person name="Abe Y."/>
<person name="Saito K."/>
<person name="Yokoyama S."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="10731668"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a022585"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-352; ASN-361; ASN-568 AND ASN-603</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="48532" last="48538">
<title>RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation.</title>
<authorList>
<person name="Derrien A."/>
<person name="Druey K.M."/>
</authorList>
<dbReference type="PubMed" id="11602604"/>
<dbReference type="DOI" id="10.1074/jbc.M108862200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RGS16</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="5478" last="5492">
<title>Characterization of glycosylation sites of the epidermal growth factor receptor.</title>
<authorList>
<person name="Zhen Y."/>
<person name="Caprioli R.M."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="12731890"/>
<dbReference type="DOI" id="10.1021/bi027101p"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568; ASN-603 AND ASN-623</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3923" last="3930">
<title>Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.</title>
<authorList>
<person name="Shao H."/>
<person name="Cheng H.Y."/>
<person name="Cook R.G."/>
<person name="Tweardy D.J."/>
</authorList>
<dbReference type="PubMed" id="12873986"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>INTERACTION WITH STAT3</scope>
<scope>PHOSPHORYLATION AT TYR-1092 AND TYR-1110</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="3270" last="3281">
<title>LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.</title>
<authorList>
<person name="Gur G."/>
<person name="Rubin C."/>
<person name="Katz M."/>
<person name="Amit I."/>
<person name="Citri A."/>
<person name="Nilsson J."/>
<person name="Amariglio N."/>
<person name="Henriksson R."/>
<person name="Rechavi G."/>
<person name="Hedman H."/>
<person name="Wides R."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15282549"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600342"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH LRIG1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>FUNCTION IN EGFR SIGNALING</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2A AND ERBB2</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND ERBB2</scope>
<scope>INTERACTION WITH PIK3C2B</scope>
<scope>MUTAGENESIS OF TYR-1016; TYR-1092; TYR-1110; TYR-1172 AND TYR-1197</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8865" last="8874">
<title>The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome.</title>
<authorList>
<person name="Habib A.A."/>
<person name="Chatterjee S."/>
<person name="Park S.-K."/>
<person name="Ratan R.R."/>
<person name="Lefebvre S."/>
<person name="Vartanian T."/>
</authorList>
<dbReference type="PubMed" id="11116146"/>
<dbReference type="DOI" id="10.1074/jbc.M008458200"/>
</citation>
<scope>FUNCTION IN NF-KAPPA-B ACTIVATION</scope>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35239" last="35242">
<title>The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Ren J."/>
<person name="Yu W."/>
<person name="Li Q."/>
<person name="Kuwahara H."/>
<person name="Yin L."/>
<person name="Carraway K.L. III"/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11483589"/>
<dbReference type="DOI" id="10.1074/jbc.C100359200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MUC1</scope>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="7038" last="7048">
<title>Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.</title>
<authorList>
<person name="Kario E."/>
<person name="Marmor M.D."/>
<person name="Adamsky K."/>
<person name="Citri A."/>
<person name="Amit I."/>
<person name="Amariglio N."/>
<person name="Rechavi G."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15590694"/>
<dbReference type="DOI" id="10.1074/jbc.M408575200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH SOCS5</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8503" last="8512">
<title>Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.</title>
<authorList>
<person name="Kochupurakkal B.S."/>
<person name="Harari D."/>
<person name="Di-Segni A."/>
<person name="Maik-Rachline G."/>
<person name="Lyass L."/>
<person name="Gur G."/>
<person name="Kerber G."/>
<person name="Citri A."/>
<person name="Lavi S."/>
<person name="Eilam R."/>
<person name="Chalifa-Caspi V."/>
<person name="Eshhar Z."/>
<person name="Pikarsky E."/>
<person name="Pinkas-Kramarski R."/>
<person name="Bacus S.S."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15611079"/>
<dbReference type="DOI" id="10.1074/jbc.M413919200"/>
</citation>
<scope>IDENTIFICATION OF EPIGEN/EPGN AS A LIGAND</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="1155" last="1170">
<title>Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).</title>
<authorList>
<person name="Wu S.L."/>
<person name="Kim J."/>
<person name="Hancock W.S."/>
<person name="Karger B."/>
</authorList>
<dbReference type="PubMed" id="16083266"/>
<dbReference type="DOI" id="10.1021/pr050113n"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-991 AND SER-1026</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="7724" last="7732">
<title>Functional implications of altered subcellular localization of PELP1 in breast cancer cells.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Manavathi B."/>
<person name="Balasenthil S."/>
<person name="Nair S.S."/>
<person name="Yang Z."/>
<person name="Sahin A.A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16140940"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-0614"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1172 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1359" last="1368">
<title>Tyrosine phosphorylation controls PCNA function through protein stability.</title>
<authorList>
<person name="Wang S.C."/>
<person name="Nakajima Y."/>
<person name="Yu Y.L."/>
<person name="Xia W."/>
<person name="Chen C.T."/>
<person name="Yang C.C."/>
<person name="McIntush E.W."/>
<person name="Li L.Y."/>
<person name="Hawke D.H."/>
<person name="Kobayashi R."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="17115032"/>
<dbReference type="DOI" id="10.1038/ncb1501"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>FUNCTION IN PCNA PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PCNA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2006" name="Traffic" volume="7" first="216" last="226">
<title>Syntaxin 9 is enriched in skin hair follicle epithelium and interacts with the epidermal growth factor receptor.</title>
<authorList>
<person name="Wang Y."/>
<person name="Foo L.Y."/>
<person name="Guo K."/>
<person name="Gan B.Q."/>
<person name="Zeng Q."/>
<person name="Hong W."/>
<person name="Tang B.L."/>
</authorList>
<dbReference type="PubMed" id="16420529"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2005.00378.x"/>
</citation>
<scope>INTERACTION WITH STX19</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="J. Clin. Invest." volume="117" first="2260" last="2267">
<title>Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.</title>
<authorList>
<person name="Groenestege W.M.T."/>
<person name="Thebault S."/>
<person name="van der Wijst J."/>
<person name="van den Berg D."/>
<person name="Janssen R."/>
<person name="Tejpar S."/>
<person name="van den Heuvel L.P."/>
<person name="van Cutsem E."/>
<person name="Hoenderop J.G."/>
<person name="Knoers N.V."/>
<person name="Bindels R.J."/>
</authorList>
<dbReference type="PubMed" id="17671655"/>
<dbReference type="DOI" id="10.1172/JCI31680"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="732" last="742">
<title>Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.</title>
<authorList>
<person name="Shen F."/>
<person name="Lin Q."/>
<person name="Gu Y."/>
<person name="Childress C."/>
<person name="Yang W."/>
</authorList>
<dbReference type="PubMed" id="17182860"/>
<dbReference type="DOI" id="10.1091/mbc.E06-02-0142"/>
</citation>
<scope>INTERACTION WITH TNF2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="1725" last="1739">
<title>Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.</title>
<authorList>
<person name="Nonis D."/>
<person name="Schmidt M.H."/>
<person name="van de Loo S."/>
<person name="Eich F."/>
<person name="Dikic I."/>
<person name="Nowock J."/>
<person name="Auburger G."/>
</authorList>
<dbReference type="PubMed" id="18602463"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.05.018"/>
</citation>
<scope>INTERACTION WITH ATX2</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2305" last="2316">
<title>Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.</title>
<authorList>
<person name="Brummer T."/>
<person name="Larance M."/>
<person name="Herrera Abreu M.T."/>
<person name="Lyons R.J."/>
<person name="Timpson P."/>
<person name="Emmerich C.H."/>
<person name="Fleuren E.D.G."/>
<person name="Lehrbach G.M."/>
<person name="Schramek D."/>
<person name="Guilhaus M."/>
<person name="James D.E."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="19172738"/>
<dbReference type="DOI" id="10.1038/emboj.2008.159"/>
</citation>
<scope>INTERACTION WITH GAB2</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="57">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-695; SER-1064; SER-1081; SER-1166 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-991; SER-995; TYR-998; SER-1039; THR-1041; SER-1042; SER-1064 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="1788" last="1798">
<title>An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.</title>
<authorList>
<person name="Tarcic G."/>
<person name="Boguslavsky S.K."/>
<person name="Wakim J."/>
<person name="Kiuchi T."/>
<person name="Liu A."/>
<person name="Reinitz F."/>
<person name="Nathanson D."/>
<person name="Takahashi T."/>
<person name="Mischel P.S."/>
<person name="Ng T."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="19836242"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.09.048"/>
</citation>
<scope>ACTIVITY REGULATION BY PTPRJ AND PTPRK</scope>
<scope>PHOSPHORYLATION AT TYR-1197</scope>
<scope>DEPHOSPHORYLATION BY PTPRJ</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CBL AND GRB2</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="20206" last="20214">
<title>GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.</title>
<authorList>
<person name="Tashiro K."/>
<person name="Tsunematsu T."/>
<person name="Okubo H."/>
<person name="Ohta T."/>
<person name="Sano E."/>
<person name="Yamauchi E."/>
<person name="Taniguchi H."/>
<person name="Konishi H."/>
</authorList>
<dbReference type="PubMed" id="19509291"/>
<dbReference type="DOI" id="10.1074/jbc.M109.021139"/>
</citation>
<scope>INTERACTION WITH GAREM1</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-352; ASN-413 AND ASN-568</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2009" name="Mol. Endocrinol." volume="23" first="1815" last="1826">
<title>G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.</title>
<authorList>
<person name="Vivacqua A."/>
<person name="Lappano R."/>
<person name="De Marco P."/>
<person name="Sisci D."/>
<person name="Aquila S."/>
<person name="De Amicis F."/>
<person name="Fuqua S.A."/>
<person name="Ando S."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="19749156"/>
<dbReference type="DOI" id="10.1210/me.2009-0120"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="498" last="504">
<title>COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport.</title>
<authorList>
<person name="Wang Y.N."/>
<person name="Wang H."/>
<person name="Yamaguchi H."/>
<person name="Lee H.J."/>
<person name="Lee H.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="20674546"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.096"/>
</citation>
<scope>INTERACTION WITH COPG1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="6036" last="6046">
<title>Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.</title>
<authorList>
<person name="Madeo A."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="20551055"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0408"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1064 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="68">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="20558" last="20568">
<title>Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.</title>
<authorList>
<person name="Huang W.C."/>
<person name="Chen Y.J."/>
<person name="Li L.Y."/>
<person name="Wei Y.L."/>
<person name="Hsu S.C."/>
<person name="Tsai S.L."/>
<person name="Chiu P.C."/>
<person name="Huang W.P."/>
<person name="Wang Y.N."/>
<person name="Chen C.H."/>
<person name="Chang W.C."/>
<person name="Chang W.C."/>
<person name="Chen A.J."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21487020"/>
<dbReference type="DOI" id="10.1074/jbc.M111.240796"/>
</citation>
<scope>PHOSPHORYLATION AT SER-229</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="174" last="181">
<title>Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.</title>
<authorList>
<person name="Hsu J.M."/>
<person name="Chen C.T."/>
<person name="Chou C.K."/>
<person name="Kuo H.P."/>
<person name="Li L.Y."/>
<person name="Lin C.Y."/>
<person name="Lee H.J."/>
<person name="Wang Y.N."/>
<person name="Liu M."/>
<person name="Liao H.W."/>
<person name="Shi B."/>
<person name="Lai C.C."/>
<person name="Bedford M.T."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21258366"/>
<dbReference type="DOI" id="10.1038/ncb2158"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND CELL MIGRATION</scope>
<scope>METHYLATION AT ARG-1199 BY PRMT5</scope>
<scope>INTERACTION WITH PRMT5 AND PTPN6</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="589" last="595">
<title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.</title>
<authorList>
<person name="Lupberger J."/>
<person name="Zeisel M.B."/>
<person name="Xiao F."/>
<person name="Thumann C."/>
<person name="Fofana I."/>
<person name="Zona L."/>
<person name="Davis C."/>
<person name="Mee C.J."/>
<person name="Turek M."/>
<person name="Gorke S."/>
<person name="Royer C."/>
<person name="Fischer B."/>
<person name="Zahid M.N."/>
<person name="Lavillette D."/>
<person name="Fresquet J."/>
<person name="Cosset F.L."/>
<person name="Rothenberg S.M."/>
<person name="Pietschmann T."/>
<person name="Patel A.H."/>
<person name="Pessaux P."/>
<person name="Doffoel M."/>
<person name="Raffelsberger W."/>
<person name="Poch O."/>
<person name="McKeating J.A."/>
<person name="Brino L."/>
<person name="Baumert T.F."/>
</authorList>
<dbReference type="PubMed" id="21516087"/>
<dbReference type="DOI" id="10.1038/nm.2341"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="7968" last="7973">
<title>FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB.</title>
<authorList>
<person name="Guo C."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="21518868"/>
<dbReference type="DOI" id="10.1073/pnas.1105369108"/>
</citation>
<scope>INTERACTION WITH FER</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="1343" last="1353">
<title>The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.</title>
<authorList>
<person name="Tanno H."/>
<person name="Yamaguchi T."/>
<person name="Goto E."/>
<person name="Ishido S."/>
<person name="Komada M."/>
</authorList>
<dbReference type="PubMed" id="22298428"/>
<dbReference type="DOI" id="10.1091/mbc.E11-09-0817"/>
</citation>
<scope>INTERACTION WITH ANKRD13A; ANKRD13B AND ALKRD13D</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4599" last="4608">
<title>Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.</title>
<authorList>
<person name="Pareja F."/>
<person name="Ferraro D.A."/>
<person name="Rubin C."/>
<person name="Cohen-Dvashi H."/>
<person name="Zhang F."/>
<person name="Aulmann S."/>
<person name="Ben-Chetrit N."/>
<person name="Pines G."/>
<person name="Navon R."/>
<person name="Crosetto N."/>
<person name="Kostler W."/>
<person name="Carvalho S."/>
<person name="Lavi S."/>
<person name="Schmitt F."/>
<person name="Dikic I."/>
<person name="Yakhini Z."/>
<person name="Sinn P."/>
<person name="Mills G.B."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="22179831"/>
<dbReference type="DOI" id="10.1038/onc.2011.587"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY OTUD7B</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="1366" last="1380">
<title>The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.</title>
<authorList>
<person name="Smith C.J."/>
<person name="Berry D.M."/>
<person name="McGlade C.J."/>
</authorList>
<dbReference type="PubMed" id="23418353"/>
<dbReference type="DOI" id="10.1242/jcs.116129"/>
</citation>
<scope>INTERACTION WITH RNF115 AND RNF126</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693 AND SER-1064</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1026 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="78">
<citation type="journal article" date="2014" name="Mol. Cancer" volume="13" first="233" last="233">
<title>EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.</title>
<authorList>
<person name="Lin X."/>
<person name="Zhong S."/>
<person name="Ye X."/>
<person name="Liao Y."/>
<person name="Yao F."/>
<person name="Yang X."/>
<person name="Sun B."/>
<person name="Zhang J."/>
<person name="Li Q."/>
<person name="Gao Y."/>
<person name="Wang Y."/>
<person name="Liu J."/>
<person name="Han B."/>
<person name="Chin Y.E."/>
<person name="Zhou B.P."/>
<person name="Deng J."/>
</authorList>
<dbReference type="PubMed" id="25311788"/>
<dbReference type="DOI" id="10.1186/1476-4598-13-233"/>
</citation>
<scope>INTERACTION WITH GPRC5A</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="3298" last="3306">
<title>Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Bryson B.L."/>
<person name="Miskimen K.L."/>
<person name="Bartel C.A."/>
<person name="Hernandez-Sanchez W."/>
<person name="Bruntz R.C."/>
<person name="Scott S.A."/>
<person name="Lindsley C.W."/>
<person name="Brown H.A."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="23912460"/>
<dbReference type="DOI" id="10.1038/onc.2013.293"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2016" name="Mol. Cell" volume="62" first="385" last="396">
<title>Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling.</title>
<authorList>
<person name="Runkle K.B."/>
<person name="Kharbanda A."/>
<person name="Stypulkowski E."/>
<person name="Cao X.J."/>
<person name="Wang W."/>
<person name="Garcia B.A."/>
<person name="Witze E.S."/>
</authorList>
<dbReference type="PubMed" id="27153536"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.04.003"/>
</citation>
<scope>FUNCTION</scope>
<scope>PALMITOYLATION AT CYS-1049 AND CYS-1146</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT TYR-1092; TYR-1172 AND TYR-1197</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 1048-ALA--ALA-1210; CYS-1049 AND CYS-1146</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2017" name="Gene" volume="626" first="48" last="53">
<title>Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer cells.</title>
<authorList>
<person name="Tian M."/>
<person name="Chen Y."/>
<person name="Tian D."/>
<person name="Qiao X."/>
<person name="Ma Z."/>
<person name="Li J."/>
</authorList>
<dbReference type="PubMed" id="28479384"/>
<dbReference type="DOI" id="10.1016/j.gene.2017.05.006"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
</reference>
<reference key="82" evidence="2">
<citation type="journal article" date="2002" name="Cell" volume="110" first="763" last="773">
<title>Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.</title>
<authorList>
<person name="Garrett T.P."/>
<person name="McKern N.M."/>
<person name="Lou M."/>
<person name="Elleman T.C."/>
<person name="Adams T.E."/>
<person name="Lovrecz G.O."/>
<person name="Zhu H.J."/>
<person name="Walker F."/>
<person name="Frenkel M.J."/>
<person name="Hoyne P.A."/>
<person name="Jorissen R.N."/>
<person name="Nice E.C."/>
<person name="Burgess A.W."/>
<person name="Ward C.W."/>
</authorList>
<dbReference type="PubMed" id="12297049"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)00940-6"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 25-525 IN COMPLEX WITH TGFA</scope>
<scope>FUNCTION</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-196 AND ASN-352</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="83" evidence="1">
<citation type="journal article" date="2002" name="Cell" volume="110" first="775" last="787">
<title>Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.</title>
<authorList>
<person name="Ogiso H."/>
<person name="Ishitani R."/>
<person name="Nureki O."/>
<person name="Fukai S."/>
<person name="Yamanaka M."/>
<person name="Kim J.H."/>
<person name="Saito K."/>
<person name="Sakamoto A."/>
<person name="Inoue M."/>
<person name="Shirouzu M."/>
<person name="Yokoyama S."/>
</authorList>
<dbReference type="PubMed" id="12297050"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)00963-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-646 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION IN MAPK1 AND/OR MAPK3 ACTIVATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-275; PHE-287; ARG-309 AND ARG-429</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-175; ASN-196; ASN-352; ASN-361 AND ASN-444</scope>
</reference>
<reference key="84" evidence="3">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="507" last="517">
<title>EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.</title>
<authorList>
<person name="Ferguson K.M."/>
<person name="Berger M.B."/>
<person name="Mendrola J.M."/>
<person name="Cho H.S."/>
<person name="Leahy D.J."/>
<person name="Lemmon M.A."/>
</authorList>
<dbReference type="PubMed" id="12620237"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00047-9"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-642 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF 587-ASP--HIS-590 AND LYS-609</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-352; ASN-361; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
</reference>
<reference key="85" evidence="4">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="6652" last="6659">
<title>A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.</title>
<authorList>
<person name="Wood E.R."/>
<person name="Truesdale A.T."/>
<person name="McDonald O.B."/>
<person name="Yuan D."/>
<person name="Hassell A."/>
<person name="Dickerson S.H."/>
<person name="Ellis B."/>
<person name="Pennisi C."/>
<person name="Horne E."/>
<person name="Lackey K."/>
<person name="Alligood K.J."/>
<person name="Rusnak D.W."/>
<person name="Gilmer T.M."/>
<person name="Shewchuk L."/>
</authorList>
<dbReference type="PubMed" id="15374980"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-1168"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 695-1022 IN COMPLEX WITH GW572016</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="86" evidence="5">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="301" last="311">
<title>Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.</title>
<authorList>
<person name="Li S."/>
<person name="Schmitz K.R."/>
<person name="Jeffrey P.D."/>
<person name="Wiltzius J.J."/>
<person name="Kussie P."/>
<person name="Ferguson K.M."/>
</authorList>
<dbReference type="PubMed" id="15837620"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.03.003"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 25-642 IN COMPLEX WITH CETUXIMAB</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24043" last="24052">
<title>A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor.</title>
<authorList>
<person name="Choowongkomon K."/>
<person name="Carlin C.R."/>
<person name="Sonnichsen F.D."/>
</authorList>
<dbReference type="PubMed" id="15840573"/>
<dbReference type="DOI" id="10.1074/jbc.M502698200"/>
</citation>
<scope>STRUCTURE BY NMR OF 669-721</scope>
</reference>
<reference key="88" evidence="9 10 11 12 13 14 15 17">
<citation type="journal article" date="2007" name="Cancer Cell" volume="11" first="217" last="227">
<title>Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Boggon T.J."/>
<person name="Li Y."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="17349580"/>
<dbReference type="DOI" id="10.1016/j.ccr.2006.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.47 ANGSTROMS) OF 696-1022 OF WILD-TYPE AND VARIANTS SER-719 AND ARG-858 IN COMPLEXES WITH ATP ANALOGS AND SYNTHETIC INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS SER-719 AND ARG-858</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2007" name="Nature" volume="450" first="741" last="744">
<title>Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.</title>
<authorList>
<person name="Zhang X."/>
<person name="Pickin K.A."/>
<person name="Bose R."/>
<person name="Jura N."/>
<person name="Cole P.A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="18046415"/>
<dbReference type="DOI" id="10.1038/nature05998"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 702-1022 IN COMPLEX WITH ERRFI1</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH ERRFI1</scope>
</reference>
<reference key="90" evidence="18 19 20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2070" last="2075">
<title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Mengwasser K.E."/>
<person name="Toms A.V."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Wong K.K."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="18227510"/>
<dbReference type="DOI" id="10.1073/pnas.0709662105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 695-1022 OF VARIANT MET-790</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANT MET-790</scope>
</reference>
<reference key="91" evidence="28">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1293" last="1307">
<title>Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.</title>
<authorList>
<person name="Jura N."/>
<person name="Endres N.F."/>
<person name="Engel K."/>
<person name="Deindl S."/>
<person name="Das R."/>
<person name="Lamers M.H."/>
<person name="Wemmer D.E."/>
<person name="Zhang X."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="19563760"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.04.025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 696-1022</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-998; TYR-1016 AND TYR-1197</scope>
<scope>MUTAGENESIS OF LEU-688; GLU-690; LEU-692; ARG-977 AND 1005-GLU-ASP-1006</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="641" last="651">
<title>The juxtamembrane region of the EGF receptor functions as an activation domain.</title>
<authorList>
<person name="Red Brewer M."/>
<person name="Choi S.H."/>
<person name="Alvarado D."/>
<person name="Moravcevic K."/>
<person name="Pozzi A."/>
<person name="Lemmon M.A."/>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="19560417"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.04.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 669-1022 OF MUTANT MET-745</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LEU-688; VAL-689; GLU-690; LEU-692; THR-693; PRO-694; PRO-699; ASN-700; LEU-704; ARG-705; ILE-706 AND LYS-745</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="400" first="231" last="243">
<title>Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.</title>
<authorList>
<person name="Mineev K.S."/>
<person name="Bocharov E.V."/>
<person name="Pustovalova Y.E."/>
<person name="Bocharova O.V."/>
<person name="Chupin V.V."/>
<person name="Arseniev A.S."/>
</authorList>
<dbReference type="PubMed" id="20471394"/>
<dbReference type="DOI" id="10.1016/j.jmb.2010.05.016"/>
</citation>
<scope>STRUCTURE BY NMR OF 634-677 IN COMPLEX WITH ERBB2</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="94" evidence="29">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="5432" last="5443">
<title>Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.</title>
<authorList>
<person name="Lu C."/>
<person name="Mi L.Z."/>
<person name="Grey M.J."/>
<person name="Zhu J."/>
<person name="Graef E."/>
<person name="Yokoyama S."/>
<person name="Springer T.A."/>
</authorList>
<dbReference type="PubMed" id="20837704"/>
<dbReference type="DOI" id="10.1128/MCB.00742-10"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-638 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-73; ASN-175; ASN-196; ASN-352; ASN-361; ASN-444 AND ASN-528</scope>
</reference>
<reference key="95">
<citation type="submission" date="2010-10" db="PDB data bank">
<title>Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide.</title>
<authorList>
<consortium name="Structural genomics consortium"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 1066-1076 IN COMPLEX WITH CBLB</scope>
<scope>INTERACTION WITH CBLB</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2012" name="J. Biochem." volume="152" first="487" last="495">
<title>Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.</title>
<authorList>
<person name="Takeshita K."/>
<person name="Tezuka T."/>
<person name="Isozaki Y."/>
<person name="Yamashita E."/>
<person name="Suzuki M."/>
<person name="Kim M."/>
<person name="Yamanashi Y."/>
<person name="Yamamoto T."/>
<person name="Nakagawa A."/>
</authorList>
<dbReference type="PubMed" id="22888118"/>
<dbReference type="DOI" id="10.1093/jb/mvs085"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1062-1074 IN COMPLEX WITH CBLC</scope>
<scope>PHOSPHORYLATION AT TYR-1069</scope>
<scope>INTERACTION WITH CBLC</scope>
<scope>MUTAGENESIS OF GLN-1067; ARG-1068 AND TYR-1069</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2004" name="Clin. Cancer Res." volume="10" first="8195" last="8203">
<title>High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.</title>
<authorList>
<person name="Huang S.F."/>
<person name="Liu H.P."/>
<person name="Li L.H."/>
<person name="Ku Y.C."/>
<person name="Fu Y.N."/>
<person name="Tsai H.Y."/>
<person name="Chen Y.T."/>
<person name="Lin Y.F."/>
<person name="Chang W.C."/>
<person name="Kuo H.P."/>
<person name="Wu Y.C."/>
<person name="Chen Y.R."/>
<person name="Tsai S.F."/>
</authorList>
<dbReference type="PubMed" id="15623594"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-04-1245"/>
</citation>
<scope>VARIANTS ALA-709; GLY-709; CYS-719; SER-719; 746-GLU--ALA-750 DEL; 746-GLU--THR-751 DELINS ALA; 746-GLU--SER-752 DELINS ASP; 747-LEU--THR-751 DEL; ILE-768; MET-769; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2004" name="Science" volume="304" first="1497" last="1500">
<title>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.</title>
<authorList>
<person name="Paez J.G."/>
<person name="Janne P.A."/>
<person name="Lee J.C."/>
<person name="Tracy S."/>
<person name="Greulich H."/>
<person name="Gabriel S."/>
<person name="Herman P."/>
<person name="Kaye F.J."/>
<person name="Lindeman N."/>
<person name="Boggon T.J."/>
<person name="Naoki K."/>
<person name="Sasaki H."/>
<person name="Fujii Y."/>
<person name="Eck M.J."/>
<person name="Sellers W.R."/>
<person name="Johnson B.E."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="15118125"/>
<dbReference type="DOI" id="10.1126/science.1099314"/>
</citation>
<scope>VARIANTS SER-719 AND ARG-858</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2006" name="Clin. Cancer Res." volume="12" first="1647" last="1653">
<title>Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.</title>
<authorList>
<person name="Tam I.Y.S."/>
<person name="Chung L.P."/>
<person name="Suen W.S."/>
<person name="Wang E."/>
<person name="Wong M.C.M."/>
<person name="Ho K.K."/>
<person name="Lam W.K."/>
<person name="Chiu S.W."/>
<person name="Girard L."/>
<person name="Minna J.D."/>
<person name="Gazdar A.F."/>
<person name="Wong M.P."/>
</authorList>
<dbReference type="PubMed" id="16533793"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-05-1981"/>
</citation>
<scope>VARIANTS ALA-709; LYS-709; ALA-719; ASP-719; CYS-719; SER-719; SER-724; LYS-734; GLU-746 DEL; PHE-747; 747-LEU--GLU-749 DEL; PRO-748; 752-SER--ILE-759 DEL; ARG-787; MET-790; VAL-833; LEU-834; MET-858; ARG-858; GLN-861 AND GLU-873</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1205" last="1215">
<title>Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants.</title>
<authorList>
<person name="Chen Y.R."/>
<person name="Fu Y.N."/>
<person name="Lin C.H."/>
<person name="Yang S.T."/>
<person name="Hu S.F."/>
<person name="Chen Y.T."/>
<person name="Tsai S.F."/>
<person name="Huang S.F."/>
</authorList>
<dbReference type="PubMed" id="16205628"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209159"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ALA-709; GLY-709; SER-719; ILE-768; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="7817" last="7822">
<title>Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.</title>
<authorList>
<person name="Ji H."/>
<person name="Zhao X."/>
<person name="Yuza Y."/>
<person name="Shimamura T."/>
<person name="Li D."/>
<person name="Protopopov A."/>
<person name="Jung B.L."/>
<person name="McNamara K."/>
<person name="Xia H."/>
<person name="Glatt K.A."/>
<person name="Thomas R.K."/>
<person name="Sasaki H."/>
<person name="Horner J.W."/>
<person name="Eck M."/>
<person name="Mitchell A."/>
<person name="Sun Y."/>
<person name="Al-Hashem R."/>
<person name="Bronson R.T."/>
<person name="Rabindran S.K."/>
<person name="Discafani C.M."/>
<person name="Maher E."/>
<person name="Shapiro G.I."/>
<person name="Meyerson M."/>
<person name="Wong K.K."/>
</authorList>
<dbReference type="PubMed" id="16672372"/>
<dbReference type="DOI" id="10.1073/pnas.0510284103"/>
</citation>
<scope>VARIANT 30-VAL--ARG-297 DEL</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LYS-521; ARG-1034 AND VAL-1210</scope>
</reference>
<reference key="103">
<citation type="journal article" date="2014" name="J. Invest. Dermatol." volume="134" first="2570" last="2578">
<title>Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR.</title>
<authorList>
<person name="Campbell P."/>
<person name="Morton P.E."/>
<person name="Takeichi T."/>
<person name="Salam A."/>
<person name="Roberts N."/>
<person name="Proudfoot L.E."/>
<person name="Mellerio J.E."/>
<person name="Aminu K."/>
<person name="Wellington C."/>
<person name="Patil S.N."/>
<person name="Akiyama M."/>
<person name="Liu L."/>
<person name="McMillan J.R."/>
<person name="Aristodemou S."/>
<person name="Ishida-Yamamoto A."/>
<person name="Abdul-Wahab A."/>
<person name="Petrof G."/>
<person name="Fong K."/>
<person name="Harnchoowong S."/>
<person name="Stone K.L."/>
<person name="Harper J.I."/>
<person name="McLean W.H."/>
<person name="Simpson M.A."/>
<person name="Parsons M."/>
<person name="McGrath J.A."/>
</authorList>
<dbReference type="PubMed" id="24691054"/>
<dbReference type="DOI" id="10.1038/jid.2014.164"/>
</citation>
<scope>VARIANT NISBD2 ASP-428</scope>
<scope>CHARACTERIZATION OF VARIANT NISBD2 ASP-428</scope>
<scope>INVOLVEMENT IN NISBD2</scope>
</reference>
<comment type="function">
<text evidence="69 77 78 79 80 81 82 83 85 89 90 91 101 112 119 120 132 133 138 139 142">Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:2790960, PubMed:10805725, PubMed:27153536). Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF (PubMed:2790960, PubMed:7679104, PubMed:8144591, PubMed:9419975, PubMed:15611079, PubMed:12297049, PubMed:27153536, PubMed:20837704). Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules (PubMed:27153536). May also activate the NF-kappa-B signaling cascade (PubMed:11116146). Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling (PubMed:11602604). Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin (PubMed:11483589). Plays a role in enhancing learning and memory performance (By similarity).</text>
</comment>
<comment type="function">
<text>Isoform 2 may act as an antagonist of EGF action.</text>
</comment>
<comment type="function">
<text evidence="122">(Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins.</text>
</comment>
<comment type="catalytic activity">
<text evidence="72 89 104 106 107 112 113">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="activity regulation">
<text evidence="87 90 106 115">Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling.</text>
</comment>
<comment type="subunit">
<text evidence="73 74 77 78 79 82 83 85 87 89 90 93 95 97 101 102 106 108 110 111 112 113 114 115 116 117 118 119 120 123 125 126 127 128 130 134 137 140 143 146">Binding of the ligand triggers homo- and/or heterodimerization of the receptor triggering its autophosphorylation. Heterodimer with ERBB2 (PubMed:10805725). Interacts with ERRFI1; inhibits dimerization of the kinase domain and autophosphorylation (PubMed:18046415). Part of a complex with ERBB2 and either PIK3C2A or PIK3C2B (PubMed:10805725). Interacts with GRB2; an adapter protein coupling the receptor to downstream signaling pathways. Interacts with GAB2; involved in signaling downstream of EGFR. Interacts with STAT3; mediates EGFR downstream signaling in cell proliferation. Interacts with RIPK1; involved in NF-kappa-B activation. Interacts (autophosphorylated) with CBL, CBLB and CBLC; involved in EGFR ubiquitination and regulation. Interacts with SOCS5; regulates EGFR degradation through ELOC- and ELOB-mediated ubiquitination and proteasomal degradation. Interacts with PRMT5; methylates EGFR and enhances interaction with PTPN6. Interacts (phosphorylated) with PTPN6; inhibits EGFR-dependent activation of MAPK/ERK. Interacts with COPG1; essential for regulation of EGF-dependent nuclear transport of EGFR by retrograde trafficking from the Golgi to the ER. Interacts with TNK2; this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts with PCNA; positively regulates PCNA (PubMed:17115032). Interacts with PELP1. Interacts with MUC1. Interacts with AP2M1. Interacts with FER. May interact with EPS8; mediates EPS8 phosphorylation. Interacts (via SH2 domains) with GRB2, NCK1 and NCK2 (PubMed:10026169). Interacts with ATX2. Interacts with GAREM1. Interacts (ubiquitinated) with ANKRD13A/B/D; the interaction is direct and may regulate EGFR internalization after EGF stimulation. Interacts with GPER1; the interaction occurs in an estrogen-dependent manner. Interacts (via C-terminal cytoplasmic kinase domain) with ZPR1 (via zinc fingers). Interacts with RNF115 and RNF126 (PubMed:23418353). Interacts with GPRC5A (via its transmembrane domain) (PubMed:25311788). Interacts with FAM83B; positively regulates EGFR inducing its autophosphorylation in absence of stimulation by EGF (PubMed:23912460). Interacts with LAPTM4B; positively correlates with EGFR activation (PubMed:28479384). Interacts with STX19 (PubMed:16420529).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297353"/>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356749">
<id>Q53FC7</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356686">
<id>Q96BE0</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1646426">
<id>Q15109</id>
<label>AGER</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-528269">
<id>Q9UKV8</id>
<label>AGO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2555881">
<id>Q09666</id>
<label>AHNAK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2562430">
<id>Q02952</id>
<label>AKAP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048612">
<id>Q92625</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297683">
<id>Q96CW1</id>
<label>AP2M1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-81694">
<id>O00213</id>
<label>APBB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79277">
<id>Q92870</id>
<label>APBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-286427">
<id>O95704</id>
<label>APBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-741243">
<id>Q9UKG1</id>
<label>APPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2850927">
<id>P30530</id>
<label>AXL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-949378">
<id>Q14457</id>
<label>BECN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397435">
<id>P62158</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397530">
<id>P62161</id>
<label>Calm3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1748958">
<id>P49069</id>
<label>CAMLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-603614">
<id>Q03135</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640919">
<id>P22682</id>
<label>Cbl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-14357960">
<id>Q9BZP6</id>
<label>CHIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617866">
<id>Q9NSE2</id>
<label>CISH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7878194">
<id>Q7Z7G1</id>
<label>CLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-287556">
<id>P46108-1</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701927">
<id>O60716</id>
<label>CTNND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351886">
<id>Q14247</id>
<label>CTTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2880244">
<id>Q6PKX4</id>
<label>DOK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640857">
<id>P01133</id>
<label>EGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375576">
<id>Q12929</id>
<label>EPS8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-750962">
<id>P07992</id>
<label>ERCC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-4309277">
<id>P03372-4</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355383">
<id>Q96A65</id>
<label>EXOC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-724839">
<id>Q14318</id>
<label>FKBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720116">
<id>P60520</id>
<label>GABARAPL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354056">
<id>P04406</id>
<label>GAPDH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-712073">
<id>Q8NBJ4</id>
<label>GOLM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7250369">
<id>Q14956</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-16191078">
<id>Q14956-1</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>36</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-301697">
<id>Q9UBN7</id>
<label>HDAC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048378">
<id>Q8WUI4</id>
<label>HDAC7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356629">
<id>Q6PK50</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-629985">
<id>P08107</id>
<label>HSPA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354932">
<id>P38646</id>
<label>HSPA9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-715709">
<id>P17936</id>
<label>IGFBP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-356594">
<id>O14654</id>
<label>IRS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3267258">
<id>Q86VI4</id>
<label>LAPTM4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1222766">
<id>O43561</id>
<label>LAT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346946">
<id>Q13094</id>
<label>LCP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-719955">
<id>Q96FE5</id>
<label>LINGO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1050422">
<id>Q38SD2</id>
<label>LRRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6895930">
<id>P07948-1</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-722813">
<id>Q13387</id>
<label>MAPK8IP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3385920">
<id>Q9Y2H9</id>
<label>MAST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-372712">
<id>P14174</id>
<label>MIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2804728">
<id>P15941</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-726944">
<id>P46934</id>
<label>NEDD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-493507">
<id>P04150</id>
<label>NR3C1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2861522">
<id>P16234</id>
<label>PDGFRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641107">
<id>O00750</id>
<label>PIK3C2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383528">
<id>P17252</id>
<label>PRKCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2272005">
<id>P97313</id>
<label>Prkdc</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-916819">
<id>P20417</id>
<label>Ptpn1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
<label>PTPN22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2258115">
<id>P23470</id>
<label>PTPRG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-913954">
<id>Q9UJ41</id>
<label>RABGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3940924">
<id>Q70E73</id>
<label>RAPH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-366017">
<id>Q13671</id>
<label>RIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6082337">
<id>Q01973</id>
<label>ROR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2952709">
<id>Q92622</id>
<label>RUBCN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3506572">
<id>Q80U62</id>
<label>Rubcn</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
<label>SH2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2339271">
<id>Q9BRG2</id>
<label>SH2D3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>28</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9691288">
<id>P29353-7</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-726214">
<id>Q13239</id>
<label>SLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1772443">
<id>P13866</id>
<label>SLC5A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-749537">
<id>P42229</id>
<label>STAT5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1054052">
<id>P31948</id>
<label>STIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-357085">
<id>Q9UNE7</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1034374">
<id>P01135</id>
<label>TGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-712991">
<id>O75674</id>
<label>TOM1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2650739">
<id>Q8K424</id>
<label>Trpv3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-302552">
<id>Q71U36</id>
<label>TUBA1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-594644">
<id>P10599</id>
<label>TXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-714860">
<id>P09936</id>
<label>UCHL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1059156">
<id>Q9P0L0</id>
<label>VAPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="102 132 133">Cell membrane</location>
<topology evidence="132">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="132">Endoplasmic reticulum membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="102 132">Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Endosome membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="101 117 118">Nucleus</location>
</subcellularLocation>
<text evidence="102 118 132 133">In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER (PubMed:20674546). Endocytosed upon activation by ligand (PubMed:2790960, PubMed:17182860, PubMed:27153536). Colocalized with GPER1 in the nucleus of estrogen agonist-induced cancer-associated fibroblasts (CAF) (PubMed:20551055).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P00533-1</id>
<name>1</name>
<name>p170</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P00533-2</id>
<name>2</name>
<name>p60</name>
<name>Truncated</name>
<name>TEGFR</name>
<sequence type="described" ref="VSP_002887 VSP_002888"/>
</isoform>
<isoform>
<id>P00533-3</id>
<name>3</name>
<name>p110</name>
<sequence type="described" ref="VSP_002889 VSP_002890"/>
</isoform>
<isoform>
<id>P00533-4</id>
<name>4</name>
<sequence type="described" ref="VSP_002891 VSP_002892"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="105">Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers.</text>
</comment>
<comment type="PTM">
<text evidence="75 85 94 113 115 120 131 132 135">Phosphorylated on Tyr residues in response to EGF (PubMed:27153536). Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2.</text>
</comment>
<comment type="PTM">
<text evidence="69 99 124 125 132">Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting (PubMed:27153536). Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="132">Palmitoylated on Cys residues by ZDHHC20. Palmitoylation inhibits internalization after ligand binding, and increases the persistence of tyrosine-phosphorylated EGFR at the cell membrane. Palmitoylation increases the amplitude and duration of EGFR signaling.</text>
</comment>
<comment type="PTM">
<text evidence="113 115 120">Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197.</text>
</comment>
<comment type="disease" evidence="86 98 100">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="129">
<disease id="DI-04271">
<name>Inflammatory skin and bowel disease, neonatal, 2</name>
<acronym>NISBD2</acronym>
<description>A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized.</description>
<dbReference type="MIM" id="616069"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="71">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/egfr/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor"/>
<text>EGFR entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X00588">
<property type="protein sequence ID" value="CAA25240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U95089">
<property type="protein sequence ID" value="AAB53063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48722">
<property type="protein sequence ID" value="AAC50802.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48723">
<property type="protein sequence ID" value="AAC50804.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48724">
<property type="protein sequence ID" value="AAC50796.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48725">
<property type="protein sequence ID" value="AAC50797.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48726">
<property type="protein sequence ID" value="AAC50798.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48727">
<property type="protein sequence ID" value="AAC50799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48728">
<property type="protein sequence ID" value="AAC50800.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48729">
<property type="protein sequence ID" value="AAC50801.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35786.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35787.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35788.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35789.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35790.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY698024">
<property type="protein sequence ID" value="AAT97979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY588246">
<property type="protein sequence ID" value="AAS83109.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277897">
<property type="protein sequence ID" value="AAK01080.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125253">
<property type="protein sequence ID" value="AAG43240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125539">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125538">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06370">
<property type="protein sequence ID" value="CAA29668.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00663">
<property type="protein sequence ID" value="CAA25282.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M38425">
<property type="protein sequence ID" value="AAA63171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M11234">
<property type="protein sequence ID" value="AAA52370.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47587.1">
<molecule id="P00533-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5514.1">
<molecule id="P00533-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5515.1">
<molecule id="P00533-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5516.1">
<molecule id="P00533-4"/>
</dbReference>
<dbReference type="PIR" id="A00641">
<property type="entry name" value="GQHUE"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005219.2">
<molecule id="P00533-1"/>
<property type="nucleotide sequence ID" value="NM_005228.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958439.1">
<molecule id="P00533-4"/>
<property type="nucleotide sequence ID" value="NM_201282.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958440.1">
<molecule id="P00533-2"/>
<property type="nucleotide sequence ID" value="NM_201283.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958441.1">
<molecule id="P00533-3"/>
<property type="nucleotide sequence ID" value="NM_201284.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.488293"/>
<dbReference type="UniGene" id="Hs.605083"/>
<dbReference type="UniGene" id="Hs.731652"/>
<dbReference type="PDB" id="1DNQ">
<property type="method" value="Model"/>
<property type="chains" value="A=25-336"/>
</dbReference>
<dbReference type="PDB" id="1DNR">
<property type="method" value="Model"/>
<property type="chains" value="A=337-645"/>
</dbReference>
<dbReference type="PDB" id="1IVO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-646"/>
</dbReference>
<dbReference type="PDB" id="1M14">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1M17">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1MOX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=25-525"/>
</dbReference>
<dbReference type="PDB" id="1NQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1XKK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1YY9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1Z9I">
<property type="method" value="NMR"/>
<property type="chains" value="A=669-721"/>
</dbReference>
<dbReference type="PDB" id="2EB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EB3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EXP">
<property type="method" value="Model"/>
<property type="chains" value="A=311-326"/>
</dbReference>
<dbReference type="PDB" id="2EXQ">
<property type="method" value="Model"/>
<property type="chains" value="A=27-536"/>
</dbReference>
<dbReference type="PDB" id="2GS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.72"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5E">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5F">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J6M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2KS1">
<property type="method" value="NMR"/>
<property type="chains" value="B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M0B">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M20">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=642-697"/>
</dbReference>
<dbReference type="PDB" id="2N5S">
<property type="method" value="NMR"/>
<property type="chains" value="A=642-690"/>
</dbReference>
<dbReference type="PDB" id="2RF9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3B2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/E/I/M/P/S/V=335-538"/>
</dbReference>
<dbReference type="PDB" id="3B2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="3BEL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3BUO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=1063-1075"/>
</dbReference>
<dbReference type="PDB" id="3C09">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/D=336-538"/>
</dbReference>
<dbReference type="PDB" id="3G5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=311-326"/>
</dbReference>
<dbReference type="PDB" id="3G5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="E=311-326"/>
</dbReference>
<dbReference type="PDB" id="3GOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=669-1022"/>
</dbReference>
<dbReference type="PDB" id="3GT8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3IKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="3LZB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-983"/>
</dbReference>
<dbReference type="PDB" id="3NJP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-638"/>
</dbReference>
<dbReference type="PDB" id="3OB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1063-1074"/>
</dbReference>
<dbReference type="PDB" id="3OP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3P0Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=334-538"/>
</dbReference>
<dbReference type="PDB" id="3PFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3POZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3QWQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=1-642"/>
</dbReference>
<dbReference type="PDB" id="3UG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3UG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="B=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3VRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3W2O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W32">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W33">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5P">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.17"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4HJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4I1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I20">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I21">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.37"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I22">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I23">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I24">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4JQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4KRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/C/E/G/I/K=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4KRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4LI5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="4LL0">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LQM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.53"/>
<property type="chains" value="A/B/C/D/E=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4R3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4TKS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4UIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=26-637"/>
</dbReference>
<dbReference type="PDB" id="4UV7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=25-645"/>
</dbReference>
<dbReference type="PDB" id="4WD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4WKQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4WRG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZJV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZSE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B/C/D=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=696-1042"/>
</dbReference>
<dbReference type="PDB" id="5CNO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B/X=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5D41">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5FED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GNK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-988"/>
</dbReference>
<dbReference type="PDB" id="5GTY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.14"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GTZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5J9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=697-1019"/>
</dbReference>
<dbReference type="PDB" id="5J9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="5JEB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5LV6">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="5SX4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5SX5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5U8L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5WB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.94"/>
<property type="chains" value="A/B/C/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5WB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5X26">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X27">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X28">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X2A">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X2C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5X2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XDK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XDL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A=1-643"/>
</dbReference>
<dbReference type="PDB" id="5Y25">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="5Y9T">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5YU9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5ZWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=675-1022"/>
</dbReference>
<dbReference type="PDB" id="6ARU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=25-640"/>
</dbReference>
<dbReference type="PDB" id="6B3S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/E/I=335-538"/>
</dbReference>
<dbReference type="PDB" id="6D8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.54"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDBsum" id="1DNQ"/>
<dbReference type="PDBsum" id="1DNR"/>
<dbReference type="PDBsum" id="1IVO"/>
<dbReference type="PDBsum" id="1M14"/>
<dbReference type="PDBsum" id="1M17"/>
<dbReference type="PDBsum" id="1MOX"/>
<dbReference type="PDBsum" id="1NQL"/>
<dbReference type="PDBsum" id="1XKK"/>
<dbReference type="PDBsum" id="1YY9"/>
<dbReference type="PDBsum" id="1Z9I"/>
<dbReference type="PDBsum" id="2EB2"/>
<dbReference type="PDBsum" id="2EB3"/>
<dbReference type="PDBsum" id="2EXP"/>
<dbReference type="PDBsum" id="2EXQ"/>
<dbReference type="PDBsum" id="2GS2"/>
<dbReference type="PDBsum" id="2GS6"/>
<dbReference type="PDBsum" id="2GS7"/>
<dbReference type="PDBsum" id="2ITN"/>
<dbReference type="PDBsum" id="2ITO"/>
<dbReference type="PDBsum" id="2ITP"/>
<dbReference type="PDBsum" id="2ITQ"/>
<dbReference type="PDBsum" id="2ITT"/>
<dbReference type="PDBsum" id="2ITU"/>
<dbReference type="PDBsum" id="2ITV"/>
<dbReference type="PDBsum" id="2ITW"/>
<dbReference type="PDBsum" id="2ITX"/>
<dbReference type="PDBsum" id="2ITY"/>
<dbReference type="PDBsum" id="2ITZ"/>
<dbReference type="PDBsum" id="2J5E"/>
<dbReference type="PDBsum" id="2J5F"/>
<dbReference type="PDBsum" id="2J6M"/>
<dbReference type="PDBsum" id="2JIT"/>
<dbReference type="PDBsum" id="2JIU"/>
<dbReference type="PDBsum" id="2JIV"/>
<dbReference type="PDBsum" id="2KS1"/>
<dbReference type="PDBsum" id="2M0B"/>
<dbReference type="PDBsum" id="2M20"/>
<dbReference type="PDBsum" id="2N5S"/>
<dbReference type="PDBsum" id="2RF9"/>
<dbReference type="PDBsum" id="2RFD"/>
<dbReference type="PDBsum" id="2RFE"/>
<dbReference type="PDBsum" id="2RGP"/>
<dbReference type="PDBsum" id="3B2U"/>
<dbReference type="PDBsum" id="3B2V"/>
<dbReference type="PDBsum" id="3BEL"/>
<dbReference type="PDBsum" id="3BUO"/>
<dbReference type="PDBsum" id="3C09"/>
<dbReference type="PDBsum" id="3G5V"/>
<dbReference type="PDBsum" id="3G5Y"/>
<dbReference type="PDBsum" id="3GOP"/>
<dbReference type="PDBsum" id="3GT8"/>
<dbReference type="PDBsum" id="3IKA"/>
<dbReference type="PDBsum" id="3LZB"/>
<dbReference type="PDBsum" id="3NJP"/>
<dbReference type="PDBsum" id="3OB2"/>
<dbReference type="PDBsum" id="3OP0"/>
<dbReference type="PDBsum" id="3P0Y"/>
<dbReference type="PDBsum" id="3PFV"/>
<dbReference type="PDBsum" id="3POZ"/>
<dbReference type="PDBsum" id="3QWQ"/>
<dbReference type="PDBsum" id="3UG1"/>
<dbReference type="PDBsum" id="3UG2"/>
<dbReference type="PDBsum" id="3VJN"/>
<dbReference type="PDBsum" id="3VJO"/>
<dbReference type="PDBsum" id="3VRP"/>
<dbReference type="PDBsum" id="3VRR"/>
<dbReference type="PDBsum" id="3W2O"/>
<dbReference type="PDBsum" id="3W2P"/>
<dbReference type="PDBsum" id="3W2Q"/>
<dbReference type="PDBsum" id="3W2R"/>
<dbReference type="PDBsum" id="3W2S"/>
<dbReference type="PDBsum" id="3W32"/>
<dbReference type="PDBsum" id="3W33"/>
<dbReference type="PDBsum" id="4G5J"/>
<dbReference type="PDBsum" id="4G5P"/>
<dbReference type="PDBsum" id="4HJO"/>
<dbReference type="PDBsum" id="4I1Z"/>
<dbReference type="PDBsum" id="4I20"/>
<dbReference type="PDBsum" id="4I21"/>
<dbReference type="PDBsum" id="4I22"/>
<dbReference type="PDBsum" id="4I23"/>
<dbReference type="PDBsum" id="4I24"/>
<dbReference type="PDBsum" id="4JQ7"/>
<dbReference type="PDBsum" id="4JQ8"/>
<dbReference type="PDBsum" id="4JR3"/>
<dbReference type="PDBsum" id="4JRV"/>
<dbReference type="PDBsum" id="4KRL"/>
<dbReference type="PDBsum" id="4KRM"/>
<dbReference type="PDBsum" id="4KRO"/>
<dbReference type="PDBsum" id="4KRP"/>
<dbReference type="PDBsum" id="4LI5"/>
<dbReference type="PDBsum" id="4LL0"/>
<dbReference type="PDBsum" id="4LQM"/>
<dbReference type="PDBsum" id="4LRM"/>
<dbReference type="PDBsum" id="4R3P"/>
<dbReference type="PDBsum" id="4R3R"/>
<dbReference type="PDBsum" id="4R5S"/>
<dbReference type="PDBsum" id="4RIW"/>
<dbReference type="PDBsum" id="4RIX"/>
<dbReference type="PDBsum" id="4RIY"/>
<dbReference type="PDBsum" id="4RJ4"/>
<dbReference type="PDBsum" id="4RJ5"/>
<dbReference type="PDBsum" id="4RJ6"/>
<dbReference type="PDBsum" id="4RJ7"/>
<dbReference type="PDBsum" id="4RJ8"/>
<dbReference type="PDBsum" id="4TKS"/>
<dbReference type="PDBsum" id="4UIP"/>
<dbReference type="PDBsum" id="4UV7"/>
<dbReference type="PDBsum" id="4WD5"/>
<dbReference type="PDBsum" id="4WKQ"/>
<dbReference type="PDBsum" id="4WRG"/>
<dbReference type="PDBsum" id="4ZAU"/>
<dbReference type="PDBsum" id="4ZJV"/>
<dbReference type="PDBsum" id="4ZSE"/>
<dbReference type="PDBsum" id="5C8K"/>
<dbReference type="PDBsum" id="5C8M"/>
<dbReference type="PDBsum" id="5C8N"/>
<dbReference type="PDBsum" id="5CAL"/>
<dbReference type="PDBsum" id="5CAN"/>
<dbReference type="PDBsum" id="5CAO"/>
<dbReference type="PDBsum" id="5CAP"/>
<dbReference type="PDBsum" id="5CAQ"/>
<dbReference type="PDBsum" id="5CAS"/>
<dbReference type="PDBsum" id="5CAU"/>
<dbReference type="PDBsum" id="5CAV"/>
<dbReference type="PDBsum" id="5CNN"/>
<dbReference type="PDBsum" id="5CNO"/>
<dbReference type="PDBsum" id="5CZH"/>
<dbReference type="PDBsum" id="5CZI"/>
<dbReference type="PDBsum" id="5D41"/>
<dbReference type="PDBsum" id="5EDP"/>
<dbReference type="PDBsum" id="5EDQ"/>
<dbReference type="PDBsum" id="5EDR"/>
<dbReference type="PDBsum" id="5EM5"/>
<dbReference type="PDBsum" id="5EM6"/>
<dbReference type="PDBsum" id="5EM7"/>
<dbReference type="PDBsum" id="5EM8"/>
<dbReference type="PDBsum" id="5FED"/>
<dbReference type="PDBsum" id="5FEE"/>
<dbReference type="PDBsum" id="5FEQ"/>
<dbReference type="PDBsum" id="5GMP"/>
<dbReference type="PDBsum" id="5GNK"/>
<dbReference type="PDBsum" id="5GTY"/>
<dbReference type="PDBsum" id="5GTZ"/>
<dbReference type="PDBsum" id="5HCX"/>
<dbReference type="PDBsum" id="5HCY"/>
<dbReference type="PDBsum" id="5HCZ"/>
<dbReference type="PDBsum" id="5HG5"/>
<dbReference type="PDBsum" id="5HG7"/>
<dbReference type="PDBsum" id="5HG8"/>
<dbReference type="PDBsum" id="5HG9"/>
<dbReference type="PDBsum" id="5HIB"/>
<dbReference type="PDBsum" id="5HIC"/>
<dbReference type="PDBsum" id="5J9Y"/>
<dbReference type="PDBsum" id="5J9Z"/>
<dbReference type="PDBsum" id="5JEB"/>
<dbReference type="PDBsum" id="5LV6"/>
<dbReference type="PDBsum" id="5SX4"/>
<dbReference type="PDBsum" id="5SX5"/>
<dbReference type="PDBsum" id="5U8L"/>
<dbReference type="PDBsum" id="5UG8"/>
<dbReference type="PDBsum" id="5UG9"/>
<dbReference type="PDBsum" id="5UGA"/>
<dbReference type="PDBsum" id="5UGB"/>
<dbReference type="PDBsum" id="5UGC"/>
<dbReference type="PDBsum" id="5UWD"/>
<dbReference type="PDBsum" id="5WB7"/>
<dbReference type="PDBsum" id="5WB8"/>
<dbReference type="PDBsum" id="5X26"/>
<dbReference type="PDBsum" id="5X27"/>
<dbReference type="PDBsum" id="5X28"/>
<dbReference type="PDBsum" id="5X2A"/>
<dbReference type="PDBsum" id="5X2C"/>
<dbReference type="PDBsum" id="5X2F"/>
<dbReference type="PDBsum" id="5X2K"/>
<dbReference type="PDBsum" id="5XDK"/>
<dbReference type="PDBsum" id="5XDL"/>
<dbReference type="PDBsum" id="5XGM"/>
<dbReference type="PDBsum" id="5XGN"/>
<dbReference type="PDBsum" id="5XWD"/>
<dbReference type="PDBsum" id="5Y25"/>
<dbReference type="PDBsum" id="5Y9T"/>
<dbReference type="PDBsum" id="5YU9"/>
<dbReference type="PDBsum" id="5ZWJ"/>
<dbReference type="PDBsum" id="6ARU"/>
<dbReference type="PDBsum" id="6B3S"/>
<dbReference type="PDBsum" id="6D8E"/>
<dbReference type="DisProt" id="DP00309"/>
<dbReference type="ProteinModelPortal" id="P00533"/>
<dbReference type="SMR" id="P00533"/>
<dbReference type="BioGrid" id="108276">
<property type="interactions" value="1213"/>
</dbReference>
<dbReference type="CORUM" id="P00533"/>
<dbReference type="DIP" id="DIP-405N"/>
<dbReference type="ELM" id="P00533"/>
<dbReference type="IntAct" id="P00533">
<property type="interactions" value="497"/>
</dbReference>
<dbReference type="MINT" id="P00533"/>
<dbReference type="STRING" id="9606.ENSP00000275493"/>
<dbReference type="BindingDB" id="P00533"/>
<dbReference type="ChEMBL" id="CHEMBL203"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05424">
<property type="generic name" value="CI-1033"/>
</dbReference>
<dbReference type="DrugBank" id="DB00530">
<property type="generic name" value="Erlotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00317">
<property type="generic name" value="Gefitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05324">
<property type="generic name" value="HuMax-EGFr"/>
</dbReference>
<dbReference type="DrugBank" id="DB11737">
<property type="generic name" value="Icotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04988">
<property type="generic name" value="IGN311"/>
</dbReference>
<dbReference type="DrugBank" id="DB05774">
<property type="generic name" value="IMC-11F8"/>
</dbReference>
<dbReference type="DrugBank" id="DB05900">
<property type="generic name" value="INSM-18"/>
</dbReference>
<dbReference type="DrugBank" id="DB01259">
<property type="generic name" value="Lapatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05101">
<property type="generic name" value="Matuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB07662">
<property type="generic name" value="N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB09559">
<property type="generic name" value="Necitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB13164">
<property type="generic name" value="Olmutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09330">
<property type="generic name" value="Osimertinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01269">
<property type="generic name" value="Panitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05374">
<property type="generic name" value="Rindopepimut"/>
</dbReference>
<dbReference type="DrugBank" id="DB07602">
<property type="generic name" value="S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1797"/>
<dbReference type="MoonDB" id="P00533">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="GlyConnect" id="137"/>
<dbReference type="iPTMnet" id="P00533"/>
<dbReference type="PhosphoSitePlus" id="P00533"/>
<dbReference type="SwissPalm" id="P00533"/>
<dbReference type="UniCarbKB" id="P00533"/>
<dbReference type="BioMuta" id="EGFR"/>
<dbReference type="DMDM" id="2811086"/>
<dbReference type="SWISS-2DPAGE" id="P00533"/>
<dbReference type="EPD" id="P00533"/>
<dbReference type="MaxQB" id="P00533"/>
<dbReference type="PaxDb" id="P00533"/>
<dbReference type="PeptideAtlas" id="P00533"/>
<dbReference type="PRIDE" id="P00533"/>
<dbReference type="ProteomicsDB" id="51261"/>
<dbReference type="ProteomicsDB" id="51262">
<molecule id="P00533-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51263">
<molecule id="P00533-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51264">
<molecule id="P00533-4"/>
</dbReference>
<dbReference type="DNASU" id="1956"/>
<dbReference type="Ensembl" id="ENST00000275493">
<molecule id="P00533-1"/>
<property type="protein sequence ID" value="ENSP00000275493"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342916">
<molecule id="P00533-4"/>
<property type="protein sequence ID" value="ENSP00000342376"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344576">
<molecule id="P00533-3"/>
<property type="protein sequence ID" value="ENSP00000345973"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420316">
<molecule id="P00533-2"/>
<property type="protein sequence ID" value="ENSP00000413843"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="GeneID" id="1956"/>
<dbReference type="KEGG" id="hsa:1956"/>
<dbReference type="UCSC" id="uc003tqh.4">
<molecule id="P00533-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1956"/>
<dbReference type="DisGeNET" id="1956"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000146648.15"/>
<dbReference type="GeneCards" id="EGFR"/>
<dbReference type="HGNC" id="HGNC:3236">
<property type="gene designation" value="EGFR"/>
</dbReference>
<dbReference type="HPA" id="CAB000035"/>
<dbReference type="HPA" id="CAB068186"/>
<dbReference type="HPA" id="CAB073534"/>
<dbReference type="HPA" id="HPA001200"/>
<dbReference type="HPA" id="HPA018530"/>
<dbReference type="MalaCards" id="EGFR"/>
<dbReference type="MIM" id="131550">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616069">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00533"/>
<dbReference type="OpenTargets" id="ENSG00000146648"/>
<dbReference type="Orphanet" id="251579">
<property type="disease" value="Giant cell glioblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="251576">
<property type="disease" value="Gliosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="294023">
<property type="disease" value="Neonatal inflammatory skin and bowel disease"/>
</dbReference>
<dbReference type="Orphanet" id="357191">
<property type="disease" value="Selection of therapeutic option in non-small cell lung carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA7360"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P00533"/>
<dbReference type="KO" id="K04361"/>
<dbReference type="OMA" id="MRRRHIV"/>
<dbReference type="OrthoDB" id="EOG091G00NO"/>
<dbReference type="PhylomeDB" id="P00533"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251932">
<property type="pathway name" value="PLCG1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-177929">
<property type="pathway name" value="Signaling by EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-179812">
<property type="pathway name" value="GRB2 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180292">
<property type="pathway name" value="GAB1 signalosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180336">
<property type="pathway name" value="SHC1 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-182971">
<property type="pathway name" value="EGFR downregulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-212718">
<property type="pathway name" value="EGFR interacts with phospholipase C-gamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2179392">
<property type="pathway name" value="EGFR Transactivation by Gastrin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5638303">
<property type="pathway name" value="Inhibition of Signaling by Overexpressed EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8857538">
<property type="pathway name" value="PTK6 promotes HIF1A stabilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013507">
<property type="pathway name" value="NOTCH3 Activation and Transmission of Signal to the Nucleus"/>
</dbReference>
<dbReference type="SignaLink" id="P00533"/>
<dbReference type="SIGNOR" id="P00533"/>
<dbReference type="ChiTaRS" id="EGFR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00533"/>
<dbReference type="GeneWiki" id="Epidermal_growth_factor_receptor"/>
<dbReference type="GenomeRNAi" id="1956"/>
<dbReference type="PMAP-CutDB" id="P00533"/>
<dbReference type="PRO" id="PR:P00533"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000146648">
<property type="expression patterns" value="Expressed in 234 organ(s), highest expression level in placenta"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P00533">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00533">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097489">
<property type="term" value="C:multivesicular body, internal vesicle lumen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070435">
<property type="term" value="C:Shc-EGFR complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048408">
<property type="term" value="F:epidermal growth factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005006">
<property type="term" value="F:epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043006">
<property type="term" value="P:activation of phospholipase A2 activity by calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007202">
<property type="term" value="P:activation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048143">
<property type="term" value="P:astrocyte activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071276">
<property type="term" value="P:cellular response to cadmium ion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071549">
<property type="term" value="P:cellular response to dexamethasone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0021795">
<property type="term" value="P:cerebral cortex cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048546">
<property type="term" value="P:digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016101">
<property type="term" value="P:diterpenoid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061029">
<property type="term" value="P:eyelid development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001942">
<property type="term" value="P:hair follicle development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042743">
<property type="term" value="P:hydrogen peroxide metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010960">
<property type="term" value="P:magnesium ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007494">
<property type="term" value="P:midgut development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060571">
<property type="term" value="P:morphogenesis of an epithelial fold"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905208">
<property type="term" value="P:negative regulation of cardiocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042059">
<property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901185">
<property type="term" value="P:negative regulation of ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045930">
<property type="term" value="P:negative regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045746">
<property type="term" value="P:negative regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048812">
<property type="term" value="P:neuron projection morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042698">
<property type="term" value="P:ovulation cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097755">
<property type="term" value="P:positive regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045780">
<property type="term" value="P:positive regulation of bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031659">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045740">
<property type="term" value="P:positive regulation of DNA replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0010750">
<property type="term" value="P:positive regulation of nitric oxide mediated signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042327">
<property type="term" value="P:positive regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902722">
<property type="term" value="P:positive regulation of prolactin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900020">
<property type="term" value="P:positive regulation of protein kinase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051205">
<property type="term" value="P:protein insertion into membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046328">
<property type="term" value="P:regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0050999">
<property type="term" value="P:regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050730">
<property type="term" value="P:regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033590">
<property type="term" value="P:response to cobalamin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033594">
<property type="term" value="P:response to hydroxyisoflavone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006970">
<property type="term" value="P:response to osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070141">
<property type="term" value="P:response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007435">
<property type="term" value="P:salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043586">
<property type="term" value="P:tongue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006412">
<property type="term" value="P:translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00064">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="88 136 144">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Epidermal growth factor receptor" id="PRO_0000016665">
<location>
<begin position="25"/>
<end position="1210"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="70">
<location>
<begin position="25"/>
<end position="645"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="70">
<location>
<begin position="646"/>
<end position="668"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="70">
<location>
<begin position="669"/>
<end position="1210"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="75"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="390"/>
<end position="600"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="71">
<location>
<begin position="712"/>
<end position="979"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="8 28 48 49 50 51 113">
<location>
<begin position="718"/>
<end position="726"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7 8 9 15 16 28 34 35 43 44 45 48 49 50 51 104 113">
<location>
<begin position="790"/>
<end position="791"/>
</location>
</feature>
<feature type="region of interest" description="Important for dimerization, phosphorylation and activation">
<location>
<begin position="688"/>
<end position="704"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="71 72">
<location>
<position position="837"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7 8 9 28 34 35 43 45 48 49 50 51 104 113">
<location>
<position position="745"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7 8 9 15 16 28 34 43 44 45 48 49 50 51 104 113">
<location>
<position position="855"/>
</location>
</feature>
<feature type="site" description="Important for interaction with PIK3C2B">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="121">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC and PKD/PRKD1" evidence="75">
<location>
<position position="678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKD/PRKD1" evidence="65 66 67 68 75 94 135">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="65 135">
<location>
<position position="695"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64 66 68 94">
<location>
<position position="991"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64">
<location>
<position position="995"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="64 113">
<location>
<position position="998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="113">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="68 94">
<location>
<position position="1026"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64">
<location>
<position position="1039"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="64">
<location>
<position position="1041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64">
<location>
<position position="1042"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64 65 66 67">
<location>
<position position="1064"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="154">
<location>
<position position="1069"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="135">
<location>
<position position="1070"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="135">
<location>
<position position="1071"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="65">
<location>
<position position="1081"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="85 132">
<location>
<position position="1092"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="85 131">
<location>
<position position="1110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="64 65 68">
<location>
<position position="1166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="63 132">
<location>
<position position="1172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="63 65 66 113 115 132">
<location>
<position position="1197"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="120">
<location>
<position position="1199"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="132">
<location>
<position position="1049"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="132">
<location>
<position position="1146"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine; atypical; partial" id="CAR_000227" evidence="1 2 29 33 76 81 82 84 94 119">
<location>
<position position="56"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; atypical" evidence="29 119">
<location>
<position position="73"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="84 94 141">
<location>
<position position="128"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 29 82 84 94 119 141">
<location>
<position position="175"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 29 81 82 84 94 119">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 5 22 23 29 30 33 39 40 41 42 46 47 76 81 82 83 84 94 109 119">
<location>
<position position="352"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 3 5 22 29 33 39 40 41 42 47 76 82 83 84 94 119">
<location>
<position position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5 22 23 30 33 41 42 84 94 109 141">
<location>
<position position="413"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 3 5 22 23 29 30 33 39 40 41 42 46 47 82 83 84 94 119 141">
<location>
<position position="444"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3 5 23 29 33 42 46 47 83 84 94 119 141">
<location>
<position position="528"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="3 5 76 83 84 94 109">
<location>
<position position="568"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="3 5 76 83 84 94">
<location>
<position position="603"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (high mannose) asparagine" evidence="153">
<location>
<position position="623"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 29 33 41 42 46 47 57 58 61 83 93 119">
<location>
<begin position="31"/>
<end position="58"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 57 58 61 81 82 83 93 119">
<location>
<begin position="157"/>
<end position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="190"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="194"/>
<end position="207"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="215"/>
<end position="223"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="219"/>
<end position="231"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 42 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="232"/>
<end position="240"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 42 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="236"/>
<end position="248"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 29 33 41 42 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 23 29 33 41 42 46 47 57 58 61 81 82 83 93 119">
<location>
<begin position="264"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 23 29 33 41 42 46 47 57 58 61">
<location>
<begin position="295"/>
<end position="307"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 23 25 26 29 33 41 42 47 57 58 61 81 82 83 93 119">
<location>
<begin position="311"/>
<end position="326"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 23 29 33 41 42 46 47 57 58 61">
<location>
<begin position="329"/>
<end position="333"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 22 23 24 29 30 33 39 40 41 42 46 47 54 55 57 58 61 62 81 82 83 93 119">
<location>
<begin position="337"/>
<end position="362"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 22 23 24 29 30 33 39 40 41 42 46 47 54 55 57 58 61 62">
<location>
<begin position="470"/>
<end position="499"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 22 23 29 30 33 39 40 41 42 46 47 54 55 57 58 61 62 81 82 83 93 119">
<location>
<begin position="506"/>
<end position="515"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 22 23 24 29 30 33 39 40 41 42 46 47 54 55 57 58 61 62 81 82 83 93 119">
<location>
<begin position="510"/>
<end position="523"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 3 5 23 29 33 39 40 41 42 46 47 61 82 83 93 119">
<location>
<begin position="526"/>
<end position="535"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 46 47 61 83 93 119">
<location>
<begin position="539"/>
<end position="555"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 46 47 61 83 93 119">
<location>
<begin position="558"/>
<end position="571"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 46 47 61 83 93 119">
<location>
<begin position="562"/>
<end position="579"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 47 61 83 93 119">
<location>
<begin position="582"/>
<end position="591"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 46 47 61 83 93 119">
<location>
<begin position="595"/>
<end position="617"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 41 42 46 47 61 83 93 119">
<location>
<begin position="620"/>
<end position="628"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 23 29 33 42 47 61 83 93 119">
<location>
<begin position="624"/>
<end position="636"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="716"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="737"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="754"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="867"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="929"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="99">
<location>
<position position="970"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002887" evidence="148 149 150 151">
<original>FL</original>
<variation>LS</variation>
<location>
<begin position="404"/>
<end position="405"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002888" evidence="148 149 150 151">
<location>
<begin position="406"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002889" evidence="147">
<original>CTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLR</original>
<variation>PGNESLKAMLFCLFKLSSCNQSNDGSVSHQSGSPAAQESCLGWIPSLLPSEFQLGWGGCSHLHAWPSASVIITASSCH</variation>
<location>
<begin position="628"/>
<end position="705"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002891" evidence="147">
<original>C</original>
<variation>S</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002892" evidence="147">
<location>
<begin position="629"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002890" evidence="147">
<location>
<begin position="706"/>
<end position="1210"/>
</location>
</feature>
<feature type="sequence variant" description="Variant EGFR vIII; found in a lung cancer sample; somatic mutation; induces lung cancer when exogenously expressed." id="VAR_066493" evidence="100">
<location>
<begin position="30"/>
<end position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17289589." id="VAR_019293" evidence="145">
<original>R</original>
<variation>Q</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17336639." id="VAR_019294" evidence="145">
<original>P</original>
<variation>R</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253." id="VAR_072435" evidence="129">
<original>G</original>
<variation>D</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227983." id="VAR_019295" evidence="103 145">
<original>R</original>
<variation>K</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337079." id="VAR_019296" evidence="145">
<original>V</original>
<variation>I</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_026084" evidence="92 96 98">
<original>E</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_069498" evidence="92 96">
<original>E</original>
<variation>G</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs727504256." id="VAR_026085" evidence="98">
<original>E</original>
<variation>K</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026086" evidence="98">
<original>G</original>
<variation>A</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs28929495." id="VAR_026087" evidence="92 98">
<original>G</original>
<variation>C</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026088" evidence="98">
<original>G</original>
<variation>D</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495." id="VAR_019297" evidence="86 92 96 98 104">
<original>G</original>
<variation>S</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs1051753269." id="VAR_026089" evidence="98">
<original>G</original>
<variation>S</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913420." id="VAR_026090" evidence="98">
<original>E</original>
<variation>K</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069499" evidence="92">
<original>ELREATS</original>
<variation>D</variation>
<location>
<begin position="746"/>
<end position="752"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069500" evidence="92">
<original>ELREAT</original>
<variation>A</variation>
<location>
<begin position="746"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026092" evidence="92">
<location>
<begin position="746"/>
<end position="750"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026091" evidence="98">
<location>
<position position="746"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069501" evidence="92">
<location>
<begin position="747"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026094" evidence="98">
<location>
<begin position="747"/>
<end position="749"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026093" evidence="98">
<original>L</original>
<variation>F</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026095" evidence="98">
<original>R</original>
<variation>P</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026096" evidence="98">
<location>
<begin position="752"/>
<end position="759"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465." id="VAR_069502" evidence="92 96">
<original>S</original>
<variation>I</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs147149347." id="VAR_069503" evidence="92">
<original>V</original>
<variation>M</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026097" evidence="98">
<original>Q</original>
<variation>R</variation>
<location>
<position position="787"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569." id="VAR_026098" evidence="98 107">
<original>T</original>
<variation>M</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517126." id="VAR_026099" evidence="92 96 98">
<original>L</original>
<variation>V</variation>
<location>
<position position="833"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs397517127." id="VAR_026100" evidence="98">
<original>V</original>
<variation>L</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517128." id="VAR_069504" evidence="92 96">
<original>H</original>
<variation>L</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs864621996." id="VAR_069505" evidence="92 96">
<original>L</original>
<variation>V</variation>
<location>
<position position="838"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913443." id="VAR_026101" evidence="98">
<original>L</original>
<variation>M</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568." id="VAR_019298" evidence="86 92 96 98 104">
<original>L</original>
<variation>R</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444." id="VAR_026102" evidence="92 96 98">
<original>L</original>
<variation>Q</variation>
<location>
<position position="861"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026103" evidence="98">
<original>G</original>
<variation>E</variation>
<location>
<position position="873"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337451." id="VAR_019299" evidence="145">
<original>R</original>
<variation>G</variation>
<location>
<position position="962"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17290699." id="VAR_019300" evidence="145">
<original>H</original>
<variation>P</variation>
<location>
<position position="988"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34352568." id="VAR_042095" evidence="103">
<original>L</original>
<variation>R</variation>
<location>
<position position="1034"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35918369." id="VAR_042096" evidence="103">
<original>A</original>
<variation>V</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="82">
<original>Y</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="82">
<original>F</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-287." evidence="82">
<original>R</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation and activation of downstream kinases." evidence="82">
<original>R</original>
<variation>E</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="83">
<original>DGPH</original>
<variation>AGPA</variation>
<location>
<begin position="587"/>
<end position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="83">
<original>K</original>
<variation>A</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="112 113">
<original>L</original>
<variation>A</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced autophosphorylation." evidence="112">
<original>V</original>
<variation>A</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="112">
<original>V</original>
<variation>M</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="112 113">
<original>E</original>
<variation>A</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="112 113">
<original>L</original>
<variation>A</variation>
<variation>P</variation>
<location>
<position position="692"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased phosphorylation." evidence="112">
<original>T</original>
<variation>A</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="112">
<original>T</original>
<variation>D</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="112">
<original>P</original>
<variation>A</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="112">
<original>P</original>
<variation>A</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="112">
<original>N</original>
<variation>A</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="112">
<original>L</original>
<variation>A</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="112">
<original>R</original>
<variation>A</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="112">
<original>I</original>
<variation>A</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="112">
<original>K</original>
<variation>A</variation>
<variation>M</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation.">
<original>D</original>
<variation>A</variation>
<location>
<position position="974"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="113">
<original>R</original>
<variation>A</variation>
<location>
<position position="977"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="113">
<original>ED</original>
<variation>RK</variation>
<location>
<begin position="1005"/>
<end position="1006"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% decrease in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1197. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1092." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1016"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes palmitoylation." evidence="132">
<location>
<begin position="1048"/>
<end position="1210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased palmitoylation." evidence="132">
<original>C</original>
<variation>A</variation>
<location>
<position position="1049"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CBLC." evidence="126">
<original>Q</original>
<variation>G</variation>
<location>
<position position="1067"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with CBLC." evidence="126">
<original>R</original>
<variation>G</variation>
<location>
<position position="1068"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBLC." evidence="126">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1069"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1016." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1092"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased palmitoylation." evidence="132">
<original>C</original>
<variation>A</variation>
<location>
<position position="1146"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1016. Abolishes interaction with PIK3C2B; when associated with F-1092 and F-1016." evidence="77">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1197"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA25240." ref="1" evidence="152">
<original>N</original>
<variation>K</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="strand" evidence="33">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="44"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="60"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="89"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="125"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="145"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="61">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="211"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="61">
<location>
<begin position="217"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="223"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="248"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="259"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="turn" evidence="47">
<location>
<begin position="272"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="turn" evidence="23">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="57">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="42">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="23">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="turn" evidence="33">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="turn" evidence="30">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="356"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="363"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="373"/>
<end position="377"/>
</location>
</feature>
<feature type="turn" evidence="30">
<location>
<begin position="380"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="389"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="400"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="405"/>
<end position="407"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="turn" evidence="30">
<location>
<begin position="433"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="458"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="477"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="488"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="496"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="54">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="515"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="30">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="30">
<location>
<begin position="523"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="39">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="540"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="strand" evidence="41">
<location>
<begin position="560"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="566"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="570"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="578"/>
<end position="587"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="590"/>
<end position="594"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="597"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="606"/>
<end position="611"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="615"/>
<end position="619"/>
</location>
</feature>
<feature type="strand" evidence="47">
<location>
<begin position="629"/>
<end position="632"/>
</location>
</feature>
<feature type="helix" evidence="47">
<location>
<begin position="633"/>
<end position="635"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="643"/>
<end position="646"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="648"/>
<end position="669"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="671"/>
<end position="673"/>
</location>
</feature>
<feature type="helix" evidence="27">
<location>
<begin position="679"/>
<end position="684"/>
</location>
</feature>
<feature type="helix" evidence="27">
<location>
<begin position="685"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="688"/>
<end position="692"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="694"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="32">
<location>
<begin position="703"/>
<end position="706"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="709"/>
<end position="711"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="712"/>
<end position="721"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="724"/>
<end position="731"/>
</location>
</feature>
<feature type="turn" evidence="56">
<location>
<begin position="734"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="740"/>
<end position="747"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="turn" evidence="36">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="756"/>
<end position="767"/>
</location>
</feature>
<feature type="strand" evidence="38">
<location>
<begin position="772"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="777"/>
<end position="791"/>
</location>
</feature>
<feature type="strand" evidence="37">
<location>
<begin position="794"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="798"/>
<end position="804"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="806"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="811"/>
<end position="830"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="840"/>
<end position="842"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="843"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="850"/>
<end position="853"/>
</location>
</feature>
<feature type="helix" evidence="32">
<location>
<begin position="858"/>
<end position="862"/>
</location>
</feature>
<feature type="turn" evidence="32">
<location>
<begin position="863"/>
<end position="865"/>
</location>
</feature>
<feature type="strand" evidence="56">
<location>
<begin position="867"/>
<end position="870"/>
</location>
</feature>
<feature type="strand" evidence="59">
<location>
<begin position="871"/>
<end position="875"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="878"/>
<end position="880"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="883"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="893"/>
<end position="908"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="909"/>
<end position="911"/>
</location>
</feature>
<feature type="turn" evidence="56">
<location>
<begin position="914"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="920"/>
<end position="922"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="923"/>
<end position="928"/>
</location>
</feature>
<feature type="strand" evidence="60">
<location>
<begin position="937"/>
<end position="939"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="941"/>
<end position="950"/>
</location>
</feature>
<feature type="strand" evidence="53">
<location>
<begin position="951"/>
<end position="953"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="955"/>
<end position="957"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="961"/>
<end position="972"/>
</location>
</feature>
<feature type="helix" evidence="56">
<location>
<begin position="975"/>
<end position="977"/>
</location>
</feature>
<feature type="helix" evidence="52">
<location>
<begin position="984"/>
<end position="986"/>
</location>
</feature>
<feature type="turn" evidence="52">
<location>
<begin position="992"/>
<end position="998"/>
</location>
</feature>
<feature type="strand" evidence="36">
<location>
<begin position="1004"/>
<end position="1010"/>
</location>
</feature>
<feature type="helix" evidence="32">
<location>
<begin position="1013"/>
<end position="1016"/>
</location>
</feature>
<feature type="strand" evidence="31">
<location>
<begin position="1068"/>
<end position="1070"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IVO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MOX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NQL"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1XKK"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YY9"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1Z9I"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2EB3"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GS7"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITN"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITO"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITP"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITQ"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITT"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITU"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITV"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITX"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J6M"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JIT"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JIU"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JIV"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KS1"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B2U"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B2V"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3C09"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G5V"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G5Y"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GOP"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GT8"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3NJP"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P0Y"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PFV"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3POZ"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QWQ"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VJN"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VJO"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3W2S"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4G5P"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I21"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRL"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRM"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRO"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRP"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RIW"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RIX"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RIY"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UIP"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UV7"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ZSE"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CNN"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CNO"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5D41"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HG8"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEB"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SX4"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SX5"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UG9"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WB7"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WB8"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5X2A"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5X2K"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5XWD"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6B3S"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01279"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000255"/>
<evidence key="71" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10026169"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10228163"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10523301"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10731668"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11116146"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483589"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11602604"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297049"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297050"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12620237"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12873986"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15118125"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15282549"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15374980"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590694"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15611079"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15623594"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837620"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16083266"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16140940"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16205628"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16420529"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16533793"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16543144"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16672372"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17115032"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17182860"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17349580"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17671655"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18046415"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18227510"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18602463"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19172738"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509291"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19560417"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19563760"/>
</source>
</evidence>
<evidence key="114" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19749156"/>
</source>
</evidence>
<evidence key="115" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19836242"/>
</source>
</evidence>
<evidence key="116" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20471394"/>
</source>
</evidence>
<evidence key="117" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20551055"/>
</source>
</evidence>
<evidence key="118" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20674546"/>
</source>
</evidence>
<evidence key="119" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20837704"/>
</source>
</evidence>
<evidence key="120" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21258366"/>
</source>
</evidence>
<evidence key="121" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21487020"/>
</source>
</evidence>
<evidence key="122" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21516087"/>
</source>
</evidence>
<evidence key="123" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21518868"/>
</source>
</evidence>
<evidence key="124" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22179831"/>
</source>
</evidence>
<evidence key="125" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22298428"/>
</source>
</evidence>
<evidence key="126" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<evidence key="127" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23418353"/>
</source>
</evidence>
<evidence key="128" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23912460"/>
</source>
</evidence>
<evidence key="129" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24691054"/>
</source>
</evidence>
<evidence key="130" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25311788"/>
</source>
</evidence>
<evidence key="131" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2543678"/>
</source>
</evidence>
<evidence key="132" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27153536"/>
</source>
</evidence>
<evidence key="133" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2790960"/>
</source>
</evidence>
<evidence key="134" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28479384"/>
</source>
</evidence>
<evidence key="135" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3138233"/>
</source>
</evidence>
<evidence key="136" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6328312"/>
</source>
</evidence>
<evidence key="137" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7657591"/>
</source>
</evidence>
<evidence key="138" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7679104"/>
</source>
</evidence>
<evidence key="139" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8144591"/>
</source>
</evidence>
<evidence key="140" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8650580"/>
</source>
</evidence>
<evidence key="141" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8962717"/>
</source>
</evidence>
<evidence key="142" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9419975"/>
</source>
</evidence>
<evidence key="143" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9852145"/>
</source>
</evidence>
<evidence key="144" type="ECO:0000269">
<source ref="16"/>
</evidence>
<evidence key="145" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="146" type="ECO:0000269">
<source ref="95"/>
</evidence>
<evidence key="147" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11161793"/>
</source>
</evidence>
<evidence key="148" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7654368"/>
</source>
</evidence>
<evidence key="149" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8918811"/>
</source>
</evidence>
<evidence key="150" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9103388"/>
</source>
</evidence>
<evidence key="151" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="152" type="ECO:0000305"/>
<evidence key="153" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="154" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<sequence length="1210" mass="134277" checksum="D8A2A50B4EFB6ED2" modified="1997-11-01" version="2" precursor="true">
MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEV
VLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALA
VLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDF
QNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGC
TGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYV
VTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFK
NCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAF
ENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKL
FGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCN
LLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVM
GENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVV
ALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGS
GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI
CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA
RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY
GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK
FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ
QGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTED
SIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLN
TVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRV
APQSSEFIGA
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2018-10-10" version="239">
<accession>P04626</accession>
<accession>B2RZG3</accession>
<accession>B4DHN3</accession>
<accession>Q14256</accession>
<accession>Q6LDV1</accession>
<accession>Q9UMK4</accession>
<accession>X5D2V5</accession>
<name>ERBB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor tyrosine-protein kinase erbB-2</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Metastatic lymph node gene 19 protein</fullName>
<shortName>MLN 19</shortName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene Neu</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-ErbB-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase-type cell surface receptor HER2</fullName>
</alternativeName>
<alternativeName>
<fullName>p185erbB2</fullName>
</alternativeName>
<cdAntigenName>CD340</cdAntigenName>
</protein>
<gene>
<name type="primary">ERBB2</name>
<name type="synonym">HER2</name>
<name type="synonym">MLN19</name>
<name type="synonym">NEU</name>
<name type="synonym">NGL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nature" volume="319" first="230" last="234">
<title>Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.</title>
<authorList>
<person name="Yamamoto T."/>
<person name="Ikawa S."/>
<person name="Akiyama T."/>
<person name="Semba K."/>
<person name="Nomura N."/>
<person name="Miyajima N."/>
<person name="Saito T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="3003577"/>
<dbReference type="DOI" id="10.1038/319230a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1985" name="Science" volume="230" first="1132" last="1139">
<title>Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.</title>
<authorList>
<person name="Coussens L."/>
<person name="Yang-Feng T.L."/>
<person name="Liao Y.C."/>
<person name="Chen E."/>
<person name="Gray A."/>
<person name="McGrath J."/>
<person name="Seeburg P.H."/>
<person name="Libermann T.A."/>
<person name="Schlessinger J."/>
<person name="Francke U."/>
<person name="Levinson A."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="2999974"/>
<dbReference type="DOI" id="10.1126/science.2999974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-1170</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CYS-452; VAL-655 AND ALA-1170</scope>
</reference>
<reference key="4">
<citation type="submission" date="2007-10" db="EMBL/GenBank/DDBJ databases">
<title>NEDO human cDNA sequencing project focused on splicing variants.</title>
<authorList>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Ishii S."/>
<person name="Watanabe K."/>
<person name="Sugiyama A."/>
<person name="Murakawa K."/>
<person name="Kaida T."/>
<person name="Tsuchiya K."/>
<person name="Fukuzumi Y."/>
<person name="Kumagai A."/>
<person name="Oishi Y."/>
<person name="Yamamoto S."/>
<person name="Ono Y."/>
<person name="Komori Y."/>
<person name="Yamazaki M."/>
<person name="Kisu Y."/>
<person name="Nishikawa T."/>
<person name="Sugano S."/>
<person name="Nomura N."/>
<person name="Isogai T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="2597" last="2601">
<title>Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.</title>
<authorList>
<person name="Tal M."/>
<person name="King C.R."/>
<person name="Kraus M.H."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
<person name="Givol D."/>
</authorList>
<dbReference type="PubMed" id="3039351"/>
<dbReference type="DOI" id="10.1128/MCB.7.7.2597"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-191 (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="3650" last="3650">
<title>Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.</title>
<authorList>
<person name="Corominas R."/>
<person name="Yang X."/>
<person name="Lin G.N."/>
<person name="Kang S."/>
<person name="Shen Y."/>
<person name="Ghamsari L."/>
<person name="Broly M."/>
<person name="Rodriguez M."/>
<person name="Tam S."/>
<person name="Wanamaker S.A."/>
<person name="Fan C."/>
<person name="Yi S."/>
<person name="Tasan M."/>
<person name="Lemmens I."/>
<person name="Kuang X."/>
<person name="Zhao N."/>
<person name="Malhotra D."/>
<person name="Michaelson J.J."/>
<person name="Vacic V."/>
<person name="Calderwood M.A."/>
<person name="Roth F.P."/>
<person name="Tavernier J."/>
<person name="Horvath S."/>
<person name="Salehi-Ashtiani K."/>
<person name="Korkin D."/>
<person name="Sebat J."/>
<person name="Hill D.E."/>
<person name="Hao T."/>
<person name="Vidal M."/>
<person name="Iakoucheva L.M."/>
</authorList>
<dbReference type="PubMed" id="24722188"/>
<dbReference type="DOI" id="10.1038/ncomms4650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-867 (ISOFORM 6)</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="6497" last="6501">
<title>A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.</title>
<authorList>
<person name="Semba K."/>
<person name="Kamata N."/>
<person name="Toyoshima K."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="2995967"/>
<dbReference type="DOI" id="10.1073/pnas.82.19.6497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 737-1031</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1985" name="Science" volume="229" first="974" last="976">
<title>Amplification of a novel v-erbB-related gene in a human mammary carcinoma.</title>
<authorList>
<person name="King C.R."/>
<person name="Kraus M.H."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="2992089"/>
<dbReference type="DOI" id="10.1126/science.2992089"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 832-909</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="DNA Cell Biol." volume="12" first="611" last="615">
<title>Molecular cloning and sequencing of an intron of Her-2/neu (ERBB2) gene.</title>
<authorList>
<person name="Sarkar F.H."/>
<person name="Ball D.E."/>
<person name="Li Y.W."/>
<person name="Crissman J.D."/>
</authorList>
<dbReference type="PubMed" id="8104414"/>
<dbReference type="DOI" id="10.1089/dna.1993.12.611"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1081-1245</scope>
<scope>VARIANT ALA-1170</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17209" last="17218">
<title>ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.</title>
<authorList>
<person name="Olayioye M.A."/>
<person name="Beuvink I."/>
<person name="Horsch K."/>
<person name="Daly J.M."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="10358079"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17209"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
<scope>FUNCTION IN ACTIVATION OF STAT5A</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2A AND EGFR</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND EGFR</scope>
<scope>INTERACTION WITH PIK3C2B</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Cancer Cell" volume="6" first="251" last="261">
<title>Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.</title>
<authorList>
<person name="Wang S.C."/>
<person name="Lien H.C."/>
<person name="Xia W."/>
<person name="Chen I.F."/>
<person name="Lo H.W."/>
<person name="Wang Z."/>
<person name="Ali-Seyed M."/>
<person name="Lee D.F."/>
<person name="Bartholomeusz G."/>
<person name="Ou-Yang F."/>
<person name="Giri D.K."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="15380516"/>
<dbReference type="DOI" id="10.1016/j.ccr.2004.07.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="869" last="880">
<title>Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.</title>
<authorList>
<person name="Swiercz J.M."/>
<person name="Kuner R."/>
<person name="Offermanns S."/>
</authorList>
<dbReference type="PubMed" id="15210733"/>
<dbReference type="DOI" id="10.1083/jcb.200312094"/>
</citation>
<scope>INTERACTION WITH PLXNB1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="515" last="522">
<title>Memo mediates ErbB2-driven cell motility.</title>
<authorList>
<person name="Marone R."/>
<person name="Hess D."/>
<person name="Dankort D."/>
<person name="Muller W.J."/>
<person name="Hynes N.E."/>
<person name="Badache A."/>
</authorList>
<dbReference type="PubMed" id="15156151"/>
<dbReference type="DOI" id="10.1038/ncb1134"/>
</citation>
<scope>INTERACTION WITH MEMO1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="11005" last="11018">
<title>Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor.</title>
<authorList>
<person name="Giri D.K."/>
<person name="Ali-Seyed M."/>
<person name="Li L.Y."/>
<person name="Lee D.F."/>
<person name="Ling P."/>
<person name="Bartholomeusz G."/>
<person name="Wang S.C."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="16314522"/>
<dbReference type="DOI" id="10.1128/MCB.25.24.11005-11018.2005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>INTERACTION WITH KPNB1; RANBP2; CRM1; EEA1 AND CLTC</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1248</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3234" last="3244">
<title>Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.</title>
<authorList>
<person name="Anido J."/>
<person name="Scaltriti M."/>
<person name="Bech Serra J.J."/>
<person name="Santiago Josefat B."/>
<person name="Todo F.R."/>
<person name="Baselga J."/>
<person name="Arribas J."/>
</authorList>
<dbReference type="PubMed" id="16794579"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601191"/>
</citation>
<scope>FUNCTION</scope>
<scope>ALTERNATIVE INITIATION (ISOFORMS 2 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF MET-611; MET-687; MET-706 AND MET-712</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Cell. Signal." volume="19" first="466" last="471">
<title>Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.</title>
<authorList>
<person name="Li Z."/>
<person name="Mei Y."/>
<person name="Liu X."/>
<person name="Zhou M."/>
</authorList>
<dbReference type="PubMed" id="16978839"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.07.020"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
<scope>AUTOPHOSPHORYLATION IN TRANS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="J. Neurosci." volume="27" first="6333" last="6347">
<title>Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo.</title>
<authorList>
<person name="Deng S."/>
<person name="Hirschberg A."/>
<person name="Worzfeld T."/>
<person name="Penachioni J.Y."/>
<person name="Korostylev A."/>
<person name="Swiercz J.M."/>
<person name="Vodrazka P."/>
<person name="Mauti O."/>
<person name="Stoeckli E.T."/>
<person name="Tamagnone L."/>
<person name="Offermanns S."/>
<person name="Kuner R."/>
</authorList>
<dbReference type="PubMed" id="17554007"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.5381-06.2007"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1248</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="12463" last="12468">
<title>Brk is coamplified with ErbB2 to promote proliferation in breast cancer.</title>
<authorList>
<person name="Xiang B."/>
<person name="Chatti K."/>
<person name="Qiu H."/>
<person name="Lakshmi B."/>
<person name="Krasnitz A."/>
<person name="Hicks J."/>
<person name="Yu M."/>
<person name="Miller W.T."/>
<person name="Muthuswamy S.K."/>
</authorList>
<dbReference type="PubMed" id="18719096"/>
<dbReference type="DOI" id="10.1073/pnas.0805009105"/>
</citation>
<scope>INTERACTION WITH PTK6</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cancer Res." volume="7" first="592" last="600">
<title>ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.</title>
<authorList>
<person name="Hawthorne V.S."/>
<person name="Huang W.C."/>
<person name="Neal C.L."/>
<person name="Tseng L.M."/>
<person name="Hung M.C."/>
<person name="Yu D."/>
</authorList>
<dbReference type="PubMed" id="19372587"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-08-0316"/>
</citation>
<scope>FUNCTION IN NUCLEUS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="1598" last="1610">
<title>Copine-III interacts with ErbB2 and promotes tumor cell migration.</title>
<authorList>
<person name="Heinrich C."/>
<person name="Keller C."/>
<person name="Boulay A."/>
<person name="Vecchi M."/>
<person name="Bianchi M."/>
<person name="Sack R."/>
<person name="Lienhard S."/>
<person name="Duss S."/>
<person name="Hofsteenge J."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="20010870"/>
<dbReference type="DOI" id="10.1038/onc.2009.456"/>
</citation>
<scope>INTERACTION WITH CPNE3</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="18517" last="18522">
<title>ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells.</title>
<authorList>
<person name="Zaoui K."/>
<person name="Benseddik K."/>
<person name="Daou P."/>
<person name="Salaun D."/>
<person name="Badache A."/>
</authorList>
<dbReference type="PubMed" id="20937854"/>
<dbReference type="DOI" id="10.1073/pnas.1000975107"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1107</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="29" last="39">
<title>Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.</title>
<authorList>
<person name="Zang Z.J."/>
<person name="Ong C.K."/>
<person name="Cutcutache I."/>
<person name="Yu W."/>
<person name="Zhang S.L."/>
<person name="Huang D."/>
<person name="Ler L.D."/>
<person name="Dykema K."/>
<person name="Gan A."/>
<person name="Tao J."/>
<person name="Lim S."/>
<person name="Liu Y."/>
<person name="Futreal P.A."/>
<person name="Grabsch H."/>
<person name="Furge K.A."/>
<person name="Goh L.K."/>
<person name="Rozen S."/>
<person name="Teh B.T."/>
<person name="Tan P."/>
</authorList>
<dbReference type="PubMed" id="21097718"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-1749"/>
</citation>
<scope>CHROMOSOMAL REARRANGEMENT WITH CDK12</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="4269" last="4279">
<title>Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes.</title>
<authorList>
<person name="Li L.Y."/>
<person name="Chen H."/>
<person name="Hsieh Y.H."/>
<person name="Wang Y.N."/>
<person name="Chu H.J."/>
<person name="Chen Y.H."/>
<person name="Chen H.Y."/>
<person name="Chien P.J."/>
<person name="Ma H.T."/>
<person name="Tsai H.C."/>
<person name="Lai C.C."/>
<person name="Sher Y.P."/>
<person name="Lien H.C."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21555369"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-3504"/>
</citation>
<scope>FUNCTION IN NUCLEUS</scope>
<scope>INTERACTION WITH ACTB AND RPA194</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Endocrinology" volume="152" first="931" last="945">
<title>Dissociation of epidermal growth factor receptor and ErbB2 heterodimers in the presence of somatostatin receptor 5 modulate signaling pathways.</title>
<authorList>
<person name="Kharmate G."/>
<person name="Rajput P.S."/>
<person name="Watt H.L."/>
<person name="Somvanshi R.K."/>
<person name="Chaudhari N."/>
<person name="Qiu X."/>
<person name="Kumar U."/>
</authorList>
<dbReference type="PubMed" id="21190959"/>
<dbReference type="DOI" id="10.1210/en.2010-0940"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-182; SER-1054; SER-1083 AND THR-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054 AND SER-1151</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0141786" last="E0141786">
<title>Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants.</title>
<authorList>
<person name="Prince T.L."/>
<person name="Kijima T."/>
<person name="Tatokoro M."/>
<person name="Lee S."/>
<person name="Tsutsumi S."/>
<person name="Yim K."/>
<person name="Rivas C."/>
<person name="Alarcon S."/>
<person name="Schwartz H."/>
<person name="Khamit-Kush K."/>
<person name="Scroggins B.T."/>
<person name="Beebe K."/>
<person name="Trepel J.B."/>
<person name="Neckers L."/>
</authorList>
<dbReference type="PubMed" id="26517842"/>
<dbReference type="DOI" id="10.1371/journal.pone.0141786"/>
</citation>
<scope>INTERACTION WITH HSP90AA1 AND HSP90AB1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2016" name="Cell Rep." volume="15" first="1345" last="1358">
<title>Crystal structure and substrate specificity of PTPN12.</title>
<authorList>
<person name="Li H."/>
<person name="Yang F."/>
<person name="Liu C."/>
<person name="Xiao P."/>
<person name="Xu Y."/>
<person name="Liang Z."/>
<person name="Liu C."/>
<person name="Wang H."/>
<person name="Wang W."/>
<person name="Zheng W."/>
<person name="Zhang W."/>
<person name="Ma X."/>
<person name="He D."/>
<person name="Song X."/>
<person name="Cui F."/>
<person name="Xu Z."/>
<person name="Yi F."/>
<person name="Sun J.P."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="27134172"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.04.016"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1112; TYR-1139; TYR-1196 AND TYR-1248</scope>
<scope>DEPHOSPHORYLATION BY PTPN12</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="36422" last="36427">
<title>Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide.</title>
<authorList>
<person name="Kuhns J.J."/>
<person name="Batalia M.A."/>
<person name="Yan S."/>
<person name="Collins E.J."/>
</authorList>
<dbReference type="PubMed" id="10593938"/>
<dbReference type="DOI" id="10.1074/jbc.274.51.36422"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 654-662 IN COMPLEX WITH HLA AND BETA-2 MICROGLOBULIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="1399" last="1402">
<title>Novel mode of ligand recognition by the Erbin PDZ domain.</title>
<authorList>
<person name="Birrane G."/>
<person name="Chung J."/>
<person name="Ladias J.A."/>
</authorList>
<dbReference type="PubMed" id="12444095"/>
<dbReference type="DOI" id="10.1074/jbc.C200571200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1247-1255 IN COMPLEX WITH ERBIN</scope>
<scope>INTERACTION WITH ERBIN</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="J. Biomol. NMR" volume="27" first="205" last="219">
<title>Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.</title>
<authorList>
<person name="Ivancic M."/>
<person name="Daly R.J."/>
<person name="Lyons B.A."/>
</authorList>
<dbReference type="PubMed" id="12975581"/>
<dbReference type="DOI" id="10.1023/A:1025498409113"/>
</citation>
<scope>STRUCTURE BY NMR OF 1135-1144 IN COMPLEX WITH GRB7</scope>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2003" name="Nature" volume="421" first="756" last="760">
<title>Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.</title>
<authorList>
<person name="Cho H.-S."/>
<person name="Mason K."/>
<person name="Ramyar K.X."/>
<person name="Stanley A.M."/>
<person name="Gabelli S.B."/>
<person name="Denney D.W. Jr."/>
<person name="Leahy D.J."/>
</authorList>
<dbReference type="PubMed" id="12610629"/>
<dbReference type="DOI" id="10.1038/nature01392"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 23-629 IN COMPLEX WITH THE ANTIBODY HERCEPTIN</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2004" name="Cancer Cell" volume="5" first="317" last="328">
<title>Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.</title>
<authorList>
<person name="Franklin M.C."/>
<person name="Carey K.D."/>
<person name="Vajdos F.F."/>
<person name="Leahy D.J."/>
<person name="de Vos A.M."/>
<person name="Sliwkowski M.X."/>
</authorList>
<dbReference type="PubMed" id="15093539"/>
<dbReference type="DOI" id="10.1016/S1535-6108(04)00083-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 23-646 IN COMPLEX WITH THE ANTIBODY PERTUZUMAB</scope>
<scope>INTERACTION WITH ERBB3</scope>
<scope>MUTAGENESIS OF 317-LEU-HIS-318</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-187; ASN-259 AND ASN-530</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Science" volume="323" first="1610" last="1614">
<title>Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site.</title>
<authorList>
<person name="Bostrom J."/>
<person name="Yu S.F."/>
<person name="Kan D."/>
<person name="Appleton B.A."/>
<person name="Lee C.V."/>
<person name="Billeci K."/>
<person name="Man W."/>
<person name="Peale F."/>
<person name="Ross S."/>
<person name="Wiesmann C."/>
<person name="Fuh G."/>
</authorList>
<dbReference type="PubMed" id="19299620"/>
<dbReference type="DOI" id="10.1126/science.1165480"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 23-646 IN COMPLEX WITH THE ANTIBODY HERCEPTIN</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-259 AND ASN-530</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="15039" last="15044">
<title>Structural basis for high-affinity HER2 receptor binding by an engineered protein.</title>
<authorList>
<person name="Eigenbrot C."/>
<person name="Ultsch M."/>
<person name="Dubnovitsky A."/>
<person name="Abrahmsen L."/>
<person name="Hard T."/>
</authorList>
<dbReference type="PubMed" id="20696930"/>
<dbReference type="DOI" id="10.1073/pnas.1005025107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 23-646 IN COMPLEX WITH ENGINEERED ANTIBODY ZHER2</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-68; ASN-259 AND ASN-571</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="18756" last="18765">
<title>Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.</title>
<authorList>
<person name="Aertgeerts K."/>
<person name="Skene R."/>
<person name="Yano J."/>
<person name="Sang B.C."/>
<person name="Zou H."/>
<person name="Snell G."/>
<person name="Jennings A."/>
<person name="Iwamoto K."/>
<person name="Habuka N."/>
<person name="Hirokawa A."/>
<person name="Ishikawa T."/>
<person name="Tanaka T."/>
<person name="Miki H."/>
<person name="Ohta Y."/>
<person name="Sogabe S."/>
</authorList>
<dbReference type="PubMed" id="21454582"/>
<dbReference type="DOI" id="10.1074/jbc.M110.206193"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 703-1029 IN COMPLEX WITH INHIBITOR SYR127063</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1993" name="Genomics" volume="15" first="426" last="429">
<title>Characterization of a new allele of the human ERBB2 gene by allele-specific competition hybridization.</title>
<authorList>
<person name="Ehsani A."/>
<person name="Low J."/>
<person name="Wallace R.B."/>
<person name="Wu A.M."/>
</authorList>
<dbReference type="PubMed" id="8095488"/>
<dbReference type="DOI" id="10.1006/geno.1993.1081"/>
</citation>
<scope>VARIANTS VAL-654 AND VAL-655</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2004" name="Nature" volume="431" first="525" last="526">
<title>Lung cancer: intragenic ERBB2 kinase mutations in tumours.</title>
<authorList>
<consortium name="Cancer genome project and collaborative group"/>
<person name="Stephens P."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Edkins S."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Stevens C."/>
<person name="O'Meara S."/>
<person name="Smith R."/>
<person name="Parker A."/>
<person name="Barthorpe A."/>
<person name="Blow M."/>
<person name="Brackenbury L."/>
<person name="Butler A."/>
<person name="Clarke O."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Dike A."/>
<person name="Drozd A."/>
<person name="Edwards K."/>
<person name="Forbes S."/>
<person name="Foster R."/>
<person name="Gray K."/>
<person name="Greenman C."/>
<person name="Halliday K."/>
<person name="Hills K."/>
<person name="Kosmidou V."/>
<person name="Lugg R."/>
<person name="Menzies A."/>
<person name="Perry J."/>
<person name="Petty R."/>
<person name="Raine K."/>
<person name="Ratford L."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Stephens Y."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Brasseur F."/>
<person name="Cooper C.S."/>
<person name="Flanagan A.M."/>
<person name="Knowles M."/>
<person name="Leung S.Y."/>
<person name="Louis D.N."/>
<person name="Looijenga L.H."/>
<person name="Malkowicz B."/>
<person name="Pierotti M.A."/>
<person name="Teh B."/>
<person name="Chenevix-Trench G."/>
<person name="Weber B.L."/>
<person name="Yuen S.T."/>
<person name="Harris G."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Futreal P.A."/>
<person name="Wooster R."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="15457249"/>
<dbReference type="DOI" id="10.1038/431525b"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
<scope>VARIANT GASC SER-776</scope>
<scope>VARIANT OC SER-857</scope>
<scope>VARIANT GLM LYS-914</scope>
<scope>VARIANTS LNCR PRO-755; ALA-TYR-VAL-MET-774 INS AND VAL-GLY-SER-779 INS</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-654; VAL-655; SER-768; ALA-1170 AND ASP-1216</scope>
<scope>VARIANT GASC SER-776</scope>
<scope>VARIANT OC SER-857</scope>
</reference>
<comment type="function">
<text evidence="60">Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.</text>
</comment>
<comment type="function">
<text evidence="30 37 51">In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth.</text>
</comment>
<comment type="catalytic activity">
<text evidence="29 50">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="activity regulation">
<text evidence="44 50">Activated by dimerization. Not activated by EGF, TGF-alpha and amphiregulin. Interaction with PTK6 increases its intrinsic kinase activity.</text>
</comment>
<comment type="subunit">
<text evidence="26 30 31 32 33 34 35 36 39 41 44 46 49 50 51 52">Homodimer (PubMed:21454582). Heterodimer with EGFR, ERBB3 and ERBB4 (PubMed:10358079, PubMed:15093539, PubMed:21190959, PubMed:16978839). Part of a complex with EGFR and either PIK3C2A or PIK3C2B. May interact with PIK3C2B when phosphorylated on Tyr-1196 (PubMed:10805725). Interacts with PLXNB1 (PubMed:15210733). Interacts (when phosphorylated on Tyr-1248) with MEMO1 (PubMed:15156151). Interacts with MUC1; the interaction is enhanced by heregulin (HRG) (PubMed:12939402). Interacts (when phosphorylated on Tyr-1139) with GRB7 (via SH2 domain) (PubMed:12975581). Interacts (when phosphorylated on Tyr-1248) with ERBIN (PubMed:12444095). Interacts with KPNB1, RANBP2, EEA1, CRM1 and CLTC (PubMed:16314522). Interacts with PTK6 (PubMed:18719096). Interacts with RPA194 and ACTB (PubMed:21555369). Interacts with PRKCABP, SRC and MYOC (By similarity). Interacts (preferentially with the tyrosine phosphorylated form) with CPNE3; this interaction occurs at the cell membrane and is increased in a growth factor heregulin-dependent manner (PubMed:20010870). Interacts with HSP90AA1 and HSP90AB1 in an ATP-dependent manner; the interaction suppresses ERBB2 kinase activity (PubMed:26517842).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-641062"/>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1222012">
<id>P15309</id>
<label>ACPP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-353944">
<id>P60709</id>
<label>ACTB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1048612">
<id>Q92625</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-81694">
<id>O00213</id>
<label>APBB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-702336">
<id>O75815</id>
<label>BCAR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-617866">
<id>Q9NSE2</id>
<label>CISH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7878194">
<id>Q7Z7G1</id>
<label>CLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1057139">
<id>Q93034</id>
<label>CUL5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1384360">
<id>Q99704</id>
<label>DOK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-6918542">
<id>Q8TEW6</id>
<label>DOK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-298113">
<id>Q15075</id>
<label>EEA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-538287">
<id>P98172</id>
<label>EFNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2868511">
<id>O75367</id>
<label>H2AFY</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-6250866">
<id>O75367-3</id>
<label>H2AFY</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-359129">
<id>P14625</id>
<label>HSP90B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-517592">
<id>P35568</id>
<label>IRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-968552">
<id>Q08881</id>
<label>ITK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383438">
<id>P23458</id>
<label>JAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-286758">
<id>Q14974</id>
<label>KPNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-722813">
<id>Q13387</id>
<label>MAPK8IP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-751664">
<id>P42679</id>
<label>MATK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1104564">
<id>Q9Y316</id>
<label>MEMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2460927">
<id>Q02297-7</id>
<label>NRG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-641107">
<id>O00750</id>
<label>PIK3C2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-359472">
<id>O95602</id>
<label>POLR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383632">
<id>Q13882</id>
<label>PTK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1384210">
<id>Q99952</id>
<label>PTPN18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-12739708">
<id>Q99952-1</id>
<label>PTPN18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1265766">
<id>P23467</id>
<label>PTPRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1341">
<id>P08575</id>
<label>PTPRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-474052">
<id>Q15262</id>
<label>PTPRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-723739">
<id>Q16827</id>
<label>PTPRO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-973138">
<id>P49792</id>
<label>RANBP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2823742">
<id>O95980</id>
<label>RECK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79084">
<id>Q92529</id>
<label>SHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1222854">
<id>Q9H6Q3</id>
<label>SLA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-968198">
<id>O15524</id>
<label>SOCS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2515547">
<id>Q7KZ85</id>
<label>SUPT6H</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7875353">
<id>Q96D37</id>
<label>VAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297549">
<id>P52735</id>
<label>VAV2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-355867">
<id>O14980</id>
<label>XPO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Translocation to the nucleus requires endocytosis, probably endosomal sorting and is mediated by importin beta-1/KPNB1.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P04626-1</id>
<name>1</name>
<name>ERBB2</name>
<name>HER2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04626-2</id>
<name>2</name>
<name>CTF-611</name>
<sequence type="described" ref="VSP_039249"/>
<text>Produced by alternative initiation at Met-611 of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-3</id>
<name>3</name>
<name>CTF-687</name>
<sequence type="described" ref="VSP_039250"/>
<text>Produced by alternative initiation at Met-687 of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-4</id>
<name>4</name>
<sequence type="described" ref="VSP_039248"/>
<text>Produced by alternative splicing of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-5</id>
<name>5</name>
<sequence type="described" ref="VSP_054787"/>
<text>No experimental confirmation available. Gene prediction based on partial mRNA and EST data.</text>
</isoform>
<isoform>
<id>P04626-6</id>
<name>6</name>
<name>B</name>
<sequence type="described" ref="VSP_055902 VSP_055903 VSP_055904"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="37">Expressed in a variety of tumor tissues including primary breast tumors and tumors from small bowel, esophagus, kidney and mouth.</text>
</comment>
<comment type="PTM">
<text evidence="43 53 60">Autophosphorylated. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit (Probable). Ligand-binding increases phosphorylation on tyrosine residues (PubMed:27134172). Signaling via SEMA4C promotes phosphorylation at Tyr-1248 (PubMed:17554007). Dephosphorylated by PTPN12 (PubMed:27134172).</text>
</comment>
<comment type="polymorphism">
<text>There are four alleles due to the variations in positions 654 and 655. Allele B1 (Ile-654/Ile-655) has a frequency of 0.782; allele B2 (Ile-654/Val-655) has a frequency of 0.206; allele B3 (Val-654/Val-655) has a frequency of 0.012.</text>
</comment>
<comment type="disease" evidence="38">
<disease id="DI-02566">
<name>Glioma</name>
<acronym>GLM</acronym>
<description>Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.</description>
<dbReference type="MIM" id="137800"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="38 42">
<disease id="DI-01655">
<name>Ovarian cancer</name>
<acronym>OC</acronym>
<description>The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.</description>
<dbReference type="MIM" id="167000"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="38">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="38 42">
<disease id="DI-02971">
<name>Gastric cancer</name>
<acronym>GASC</acronym>
<description>A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease.</description>
<dbReference type="MIM" id="613659"/>
</disease>
<text>The protein represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text evidence="48">Chromosomal aberrations involving ERBB2 may be a cause gastric cancer. Deletions within 17q12 region producing fusion transcripts with CDK12, leading to CDK12-ERBB2 fusion leading to truncated CDK12 protein not in-frame with ERBB2.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ERBB2ID162ch17q11.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/erbb2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/ERBB2"/>
<text>ERBB2 entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="AH001455">
<property type="protein sequence ID" value="AAA35808.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X03363">
<property type="protein sequence ID" value="CAA27060.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M11730">
<property type="protein sequence ID" value="AAA75493.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M12036">
<property type="protein sequence ID" value="AAA35978.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY208911">
<property type="protein sequence ID" value="AAO18082.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295195">
<property type="protein sequence ID" value="BAG58195.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471152">
<property type="protein sequence ID" value="EAW60597.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC167147">
<property type="protein sequence ID" value="AAI67147.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M16792">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16789">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16790">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16791">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KJ534964">
<property type="protein sequence ID" value="AHW56604.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L29395">
<property type="protein sequence ID" value="AAA35809.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M95667">
<property type="protein sequence ID" value="AAC37531.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32642.1">
<molecule id="P04626-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45667.1">
<molecule id="P04626-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74052.1">
<molecule id="P04626-4"/>
</dbReference>
<dbReference type="PIR" id="A24571">
<property type="entry name" value="A24571"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005862.1">
<molecule id="P04626-5"/>
<property type="nucleotide sequence ID" value="NM_001005862.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276865.1">
<molecule id="P04626-4"/>
<property type="nucleotide sequence ID" value="NM_001289936.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276867.1">
<property type="nucleotide sequence ID" value="NM_001289938.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004439.2">
<molecule id="P04626-1"/>
<property type="nucleotide sequence ID" value="NM_004448.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.446352"/>
<dbReference type="PDB" id="1MFG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="B=1247-1255"/>
</dbReference>
<dbReference type="PDB" id="1MFL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="B=1247-1255"/>
</dbReference>
<dbReference type="PDB" id="1MW4">
<property type="method" value="NMR"/>
<property type="chains" value="B=1135-1144"/>
</dbReference>
<dbReference type="PDB" id="1N8Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="C=23-629"/>
</dbReference>
<dbReference type="PDB" id="1OVC">
<property type="method" value="Model"/>
<property type="chains" value="A=737-1031"/>
</dbReference>
<dbReference type="PDB" id="1QR1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C/F=654-662"/>
</dbReference>
<dbReference type="PDB" id="1S78">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B=23-646"/>
</dbReference>
<dbReference type="PDB" id="2A91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=22-530"/>
</dbReference>
<dbReference type="PDB" id="2JWA">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=641-684"/>
</dbReference>
<dbReference type="PDB" id="2KS1">
<property type="method" value="NMR"/>
<property type="chains" value="A=641-684"/>
</dbReference>
<dbReference type="PDB" id="2L4K">
<property type="method" value="NMR"/>
<property type="chains" value="B=1135-1144"/>
</dbReference>
<dbReference type="PDB" id="2N2A">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=644-700"/>
</dbReference>
<dbReference type="PDB" id="3BE1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3H3B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=23-214"/>
</dbReference>
<dbReference type="PDB" id="3MZW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3N85">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3PP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=703-1029"/>
</dbReference>
<dbReference type="PDB" id="3RCD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D=713-1028"/>
</dbReference>
<dbReference type="PDB" id="3WLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.09"/>
<property type="chains" value="A/B=23-586"/>
</dbReference>
<dbReference type="PDB" id="3WSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=23-586"/>
</dbReference>
<dbReference type="PDB" id="4GFU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="F=1246-1252"/>
</dbReference>
<dbReference type="PDB" id="4HRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="C=24-219"/>
</dbReference>
<dbReference type="PDB" id="4HRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/C=24-219"/>
</dbReference>
<dbReference type="PDB" id="4HRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="C/D=529-625"/>
</dbReference>
<dbReference type="PDB" id="5K33">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="C=23-629"/>
</dbReference>
<dbReference type="PDB" id="5KWG">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.30"/>
<property type="chains" value="C=23-653"/>
</dbReference>
<dbReference type="PDB" id="5MY6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=24-645"/>
</dbReference>
<dbReference type="PDB" id="5O4G">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=23-628"/>
</dbReference>
<dbReference type="PDB" id="5OB4">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=641-684"/>
</dbReference>
<dbReference type="PDB" id="5TQS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="E/F/G/H=1218-1228"/>
</dbReference>
<dbReference type="PDB" id="6ATT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.77"/>
<property type="chains" value="A=23-652"/>
</dbReference>
<dbReference type="PDBsum" id="1MFG"/>
<dbReference type="PDBsum" id="1MFL"/>
<dbReference type="PDBsum" id="1MW4"/>
<dbReference type="PDBsum" id="1N8Z"/>
<dbReference type="PDBsum" id="1OVC"/>
<dbReference type="PDBsum" id="1QR1"/>
<dbReference type="PDBsum" id="1S78"/>
<dbReference type="PDBsum" id="2A91"/>
<dbReference type="PDBsum" id="2JWA"/>
<dbReference type="PDBsum" id="2KS1"/>
<dbReference type="PDBsum" id="2L4K"/>
<dbReference type="PDBsum" id="2N2A"/>
<dbReference type="PDBsum" id="3BE1"/>
<dbReference type="PDBsum" id="3H3B"/>
<dbReference type="PDBsum" id="3MZW"/>
<dbReference type="PDBsum" id="3N85"/>
<dbReference type="PDBsum" id="3PP0"/>
<dbReference type="PDBsum" id="3RCD"/>
<dbReference type="PDBsum" id="3WLW"/>
<dbReference type="PDBsum" id="3WSQ"/>
<dbReference type="PDBsum" id="4GFU"/>
<dbReference type="PDBsum" id="4HRL"/>
<dbReference type="PDBsum" id="4HRM"/>
<dbReference type="PDBsum" id="4HRN"/>
<dbReference type="PDBsum" id="5K33"/>
<dbReference type="PDBsum" id="5KWG"/>
<dbReference type="PDBsum" id="5MY6"/>
<dbReference type="PDBsum" id="5O4G"/>
<dbReference type="PDBsum" id="5OB4"/>
<dbReference type="PDBsum" id="5TQS"/>
<dbReference type="PDBsum" id="6ATT"/>
<dbReference type="ProteinModelPortal" id="P04626"/>
<dbReference type="SMR" id="P04626"/>
<dbReference type="BioGrid" id="108376">
<property type="interactions" value="203"/>
</dbReference>
<dbReference type="CORUM" id="P04626"/>
<dbReference type="DIP" id="DIP-8N"/>
<dbReference type="ELM" id="P04626"/>
<dbReference type="IntAct" id="P04626">
<property type="interactions" value="250"/>
</dbReference>
<dbReference type="MINT" id="P04626"/>
<dbReference type="STRING" id="9606.ENSP00000269571"/>
<dbReference type="BindingDB" id="P04626"/>
<dbReference type="ChEMBL" id="CHEMBL1824"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04988">
<property type="generic name" value="IGN311"/>
</dbReference>
<dbReference type="DrugBank" id="DB01259">
<property type="generic name" value="Lapatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06366">
<property type="generic name" value="Pertuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05773">
<property type="generic name" value="Trastuzumab emtansine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05007">
<property type="generic name" value="XL647"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2019"/>
<dbReference type="MoonDB" id="P04626">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="CarbonylDB" id="P04626"/>
<dbReference type="GlyConnect" id="1710"/>
<dbReference type="iPTMnet" id="P04626"/>
<dbReference type="PhosphoSitePlus" id="P04626"/>
<dbReference type="BioMuta" id="ERBB2"/>
<dbReference type="DMDM" id="119533"/>
<dbReference type="EPD" id="P04626"/>
<dbReference type="PaxDb" id="P04626"/>
<dbReference type="PeptideAtlas" id="P04626"/>
<dbReference type="PRIDE" id="P04626"/>
<dbReference type="ProteomicsDB" id="51718"/>
<dbReference type="ProteomicsDB" id="51719">
<molecule id="P04626-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51720">
<molecule id="P04626-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51721">
<molecule id="P04626-4"/>
</dbReference>
<dbReference type="DNASU" id="2064"/>
<dbReference type="Ensembl" id="ENST00000269571">
<molecule id="P04626-1"/>
<property type="protein sequence ID" value="ENSP00000269571"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406381">
<molecule id="P04626-5"/>
<property type="protein sequence ID" value="ENSP00000385185"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000541774">
<molecule id="P04626-4"/>
<property type="protein sequence ID" value="ENSP00000446466"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000584601">
<molecule id="P04626-5"/>
<property type="protein sequence ID" value="ENSP00000462438"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="GeneID" id="2064"/>
<dbReference type="KEGG" id="hsa:2064"/>
<dbReference type="UCSC" id="uc060esv.1">
<molecule id="P04626-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2064"/>
<dbReference type="DisGeNET" id="2064"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141736.13"/>
<dbReference type="GeneCards" id="ERBB2"/>
<dbReference type="HGNC" id="HGNC:3430">
<property type="gene designation" value="ERBB2"/>
</dbReference>
<dbReference type="HPA" id="CAB000043"/>
<dbReference type="HPA" id="CAB020416"/>
<dbReference type="HPA" id="CAB062555"/>
<dbReference type="HPA" id="HPA001060"/>
<dbReference type="HPA" id="HPA001338"/>
<dbReference type="HPA" id="HPA001383"/>
<dbReference type="MalaCards" id="ERBB2"/>
<dbReference type="MIM" id="137800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164870">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="167000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613659">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04626"/>
<dbReference type="OpenTargets" id="ENSG00000141736"/>
<dbReference type="PharmGKB" id="PA27844"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000230982"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P04626"/>
<dbReference type="KO" id="K05083"/>
<dbReference type="OMA" id="PINCTHS"/>
<dbReference type="OrthoDB" id="EOG091G00NO"/>
<dbReference type="PhylomeDB" id="P04626"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251932">
<property type="pathway name" value="PLCG1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1306955">
<property type="pathway name" value="GRB7 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1358803">
<property type="pathway name" value="Downregulation of ERBB2:ERBB3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416572">
<property type="pathway name" value="Sema4D induced cell migration and growth-cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="SignaLink" id="P04626"/>
<dbReference type="SIGNOR" id="P04626"/>
<dbReference type="ChiTaRS" id="ERBB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04626"/>
<dbReference type="GeneWiki" id="HER2/neu"/>
<dbReference type="GenomeRNAi" id="2064"/>
<dbReference type="PMAP-CutDB" id="P04626"/>
<dbReference type="PRO" id="PR:P04626"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141736">
<property type="expression patterns" value="Expressed in 212 organ(s), highest expression level in esophagus mucosa"/>
</dbReference>
<dbReference type="CleanEx" id="HS_ERBB2"/>
<dbReference type="ExpressionAtlas" id="P04626">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04626">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043125">
<property type="term" value="F:ErbB-3 class receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001042">
<property type="term" value="F:RNA polymerase I core binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007167">
<property type="term" value="P:enzyme linked receptor protein signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008045">
<property type="term" value="P:motor neuron axon guidance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042552">
<property type="term" value="P:myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901185">
<property type="term" value="P:negative regulation of ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033088">
<property type="term" value="P:negative regulation of immature T cell proliferation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007528">
<property type="term" value="P:neuromuscular junction development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048709">
<property type="term" value="P:oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007422">
<property type="term" value="P:peripheral nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045785">
<property type="term" value="P:positive regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090314">
<property type="term" value="P:positive regulation of protein targeting to membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045943">
<property type="term" value="P:positive regulation of transcription by RNA polymerase I"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045945">
<property type="term" value="P:positive regulation of transcription by RNA polymerase III"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045765">
<property type="term" value="P:regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032886">
<property type="term" value="P:regulation of microtubule-based process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd00064">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="signal peptide" evidence="27">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Receptor tyrosine-protein kinase erbB-2" id="PRO_0000016669">
<location>
<begin position="23"/>
<end position="1255"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="27">
<location>
<begin position="23"/>
<end position="652"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="27">
<location>
<begin position="653"/>
<end position="675"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="27">
<location>
<begin position="676"/>
<end position="1255"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="28">
<location>
<begin position="720"/>
<end position="987"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="28">
<location>
<begin position="726"/>
<end position="734"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with KPNB1 and EEA1" evidence="39">
<location>
<begin position="676"/>
<end position="689"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PIK3C2B" evidence="60">
<location>
<begin position="1195"/>
<end position="1197"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="676"/>
<end position="689"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="28 29">
<location>
<position position="845"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="28">
<location>
<position position="753"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="23">
<location>
<position position="182"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19 20 22 23 24">
<location>
<position position="1054"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="1078"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="1083"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="1107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="53">
<location>
<position position="1112"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="53">
<location>
<position position="1139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="24">
<location>
<position position="1151"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="23">
<location>
<position position="1166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="53">
<location>
<position position="1196"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18 43 53">
<location>
<position position="1248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4 9 47">
<location>
<position position="68"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="27">
<location>
<position position="124"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2 3 4 10 27">
<location>
<position position="187"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2 3 4 9 10 34 45 47">
<location>
<position position="259"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3 34 45">
<location>
<position position="530"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9 47">
<location>
<position position="571"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="27">
<location>
<position position="629"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="26"/>
<end position="53"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="162"/>
<end position="192"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="195"/>
<end position="204"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="199"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="220"/>
<end position="227"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="224"/>
<end position="235"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="236"/>
<end position="244"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="240"/>
<end position="252"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="255"/>
<end position="264"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="268"/>
<end position="295"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="299"/>
<end position="311"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="315"/>
<end position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="342"/>
<end position="367"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="475"/>
<end position="504"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="511"/>
<end position="520"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="515"/>
<end position="528"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="531"/>
<end position="540"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="544"/>
<end position="560"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="563"/>
<end position="576"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="567"/>
<end position="584"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 16">
<location>
<begin position="587"/>
<end position="596"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 7 10">
<location>
<begin position="600"/>
<end position="623"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="626"/>
<end position="634"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="630"/>
<end position="642"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_039250" evidence="60">
<location>
<begin position="1"/>
<end position="686"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_039249" evidence="60">
<location>
<begin position="1"/>
<end position="610"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_054787" evidence="60">
<location>
<begin position="1"/>
<end position="30"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_039248" evidence="59">
<original>MELAALCRWGLLLALLPPGAAST</original>
<variation>MPRGSWKP</variation>
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055902" evidence="58">
<location>
<begin position="633"/>
<end position="648"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055903" evidence="58">
<original>AYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK</original>
<variation>TISNLFSNFAPRGPSACCEPTCWCHSGKGQDSLPREEWGRQRRFCLWGCRGEPRVLDTPGRSCPSAPPSSCLQPSLRQPLLLGPGPTRAGGSTQHLQRDTYGREPRVPGSGRASVNQKAKSAEALMCPQGAGKA</variation>
<location>
<begin position="771"/>
<end position="883"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055904" evidence="58">
<location>
<begin position="884"/>
<end position="1255"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252633." id="VAR_016317" evidence="57">
<original>W</original>
<variation>C</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In allele B3; dbSNP:rs1801201." id="VAR_004077" evidence="42 55">
<original>I</original>
<variation>V</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="sequence variant" description="In allele B2 and allele B3; dbSNP:rs1136201." id="VAR_004078" evidence="42 55 57">
<original>I</original>
<variation>V</variation>
<location>
<position position="655"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance; dbSNP:rs121913469." id="VAR_055432" evidence="38">
<original>L</original>
<variation>P</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56366519." id="VAR_042097" evidence="42">
<original>L</original>
<variation>S</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance." id="VAR_055433" evidence="38">
<original>M</original>
<variation>MAYVM</variation>
<location>
<position position="774"/>
</location>
</feature>
<feature type="sequence variant" description="In GASC; somatic mutation; unknown pathological significance; dbSNP:rs28933369." id="VAR_042098" evidence="38 42">
<original>G</original>
<variation>S</variation>
<location>
<position position="776"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance." id="VAR_055434" evidence="38">
<original>S</original>
<variation>SVGS</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence variant" description="In OC; somatic mutation; unknown pathological significance; dbSNP:rs28933370." id="VAR_042099" evidence="38 42">
<original>N</original>
<variation>S</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="sequence variant" description="In GLM; somatic mutation; unknown pathological significance; dbSNP:rs28933368." id="VAR_055435" evidence="38">
<original>E</original>
<variation>K</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1058808." id="VAR_016318" evidence="42 54 56 57">
<original>P</original>
<variation>A</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55943169." id="VAR_042100" evidence="42">
<original>A</original>
<variation>D</variation>
<location>
<position position="1216"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces dimerization with ERBB3." evidence="34">
<original>LH</original>
<variation>AA</variation>
<location>
<begin position="317"/>
<end position="318"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents synthesis of isoform 2." evidence="40">
<original>M</original>
<variation>A</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents synthesis of isoform 3." evidence="40">
<original>M</original>
<variation>A</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on isoform production." evidence="40">
<original>M</original>
<variation>A</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on isoform production." evidence="40">
<original>M</original>
<variation>A</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="39"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="55"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="84"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="112"/>
<end position="117"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="147"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="152"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="169"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="227"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="232"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="240"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="263"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="271"/>
<end position="274"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="294"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="309"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="319"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="329"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="348"/>
<end position="350"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="361"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="368"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="385"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="394"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="405"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="410"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="423"/>
<end position="425"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="430"/>
<end position="435"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="441"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="463"/>
<end position="469"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="477"/>
<end position="479"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="482"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="486"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="493"/>
<end position="499"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="501"/>
<end position="506"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="507"/>
<end position="509"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="516"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="520"/>
<end position="524"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="527"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="539"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="545"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="553"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="565"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="571"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="576"/>
<end position="580"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="583"/>
<end position="585"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="587"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="595"/>
<end position="599"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="602"/>
<end position="604"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="615"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="621"/>
<end position="625"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="628"/>
<end position="632"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="635"/>
<end position="637"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="651"/>
<end position="678"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="684"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="691"/>
<end position="697"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="717"/>
<end position="719"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="720"/>
<end position="728"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="730"/>
<end position="739"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="748"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="761"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="785"/>
<end position="799"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="806"/>
<end position="812"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="814"/>
<end position="816"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="819"/>
<end position="838"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="848"/>
<end position="850"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="851"/>
<end position="855"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="858"/>
<end position="861"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="886"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="891"/>
<end position="896"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="901"/>
<end position="916"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="922"/>
<end position="925"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="928"/>
<end position="930"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="931"/>
<end position="936"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="949"/>
<end position="958"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="963"/>
<end position="965"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="969"/>
<end position="980"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="983"/>
<end position="986"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="989"/>
<end position="992"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="1003"/>
<end position="1007"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1140"/>
<end position="1142"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MW4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N8Z"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1S78"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A91"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JWA"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N2A"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BE1"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3H3B"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MZW"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3N85"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PP0"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WLW"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WSQ"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRL"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRM"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRN"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5MY6"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06494"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70424"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255"/>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358079"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12975581"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15093539"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15156151"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15210733"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15380516"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15457249"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16314522"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16794579"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16978839"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17554007"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18719096"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19299620"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20010870"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20696930"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21097718"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21190959"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454582"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21555369"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26517842"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27134172"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2999974"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8095488"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8104414"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="58" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="24722188"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="60" type="ECO:0000305"/>
<sequence length="1255" mass="137910" checksum="39E9DFDA04DCF962" modified="1987-08-13" version="1" precursor="true">
MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNL
ELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNG
DPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLA
LTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQC
AAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACP
YNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSAN
IQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLP
DLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTV
PWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQEC
VEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARC
PSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVG
ILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETEL
RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP
YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR
LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT
HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM
IDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDA
EEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEG
AGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYV
NQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQ
GGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1991-05-01" modified="2018-10-10" version="213">
<accession>P21860</accession>
<accession>A8K6L6</accession>
<accession>B4DIK7</accession>
<accession>B4DV32</accession>
<accession>E9PDT8</accession>
<accession>Q9BUD7</accession>
<name>ERBB3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor tyrosine-protein kinase erbB-3</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene-like protein c-ErbB-3</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase-type cell surface receptor HER3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ERBB3</name>
<name type="synonym">HER3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="9193" last="9197">
<title>Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.</title>
<authorList>
<person name="Kraus M.H."/>
<person name="Issing W."/>
<person name="Miki T."/>
<person name="Popescu N.C."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="2687875"/>
<dbReference type="DOI" id="10.1073/pnas.86.23.9193"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="4905" last="4909">
<title>Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.</title>
<authorList>
<person name="Plowman G.D."/>
<person name="Whitney G.S."/>
<person name="Neubauer M.G."/>
<person name="Green J.M."/>
<person name="McDonald V.L."/>
<person name="Todaro G.J."/>
<person name="Shoyab M."/>
</authorList>
<dbReference type="PubMed" id="2164210"/>
<dbReference type="DOI" id="10.1073/pnas.87.13.4905"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="192" first="1189" last="1197">
<title>c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.</title>
<authorList>
<person name="Katoh M."/>
<person name="Yazaki Y."/>
<person name="Sugimura T."/>
<person name="Terada M."/>
</authorList>
<dbReference type="PubMed" id="7685162"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1542"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5)</scope>
<source>
<tissue>Hippocampus</tissue>
<tissue>Placenta</tissue>
<tissue>Small intestine</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
<title>The finished DNA sequence of human chromosome 12.</title>
<authorList>
<person name="Scherer S.E."/>
<person name="Muzny D.M."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Montgomery K.T."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Lovering R.C."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Draper H."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Havlak P."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Li L."/>
<person name="Li Z."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Plopper F.J.H."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Allen C.C."/>
<person name="Amin A.G."/>
<person name="Anyalebechi V."/>
<person name="Bailey M."/>
<person name="Barbaria J.A."/>
<person name="Bimage K.E."/>
<person name="Bryant N.P."/>
<person name="Burch P.E."/>
<person name="Burkett C.E."/>
<person name="Burrell K.L."/>
<person name="Calderon E."/>
<person name="Cardenas V."/>
<person name="Carter K."/>
<person name="Casias K."/>
<person name="Cavazos I."/>
<person name="Cavazos S.R."/>
<person name="Ceasar H."/>
<person name="Chacko J."/>
<person name="Chan S.N."/>
<person name="Chavez D."/>
<person name="Christopoulos C."/>
<person name="Chu J."/>
<person name="Cockrell R."/>
<person name="Cox C.D."/>
<person name="Dang M."/>
<person name="Dathorne S.R."/>
<person name="David R."/>
<person name="Davis C.M."/>
<person name="Davy-Carroll L."/>
<person name="Deshazo D.R."/>
<person name="Donlin J.E."/>
<person name="D'Souza L."/>
<person name="Eaves K.A."/>
<person name="Egan A."/>
<person name="Emery-Cohen A.J."/>
<person name="Escotto M."/>
<person name="Flagg N."/>
<person name="Forbes L.D."/>
<person name="Gabisi A.M."/>
<person name="Garza M."/>
<person name="Hamilton C."/>
<person name="Henderson N."/>
<person name="Hernandez O."/>
<person name="Hines S."/>
<person name="Hogues M.E."/>
<person name="Huang M."/>
<person name="Idlebird D.G."/>
<person name="Johnson R."/>
<person name="Jolivet A."/>
<person name="Jones S."/>
<person name="Kagan R."/>
<person name="King L.M."/>
<person name="Leal B."/>
<person name="Lebow H."/>
<person name="Lee S."/>
<person name="LeVan J.M."/>
<person name="Lewis L.C."/>
<person name="London P."/>
<person name="Lorensuhewa L.M."/>
<person name="Loulseged H."/>
<person name="Lovett D.A."/>
<person name="Lucier A."/>
<person name="Lucier R.L."/>
<person name="Ma J."/>
<person name="Madu R.C."/>
<person name="Mapua P."/>
<person name="Martindale A.D."/>
<person name="Martinez E."/>
<person name="Massey E."/>
<person name="Mawhiney S."/>
<person name="Meador M.G."/>
<person name="Mendez S."/>
<person name="Mercado C."/>
<person name="Mercado I.C."/>
<person name="Merritt C.E."/>
<person name="Miner Z.L."/>
<person name="Minja E."/>
<person name="Mitchell T."/>
<person name="Mohabbat F."/>
<person name="Mohabbat K."/>
<person name="Montgomery B."/>
<person name="Moore N."/>
<person name="Morris S."/>
<person name="Munidasa M."/>
<person name="Ngo R.N."/>
<person name="Nguyen N.B."/>
<person name="Nickerson E."/>
<person name="Nwaokelemeh O.O."/>
<person name="Nwokenkwo S."/>
<person name="Obregon M."/>
<person name="Oguh M."/>
<person name="Oragunye N."/>
<person name="Oviedo R.J."/>
<person name="Parish B.J."/>
<person name="Parker D.N."/>
<person name="Parrish J."/>
<person name="Parks K.L."/>
<person name="Paul H.A."/>
<person name="Payton B.A."/>
<person name="Perez A."/>
<person name="Perrin W."/>
<person name="Pickens A."/>
<person name="Primus E.L."/>
<person name="Pu L.-L."/>
<person name="Puazo M."/>
<person name="Quiles M.M."/>
<person name="Quiroz J.B."/>
<person name="Rabata D."/>
<person name="Reeves K."/>
<person name="Ruiz S.J."/>
<person name="Shao H."/>
<person name="Sisson I."/>
<person name="Sonaike T."/>
<person name="Sorelle R.P."/>
<person name="Sutton A.E."/>
<person name="Svatek A.F."/>
<person name="Svetz L.A."/>
<person name="Tamerisa K.S."/>
<person name="Taylor T.R."/>
<person name="Teague B."/>
<person name="Thomas N."/>
<person name="Thorn R.D."/>
<person name="Trejos Z.Y."/>
<person name="Trevino B.K."/>
<person name="Ukegbu O.N."/>
<person name="Urban J.B."/>
<person name="Vasquez L.I."/>
<person name="Vera V.A."/>
<person name="Villasana D.M."/>
<person name="Wang L."/>
<person name="Ward-Moore S."/>
<person name="Warren J.T."/>
<person name="Wei X."/>
<person name="White F."/>
<person name="Williamson A.L."/>
<person name="Wleczyk R."/>
<person name="Wooden H.S."/>
<person name="Wooden S.H."/>
<person name="Yen J."/>
<person name="Yoon L."/>
<person name="Yoon V."/>
<person name="Zorrilla S.E."/>
<person name="Nelson D."/>
<person name="Kucherlapati R."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16541075"/>
<dbReference type="DOI" id="10.1038/nature04569"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="7717" last="7724">
<title>Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3.</title>
<authorList>
<person name="Fiddes R.J."/>
<person name="Campbell D.H."/>
<person name="Janes P.W."/>
<person name="Sivertsen S.P."/>
<person name="Sasaki H."/>
<person name="Wallasch C."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="9516479"/>
<dbReference type="DOI" id="10.1074/jbc.273.13.7717"/>
</citation>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Mol. Cell. Endocrinol." volume="175" first="185" last="191">
<title>Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.</title>
<authorList>
<person name="Lessor T.J."/>
<person name="Hamburger A.W."/>
</authorList>
<dbReference type="PubMed" id="11325528"/>
<dbReference type="DOI" id="10.1016/S0303-7207(01)00387-2"/>
</citation>
<scope>INTERACTION WITH PA2G4</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="321" first="1045" last="1049">
<title>Neuroglycan C, a novel member of the neuregulin family.</title>
<authorList>
<person name="Kinugasa Y."/>
<person name="Ishiguro H."/>
<person name="Tokita Y."/>
<person name="Oohira A."/>
<person name="Ohmoto H."/>
<person name="Higashiyama S."/>
</authorList>
<dbReference type="PubMed" id="15358134"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.07.066"/>
</citation>
<scope>INTERACTION WITH CSPG5</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10917" last="10922">
<title>Ebp1 isoforms distinctively regulate cell survival and differentiation.</title>
<authorList>
<person name="Liu Z."/>
<person name="Ahn J.Y."/>
<person name="Liu X."/>
<person name="Ye K."/>
</authorList>
<dbReference type="PubMed" id="16832058"/>
<dbReference type="DOI" id="10.1073/pnas.0602923103"/>
</citation>
<scope>INTERACTION WITH PA2G4</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="589" last="595">
<title>Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway.</title>
<authorList>
<person name="Narkis G."/>
<person name="Ofir R."/>
<person name="Manor E."/>
<person name="Landau D."/>
<person name="Elbedour K."/>
<person name="Birk O.S."/>
</authorList>
<dbReference type="PubMed" id="17701904"/>
<dbReference type="DOI" id="10.1086/520770"/>
</citation>
<scope>INVOLVEMENT IN LCCS2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="31388" last="31398">
<title>Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.</title>
<authorList>
<person name="Ieguchi K."/>
<person name="Fujita M."/>
<person name="Ma Z."/>
<person name="Davari P."/>
<person name="Taniguchi Y."/>
<person name="Sekiguchi K."/>
<person name="Wang B."/>
<person name="Takada Y.K."/>
<person name="Takada Y."/>
</authorList>
<dbReference type="PubMed" id="20682778"/>
<dbReference type="DOI" id="10.1074/jbc.M110.113878"/>
</citation>
<scope>FUNCTION</scope>
<scope>BINDING TO NRG1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NRG1 AND INTEGRINS</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686 AND SER-982</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="Science" volume="297" first="1330" last="1333">
<title>Structure of the extracellular region of HER3 reveals an interdomain tether.</title>
<authorList>
<person name="Cho H.S."/>
<person name="Leahy D.J."/>
</authorList>
<dbReference type="PubMed" id="12154198"/>
<dbReference type="DOI" id="10.1126/science.1074611"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 20-640</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-250; ASN-353; ASN-408; ASN-414; ASN-437; ASN-469; ASN-522 AND ASN-566</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="21608" last="21613">
<title>Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.</title>
<authorList>
<person name="Jura N."/>
<person name="Shan Y."/>
<person name="Cao X."/>
<person name="Shaw D.E."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="20007378"/>
<dbReference type="DOI" id="10.1073/pnas.0912101106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 698-1019 IN COMPLEX WITH AMP-PNP</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="7692" last="7697">
<title>ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.</title>
<authorList>
<person name="Shi F."/>
<person name="Telesco S.E."/>
<person name="Liu Y."/>
<person name="Radhakrishnan R."/>
<person name="Lemmon M.A."/>
</authorList>
<dbReference type="PubMed" id="20351256"/>
<dbReference type="DOI" id="10.1073/pnas.1002753107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 684-1020 IN COMPLEX WITH AMP-PNP</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-742 AND TYR-868</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Biochim. Biophys. Acta" volume="1808" first="2081" last="2088">
<title>Spatial structure and dimer-monomer equilibrium of the ErbB3 transmembrane domain in DPC micelles.</title>
<authorList>
<person name="Mineev K.S."/>
<person name="Khabibullina N.F."/>
<person name="Lyukmanova E.N."/>
<person name="Dolgikh D.A."/>
<person name="Kirpichnikov M.P."/>
<person name="Arseniev A.S."/>
</authorList>
<dbReference type="PubMed" id="21575594"/>
<dbReference type="DOI" id="10.1016/j.bbamem.2011.04.017"/>
</citation>
<scope>STRUCTURE BY NMR OF 640-670</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] TYR-20; LEU-30; MET-104; ILE-204; TRP-683; LEU-717; THR-744; ARG-998; CYS-1119; HIS-1127; ILE-1177 AND LYS-1254</scope>
</reference>
<comment type="function">
<text evidence="18 23">Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). May also be activated by CSPG5 (PubMed:15358134).</text>
</comment>
<comment type="catalytic activity">
<text evidence="22">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="12 15 17 18 19 23 24 29">Monomer and homodimer. Heterodimer with each of the other ERBB receptors (Potential). Interacts with CSPG5 (PubMed:15358134). Interacts with GRB7 (PubMed:9516479). Interacts with MUC1 (PubMed:12939402). Interacts with MYOC (By similarity). Interacts with isoform 2 of PA2G4 (PubMed:11325528, PubMed:16832058). Found in a ternary complex with NRG1 and ITGAV:ITGB3 or ITGA6:ITGB4 (PubMed:20682778).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-720706"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-2460927">
<id>Q02297-7</id>
<label>NRG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-2116585">
<id>P42336</id>
<label>PIK3CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>41</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-79084">
<id>Q92529</id>
<label>SHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-720706"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P21860-1</id>
<name>1</name>
<name>long form</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P21860-2</id>
<name>2</name>
<name>short form</name>
<sequence type="described" ref="VSP_002893 VSP_002894"/>
</isoform>
<isoform>
<id>P21860-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041663 VSP_041664"/>
</isoform>
<isoform>
<id>P21860-4</id>
<name>4</name>
<sequence type="described" ref="VSP_041662"/>
</isoform>
<isoform>
<id>P21860-5</id>
<name>5</name>
<sequence type="described" ref="VSP_041661"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Epithelial tissues and brain.</text>
</comment>
<comment type="developmental stage">
<text>Overexpressed in a subset of human mammary tumors.</text>
</comment>
<comment type="domain">
<text>The cytoplasmic part of the receptor may interact with the SH2 or SH3 domains of many signal-transducing proteins.</text>
</comment>
<comment type="PTM">
<text evidence="22 23">Autophosphorylated (PubMed:20351256). Ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778).</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-00645">
<name>Lethal congenital contracture syndrome 2</name>
<acronym>LCCS2</acronym>
<description>A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS2 patients manifest craniofacial/ocular findings, lack of hydrops, multiple pterygia, and fractures, as well as a normal duration of pregnancy and a unique feature of a markedly distended urinary bladder (neurogenic bladder defect). The phenotype suggests a spinal cord neuropathic etiology.</description>
<dbReference type="MIM" id="607598"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="14">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ERBB3ID40479ch12q13.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="M29366">
<property type="protein sequence ID" value="AAA35790.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M34309">
<property type="protein sequence ID" value="AAA35979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S61953">
<property type="protein sequence ID" value="AAB26935.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007226">
<property type="protein sequence ID" value="AAP35890.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291681">
<property type="protein sequence ID" value="BAF84370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295650">
<property type="protein sequence ID" value="BAG58519.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300909">
<property type="protein sequence ID" value="BAG62544.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC034102">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002706">
<property type="protein sequence ID" value="AAH02706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC082992">
<property type="protein sequence ID" value="AAH82992.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31833.1">
<molecule id="P21860-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS44918.1">
<molecule id="P21860-2"/>
</dbReference>
<dbReference type="PIR" id="A36223">
<property type="entry name" value="A36223"/>
</dbReference>
<dbReference type="PIR" id="JH0803">
<property type="entry name" value="JH0803"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005915.1">
<molecule id="P21860-2"/>
<property type="nucleotide sequence ID" value="NM_001005915.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001973.2">
<molecule id="P21860-1"/>
<property type="nucleotide sequence ID" value="NM_001982.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.118681"/>
<dbReference type="UniGene" id="Hs.622058"/>
<dbReference type="PDB" id="1M6B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=20-640"/>
</dbReference>
<dbReference type="PDB" id="2L9U">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=639-670"/>
</dbReference>
<dbReference type="PDB" id="3KEX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=698-1019"/>
</dbReference>
<dbReference type="PDB" id="3LMG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=684-1020"/>
</dbReference>
<dbReference type="PDB" id="3P11">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A=20-532"/>
</dbReference>
<dbReference type="PDB" id="4LEO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="C=20-631"/>
</dbReference>
<dbReference type="PDB" id="4OTW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=698-1020"/>
</dbReference>
<dbReference type="PDB" id="4P59">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=20-640"/>
</dbReference>
<dbReference type="PDB" id="4RIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/C=698-1020"/>
</dbReference>
<dbReference type="PDB" id="4RIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/C=698-1020"/>
</dbReference>
<dbReference type="PDB" id="4RIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A/C=698-1020"/>
</dbReference>
<dbReference type="PDB" id="5CUS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D=20-641"/>
</dbReference>
<dbReference type="PDB" id="5O4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="C=1-643"/>
</dbReference>
<dbReference type="PDB" id="5O7P">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="C=1-643"/>
</dbReference>
<dbReference type="PDBsum" id="1M6B"/>
<dbReference type="PDBsum" id="2L9U"/>
<dbReference type="PDBsum" id="3KEX"/>
<dbReference type="PDBsum" id="3LMG"/>
<dbReference type="PDBsum" id="3P11"/>
<dbReference type="PDBsum" id="4LEO"/>
<dbReference type="PDBsum" id="4OTW"/>
<dbReference type="PDBsum" id="4P59"/>
<dbReference type="PDBsum" id="4RIW"/>
<dbReference type="PDBsum" id="4RIX"/>
<dbReference type="PDBsum" id="4RIY"/>
<dbReference type="PDBsum" id="5CUS"/>
<dbReference type="PDBsum" id="5O4O"/>
<dbReference type="PDBsum" id="5O7P"/>
<dbReference type="ProteinModelPortal" id="P21860"/>
<dbReference type="SMR" id="P21860"/>
<dbReference type="BioGrid" id="108377">
<property type="interactions" value="186"/>
</dbReference>
<dbReference type="CORUM" id="P21860"/>
<dbReference type="DIP" id="DIP-36441N"/>
<dbReference type="ELM" id="P21860"/>
<dbReference type="IntAct" id="P21860">
<property type="interactions" value="94"/>
</dbReference>
<dbReference type="MINT" id="P21860"/>
<dbReference type="STRING" id="9606.ENSP00000267101"/>
<dbReference type="BindingDB" id="P21860"/>
<dbReference type="ChEMBL" id="CHEMBL5838"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1798"/>
<dbReference type="MoonDB" id="P21860">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="CarbonylDB" id="P21860"/>
<dbReference type="GlyConnect" id="1711"/>
<dbReference type="iPTMnet" id="P21860"/>
<dbReference type="PhosphoSitePlus" id="P21860"/>
<dbReference type="BioMuta" id="ERBB3"/>
<dbReference type="DMDM" id="119534"/>
<dbReference type="EPD" id="P21860"/>
<dbReference type="MaxQB" id="P21860"/>
<dbReference type="PaxDb" id="P21860"/>
<dbReference type="PeptideAtlas" id="P21860"/>
<dbReference type="PRIDE" id="P21860"/>
<dbReference type="ProteomicsDB" id="53934"/>
<dbReference type="ProteomicsDB" id="53935">
<molecule id="P21860-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53936">
<molecule id="P21860-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53937">
<molecule id="P21860-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53938">
<molecule id="P21860-5"/>
</dbReference>
<dbReference type="DNASU" id="2065"/>
<dbReference type="Ensembl" id="ENST00000267101">
<molecule id="P21860-1"/>
<property type="protein sequence ID" value="ENSP00000267101"/>
<property type="gene ID" value="ENSG00000065361"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000411731">
<molecule id="P21860-2"/>
<property type="protein sequence ID" value="ENSP00000415753"/>
<property type="gene ID" value="ENSG00000065361"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415288">
<molecule id="P21860-4"/>
<property type="protein sequence ID" value="ENSP00000408340"/>
<property type="gene ID" value="ENSG00000065361"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000551242">
<molecule id="P21860-3"/>
<property type="protein sequence ID" value="ENSP00000447510"/>
<property type="gene ID" value="ENSG00000065361"/>
</dbReference>
<dbReference type="GeneID" id="2065"/>
<dbReference type="KEGG" id="hsa:2065"/>
<dbReference type="UCSC" id="uc001sjg.4">
<molecule id="P21860-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2065"/>
<dbReference type="DisGeNET" id="2065"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000065361.14"/>
<dbReference type="GeneCards" id="ERBB3"/>
<dbReference type="HGNC" id="HGNC:3431">
<property type="gene designation" value="ERBB3"/>
</dbReference>
<dbReference type="HPA" id="CAB025331"/>
<dbReference type="HPA" id="HPA045396"/>
<dbReference type="MalaCards" id="ERBB3"/>
<dbReference type="MIM" id="190151">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="607598">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P21860"/>
<dbReference type="OpenTargets" id="ENSG00000065361"/>
<dbReference type="Orphanet" id="137776">
<property type="disease" value="Lethal congenital contracture syndrome type 2"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27846"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000230982"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P21860"/>
<dbReference type="KO" id="K05084"/>
<dbReference type="OMA" id="CYHHSLN"/>
<dbReference type="OrthoDB" id="EOG091G00IX"/>
<dbReference type="PhylomeDB" id="P21860"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1306955">
<property type="pathway name" value="GRB7 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1358803">
<property type="pathway name" value="Downregulation of ERBB2:ERBB3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P21860"/>
<dbReference type="SIGNOR" id="P21860"/>
<dbReference type="ChiTaRS" id="ERBB3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P21860"/>
<dbReference type="GeneWiki" id="ERBB3"/>
<dbReference type="GenomeRNAi" id="2065"/>
<dbReference type="PRO" id="PR:P21860"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000065361">
<property type="expression patterns" value="Expressed in 217 organ(s), highest expression level in corpus callosum"/>
</dbReference>
<dbReference type="CleanEx" id="HS_ERBB3"/>
<dbReference type="ExpressionAtlas" id="P21860">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P21860">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0016328">
<property type="term" value="C:lateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019838">
<property type="term" value="F:growth factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0038132">
<property type="term" value="F:neuregulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030296">
<property type="term" value="F:protein tyrosine kinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0021545">
<property type="term" value="P:cranial nerve development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003197">
<property type="term" value="P:endocardial cushion development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097192">
<property type="term" value="P:extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007162">
<property type="term" value="P:negative regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051048">
<property type="term" value="P:negative regulation of secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009968">
<property type="term" value="P:negative regulation of signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051402">
<property type="term" value="P:neuron apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007422">
<property type="term" value="P:peripheral nervous system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070886">
<property type="term" value="P:positive regulation of calcineurin-NFAT signaling cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0055025">
<property type="term" value="P:positive regulation of cardiac muscle tissue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061098">
<property type="term" value="P:positive regulation of protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014037">
<property type="term" value="P:Schwann cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd00064">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="signal peptide" evidence="13">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Receptor tyrosine-protein kinase erbB-3" id="PRO_0000016672">
<location>
<begin position="20"/>
<end position="1342"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="13">
<location>
<begin position="20"/>
<end position="643"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="13">
<location>
<begin position="644"/>
<end position="664"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="13">
<location>
<begin position="665"/>
<end position="1342"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="14">
<location>
<begin position="709"/>
<end position="966"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="715"/>
<end position="723"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="788"/>
<end position="790"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="834"/>
<end position="839"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14">
<location>
<position position="834"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="742"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="686"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="982"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="126"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="250"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="353"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="408"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="414"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="437"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="469"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="522"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="566"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="616"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="29"/>
<end position="56"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="156"/>
<end position="183"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="186"/>
<end position="194"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="190"/>
<end position="202"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="210"/>
<end position="218"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="214"/>
<end position="226"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="227"/>
<end position="235"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="231"/>
<end position="243"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="246"/>
<end position="255"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="259"/>
<end position="286"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="290"/>
<end position="301"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="305"/>
<end position="320"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="323"/>
<end position="327"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="500"/>
<end position="509"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="504"/>
<end position="517"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="520"/>
<end position="529"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="533"/>
<end position="549"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="552"/>
<end position="565"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="556"/>
<end position="573"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16">
<location>
<begin position="576"/>
<end position="585"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="589"/>
<end position="610"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="613"/>
<end position="621"/>
</location>
</feature>
<feature type="disulfide bond" evidence="11">
<location>
<begin position="617"/>
<end position="629"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_041661" evidence="25">
<location>
<begin position="1"/>
<end position="643"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_041662" evidence="25">
<location>
<begin position="1"/>
<end position="59"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002893" evidence="27">
<original>EILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNGRSC</original>
<variation>GQFPMVPSGLTPQPAQDWYLLDDDPRLLTLSASSKVPVTLAAV</variation>
<location>
<begin position="141"/>
<end position="183"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002894" evidence="27">
<location>
<begin position="184"/>
<end position="1342"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041663" evidence="26 28">
<original>C</original>
<variation>F</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041664" evidence="26 28">
<location>
<begin position="332"/>
<end position="1342"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34379766." id="VAR_042101" evidence="20">
<original>S</original>
<variation>Y</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56017157." id="VAR_042102" evidence="20">
<original>P</original>
<variation>L</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian mucinous carcinoma sample; somatic mutation; dbSNP:rs1057519893." id="VAR_042103" evidence="20">
<original>V</original>
<variation>M</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56107455." id="VAR_042104" evidence="20">
<original>T</original>
<variation>I</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12320176." id="VAR_049710">
<original>N</original>
<variation>S</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56387488." id="VAR_042105" evidence="20">
<original>R</original>
<variation>W</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35961836." id="VAR_042106" evidence="20">
<original>S</original>
<variation>L</variation>
<location>
<position position="717"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55787439." id="VAR_042107" evidence="20">
<original>I</original>
<variation>T</variation>
<location>
<position position="744"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56259600." id="VAR_042108" evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="998"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs773123." id="VAR_042109" evidence="20">
<original>S</original>
<variation>C</variation>
<location>
<position position="1119"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2271188." id="VAR_042110" evidence="20">
<original>R</original>
<variation>H</variation>
<location>
<position position="1127"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55699040." id="VAR_042111" evidence="20">
<original>L</original>
<variation>I</variation>
<location>
<position position="1177"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55709407." id="VAR_042112" evidence="20">
<original>T</original>
<variation>K</variation>
<location>
<position position="1254"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11171743." id="VAR_049711">
<original>G</original>
<variation>S</variation>
<location>
<position position="1271"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation." evidence="22">
<original>K</original>
<variation>M</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced tyrosine phosphorylation." evidence="22">
<original>Y</original>
<variation>E</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA35979." ref="2" evidence="29">
<original>E</original>
<variation>G</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAF84370." ref="5" evidence="29">
<original>G</original>
<variation>S</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA35979." ref="2" evidence="29">
<original>E</original>
<variation>G</variation>
<location>
<position position="1064"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG62544." ref="5" evidence="29">
<original>C</original>
<variation>S</variation>
<location>
<position position="1078"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAF84370." ref="5" evidence="29">
<original>D</original>
<variation>G</variation>
<location>
<position position="1163"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="43"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="58"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="75"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="87"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="141"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="150"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="158"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="163"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="174"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="194"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="218"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="235"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="243"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="254"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="262"/>
<end position="265"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="270"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="280"/>
<end position="282"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="285"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="300"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="309"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="322"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="324"/>
<end position="326"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="338"/>
<end position="342"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="345"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="348"/>
<end position="351"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="356"/>
<end position="363"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="365"/>
<end position="369"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="372"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="381"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="392"/>
<end position="395"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="410"/>
<end position="412"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="425"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="451"/>
<end position="457"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="482"/>
<end position="488"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="490"/>
<end position="493"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="494"/>
<end position="497"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="509"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="517"/>
<end position="527"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="529"/>
<end position="531"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="542"/>
<end position="545"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="560"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="564"/>
<end position="570"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="573"/>
<end position="581"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="584"/>
<end position="588"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="591"/>
<end position="594"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="600"/>
<end position="604"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="608"/>
<end position="612"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="622"/>
<end position="625"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="626"/>
<end position="628"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="641"/>
<end position="670"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="706"/>
<end position="708"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="709"/>
<end position="716"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="722"/>
<end position="728"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="731"/>
<end position="733"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="737"/>
<end position="744"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="747"/>
<end position="749"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="758"/>
<end position="764"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="774"/>
<end position="778"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="780"/>
<end position="788"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="795"/>
<end position="802"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="803"/>
<end position="805"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="808"/>
<end position="827"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="837"/>
<end position="839"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="840"/>
<end position="846"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="848"/>
<end position="850"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="855"/>
<end position="858"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="865"/>
<end position="868"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="870"/>
<end position="872"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="875"/>
<end position="877"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="880"/>
<end position="885"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="890"/>
<end position="905"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="911"/>
<end position="914"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="917"/>
<end position="919"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="920"/>
<end position="925"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="938"/>
<end position="947"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="952"/>
<end position="954"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="958"/>
<end position="968"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="972"/>
<end position="975"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="980"/>
<end position="983"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1M6B"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L9U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KEX"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LMG"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4LEO"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OTW"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RIY"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CUS"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61526"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255"/>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11325528"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12154198"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15358134"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16832058"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17701904"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20351256"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20682778"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9516479"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7685162"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="1342" mass="148098" checksum="7201E7F66CA374BD" modified="1991-05-01" version="1" precursor="true">
MRANDALQVLGLLFSLARGSEVGNSQAVCPGTLNGLSVTGDAENQYQTLYKLYERCEVVM
GNLEIVLTGHNADLSFLQWIREVTGYVLVAMNEFSTLPLPNLRVVRGTQVYDGKFAIFVM
LNYNTNSSHALRQLRLTQLTEILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNG
RSCPPCHEVCKGRCWGPGSEDCQTLTKTICAPQCNGHCFGPNPNQCCHDECAGGCSGPQD
TDCFACRHFNDSGACVPRCPQPLVYNKLTFQLEPNPHTKYQYGGVCVASCPHNFVVDQTS
CVRACPPDKMEVDKNGLKMCEPCGGLCPKACEGTGSGSRFQTVDSSNIDGFVNCTKILGN
LDFLITGLNGDPWHKIPALDPEKLNVFRTVREITGYLNIQSWPPHMHNFSVFSNLTTIGG
RSLYNRGFSLLIMKNLNVTSLGFRSLKEISAGRIYISANRQLCYHHSLNWTKVLRGPTEE
RLDIKHNRPRRDCVAEGKVCDPLCSSGGCWGPGPGQCLSCRNYSRGGVCVTHCNFLNGEP
REFAHEAECFSCHPECQPMEGTATCNGSGSDTCAQCAHFRDGPHCVSSCPHGVLGAKGPI
YKYPDVQNECRPCHENCTQGCKGPELQDCLGQTLVLIGKTHLTMALTVIAGLVVIFMMLG
GTFLYWRGRRIQNKRAMRRYLERGESIEPLDPSEKANKVLARIFKETELRKLKVLGSGVF
GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG
SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNV
LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVT
VWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKE
LANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAEED
NLATTTLGSALSLPVGTLNRPRGSQSLLSPSSGYMPMNQGNLGESCQESAVSGSSERCPR
PVSLHPMPRGCLASESSEGHVTGSEAELQEKVSMCRSRSRSRSPRPRGDSAYHSQRHSLL
TPVTPLSPPGLEEEDVNGYVMPDTHLKGTPSSREGTLSSVGLSSVLGTEEEDEDEEYEYM
NRRRRHSPPHPPRPSSLEELGYEYMDVGSDLSASLGSTQSCPLHPVPIMPTAGTTPDEDY
EYMNRQRDGGGPGGDYAAMGACPASEQGYEEMRAFQGPGHQAPHVHYARLKTLRSLEATD
SAFDNPDYWHSRLFPKANAQRT
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2018-10-10" version="210">
<accession>Q15303</accession>
<accession>B7ZLD7</accession>
<accession>B7ZLE2</accession>
<accession>B7ZLE3</accession>
<accession>Q2M1W1</accession>
<accession>Q59EW4</accession>
<name>ERBB4_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor tyrosine-protein kinase erbB-4</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene-like protein c-ErbB-4</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase-type cell surface receptor HER4</fullName>
</alternativeName>
<alternativeName>
<fullName>p180erbB4</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>ERBB4 intracellular domain</fullName>
<shortName>4ICD</shortName>
<shortName>E4ICD</shortName>
</recommendedName>
<alternativeName>
<fullName>s80HER4</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">ERBB4</name>
<name type="synonym">HER4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="1746" last="1750">
<title>Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.</title>
<authorList>
<person name="Plowman G.D."/>
<person name="Culouscou J.-M."/>
<person name="Whitney G.S."/>
<person name="Green J.M."/>
<person name="Carlton G.W."/>
<person name="Foy L."/>
<person name="Neubauer M.G."/>
<person name="Shoyab M."/>
</authorList>
<dbReference type="PubMed" id="8383326"/>
<dbReference type="DOI" id="10.1073/pnas.90.5.1746"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM JM-A CYT-1)</scope>
<scope>FUNCTION AS CELL SURFACE RECEPTOR</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="26761" last="26768">
<title>A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester.</title>
<authorList>
<person name="Elenius K."/>
<person name="Corfas G."/>
<person name="Paul S."/>
<person name="Choi C.J."/>
<person name="Rio C."/>
<person name="Plowman G.D."/>
<person name="Klagsbrun M."/>
</authorList>
<dbReference type="PubMed" id="9334263"/>
<dbReference type="DOI" id="10.1074/jbc.272.42.26761"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS JM-A CYT-1 AND JM-B CYT-1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>FUNCTION AS CELL SURFACE RECEPTOR FOR NRG1 AND BTC</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS JM-A CYT-1; JM-B CYT-1; JM-A CYT-2 AND JM-B CYT-2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 401-1308 (ISOFORM JM-A CYT-2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="18407" last="18410">
<title>Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor.</title>
<authorList>
<person name="Culouscou J.-M."/>
<person name="Plowman G.D."/>
<person name="Carlton G.W."/>
<person name="Green J.M."/>
<person name="Shoyab M."/>
</authorList>
<dbReference type="PubMed" id="7689552"/>
</citation>
<scope>INTERACTION WITH NRG1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Nature" volume="366" first="473" last="475">
<title>Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.</title>
<authorList>
<person name="Plowman G.D."/>
<person name="Green J.M."/>
<person name="Culouscou J.M."/>
<person name="Carlton G.W."/>
<person name="Rothwell V.M."/>
<person name="Buckley S."/>
</authorList>
<dbReference type="PubMed" id="7902537"/>
<dbReference type="DOI" id="10.1038/366473a0"/>
</citation>
<scope>INTERACTION WITH NRG1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="4813" last="4818">
<title>HER4-mediated biological and biochemical properties in NIH 3T3 cells. Evidence for HER1-HER4 heterodimers.</title>
<authorList>
<person name="Cohen B.D."/>
<person name="Green J.M."/>
<person name="Foy L."/>
<person name="Fell H.P."/>
</authorList>
<dbReference type="PubMed" id="8617750"/>
<dbReference type="DOI" id="10.1074/jbc.271.9.4813"/>
</citation>
<scope>FUNCTION AS NRG1 RECEPTOR IN REGULATION OF CELL PROLIFERATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT TYR-1056; TYR-1188 AND TYR-1242</scope>
<scope>INTERACTION WITH EGFR; SHC1 AND PIK3R1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Oncogene" volume="12" first="345" last="353">
<title>Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.</title>
<authorList>
<person name="Riese D.J. II"/>
<person name="Bermingham Y."/>
<person name="van Raaij T.M."/>
<person name="Buckley S."/>
<person name="Plowman G.D."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="8570211"/>
</citation>
<scope>INTERACTION WITH BTC</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="1268" last="1278">
<title>Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.</title>
<authorList>
<person name="Elenius K."/>
<person name="Paul S."/>
<person name="Allison G."/>
<person name="Sun J."/>
<person name="Klagsbrun M."/>
</authorList>
<dbReference type="PubMed" id="9135143"/>
<dbReference type="DOI" id="10.1093/emboj/16.6.1268"/>
</citation>
<scope>FUNCTION AS HBEGF RECEPTOR; IN CELL MIGRATION; CELL PROLIFERATION AND IN ACTIVATION OF PIK3R1</scope>
<scope>INTERACTION WITH HBEGF AND PIK3R1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Nature" volume="387" first="512" last="516">
<title>Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.</title>
<authorList>
<person name="Carraway K.L. III"/>
<person name="Weber J.L."/>
<person name="Unger M.J."/>
<person name="Ledesma J."/>
<person name="Yu N."/>
<person name="Gassmann M."/>
<person name="Lai C."/>
</authorList>
<dbReference type="PubMed" id="9168115"/>
<dbReference type="DOI" id="10.1038/387512a0"/>
</citation>
<scope>INTERACTION WITH NRG2</scope>
<scope>FUNCTION AS NRG2 RECEPTOR</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2841" last="2848">
<title>Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.</title>
<authorList>
<person name="Komurasaki T."/>
<person name="Toyoda H."/>
<person name="Uchida D."/>
<person name="Morimoto S."/>
</authorList>
<dbReference type="PubMed" id="9419975"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201458"/>
</citation>
<scope>INTERACTION WITH EREG</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="9562" last="9567">
<title>Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4.</title>
<authorList>
<person name="Zhang D."/>
<person name="Sliwkowski M.X."/>
<person name="Mark M."/>
<person name="Frantz G."/>
<person name="Akita R."/>
<person name="Sun Y."/>
<person name="Hillan K."/>
<person name="Crowley C."/>
<person name="Brush J."/>
<person name="Godowski P.J."/>
</authorList>
<dbReference type="PubMed" id="9275162"/>
<dbReference type="DOI" id="10.1073/pnas.94.18.9562"/>
</citation>
<scope>INTERACTION WITH NRG3</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="7717" last="7724">
<title>Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3.</title>
<authorList>
<person name="Fiddes R.J."/>
<person name="Campbell D.H."/>
<person name="Janes P.W."/>
<person name="Sivertsen S.P."/>
<person name="Sasaki H."/>
<person name="Wallasch C."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="9516479"/>
<dbReference type="DOI" id="10.1074/jbc.273.13.7717"/>
</citation>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17209" last="17218">
<title>ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.</title>
<authorList>
<person name="Olayioye M.A."/>
<person name="Beuvink I."/>
<person name="Horsch K."/>
<person name="Daly J.M."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="10358079"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17209"/>
</citation>
<scope>INTERACTION WITH ERBB2</scope>
<scope>FUNCTION IN ACTIVATION OF STAT5A</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="2607" last="2615">
<title>Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.</title>
<authorList>
<person name="Elenius K."/>
<person name="Choi C.J."/>
<person name="Paul S."/>
<person name="Santiestevan E."/>
<person name="Nishi E."/>
<person name="Klagsbrun M."/>
</authorList>
<dbReference type="PubMed" id="10353604"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202612"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
<scope>FUNCTION IN PHOSPHORYLATION AND ACTIVATION OF PIK3R1</scope>
<scope>INTERACTION WITH NRG1 AND PIKR3R1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="2681" last="2689">
<title>Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.</title>
<authorList>
<person name="Harari D."/>
<person name="Tzahar E."/>
<person name="Romano J."/>
<person name="Shelly M."/>
<person name="Pierce J.H."/>
<person name="Andrews G.C."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="10348342"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202631"/>
</citation>
<scope>FUNCTION AS NRG4 RECEPTOR IN ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1 AND IN CELL PROLIFERATION</scope>
<scope>INTERACTION WITH NRG4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="8641" last="8649">
<title>A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.</title>
<authorList>
<person name="Kainulainen V."/>
<person name="Sundvall M."/>
<person name="Maatta J.A."/>
<person name="Santiestevan E."/>
<person name="Klagsbrun M."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="10722704"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.8641"/>
</citation>
<scope>FUNCTION AS NRG1 RECEPTOR IN CELL PROLIFERATION; MIGRATION; SURVIVAL AND IN PHOSPHORYLATION OF SHC1; ACTIVATION OF MAPK1/ERK2 AND MAPK3/ERK1</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="10379" last="10387">
<title>Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4.</title>
<authorList>
<person name="Rio C."/>
<person name="Buxbaum J.D."/>
<person name="Peschon J.J."/>
<person name="Corfas G."/>
</authorList>
<dbReference type="PubMed" id="10744726"/>
<dbReference type="DOI" id="10.1074/jbc.275.14.10379"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="19803" last="19807">
<title>Ligand discrimination in signaling through an ErbB4 receptor homodimer.</title>
<authorList>
<person name="Sweeney C."/>
<person name="Lai C."/>
<person name="Riese D.J. II"/>
<person name="Diamonti A.J."/>
<person name="Cantley L.C."/>
<person name="Carraway K.L. III"/>
</authorList>
<dbReference type="PubMed" id="10867024"/>
<dbReference type="DOI" id="10.1074/jbc.C901015199"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF AKT1; MAPK1/ERK2 AND MAPK3/ERK1</scope>
<scope>INTERACTION WITH PIK3R1; GRB2; SHC1; BTC; NRG1; NRG2 AND NRG3</scope>
<scope>LIGAND-SPECIFIC AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="3596" last="3601">
<title>The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.</title>
<authorList>
<person name="Garcia R.A."/>
<person name="Vasudevan K."/>
<person name="Buonanno A."/>
</authorList>
<dbReference type="PubMed" id="10725395"/>
<dbReference type="DOI" id="10.1073/pnas.97.7.3596"/>
</citation>
<scope>INTERACTION WITH DLG2; DLG3; DLG4 AND SNTB2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="281" first="25" last="31">
<title>BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.</title>
<authorList>
<person name="Egeblad M."/>
<person name="Mortensen O.H."/>
<person name="van Kempen L.C."/>
<person name="Jaattela M."/>
</authorList>
<dbReference type="PubMed" id="11178955"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.4302"/>
</citation>
<scope>FUNCTION AS NRG1 RECEPTOR AND IN ACTIVATION OF MAP KINASES</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="4265" last="4275">
<title>Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.</title>
<authorList>
<person name="Sartor C.I."/>
<person name="Zhou H."/>
<person name="Kozlowska E."/>
<person name="Guttridge K."/>
<person name="Kawata E."/>
<person name="Caskey L."/>
<person name="Harrelson J."/>
<person name="Hynes N."/>
<person name="Ethier S."/>
<person name="Calvo B."/>
<person name="Earp H.S. III"/>
</authorList>
<dbReference type="PubMed" id="11390655"/>
<dbReference type="DOI" id="10.1128/MCB.21.13.4265-4275.2001"/>
</citation>
<scope>MUTAGENESIS OF LYS-751</scope>
<scope>FUNCTION IN PROMOTING CELL DIFFERENTIATION AND INHIBITING CELL PROLIFERATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="33334" last="33341">
<title>WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.</title>
<authorList>
<person name="Komuro A."/>
<person name="Nagai M."/>
<person name="Navin N.E."/>
<person name="Sudol M."/>
</authorList>
<dbReference type="PubMed" id="12807903"/>
<dbReference type="DOI" id="10.1074/jbc.M305597200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH YAP1</scope>
<scope>MUTAGENESIS OF TYR-1301</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="167" first="469" last="478">
<title>The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.</title>
<authorList>
<person name="Williams C.C."/>
<person name="Allison J.G."/>
<person name="Vidal G.A."/>
<person name="Burow M.E."/>
<person name="Beckman B.S."/>
<person name="Marrero L."/>
<person name="Jones F.E."/>
</authorList>
<dbReference type="PubMed" id="15534001"/>
<dbReference type="DOI" id="10.1083/jcb.200403155"/>
</citation>
<scope>INTERACTION WITH STAT5A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION IN NUCLEAR LOCALIZATION OF STAT5A; DNA-BINDING</scope>
<scope>MUTAGENESIS OF 681-LYS--ARG-684</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="6764" last="6772">
<title>WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.</title>
<authorList>
<person name="Aqeilan R.I."/>
<person name="Donati V."/>
<person name="Palamarchuk A."/>
<person name="Trapasso F."/>
<person name="Kaou M."/>
<person name="Pekarsky Y."/>
<person name="Sudol M."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="16061658"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-1150"/>
</citation>
<scope>INTERACTION WITH WWOX</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF TYR-1035 AND TYR-1301</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="19777" last="19783">
<title>Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.</title>
<authorList>
<person name="Vidal G.A."/>
<person name="Naresh A."/>
<person name="Marrero L."/>
<person name="Jones F.E."/>
</authorList>
<dbReference type="PubMed" id="15746097"/>
<dbReference type="DOI" id="10.1074/jbc.M412457200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>MUTAGENESIS OF VAL-675</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="6412" last="6420">
<title>The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.</title>
<authorList>
<person name="Naresh A."/>
<person name="Long W."/>
<person name="Vidal G.A."/>
<person name="Wimley W.C."/>
<person name="Marrero L."/>
<person name="Sartor C.I."/>
<person name="Tovey S."/>
<person name="Cooke T.G."/>
<person name="Bartlett J.M."/>
<person name="Jones F.E."/>
</authorList>
<dbReference type="PubMed" id="16778220"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-2368"/>
</citation>
<scope>FUNCTION IN PROMOTING APOPTOSIS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BCL2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="25373" last="25380">
<title>ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression.</title>
<authorList>
<person name="Linggi B."/>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="16815842"/>
<dbReference type="DOI" id="10.1074/jbc.M603998200"/>
</citation>
<scope>INTERACTION WITH CBFA2T3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="67" last="79">
<title>Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.</title>
<authorList>
<person name="Maatta J.A."/>
<person name="Sundvall M."/>
<person name="Junttila T.T."/>
<person name="Peri L."/>
<person name="Laine V.J."/>
<person name="Isola J."/>
<person name="Egeblad M."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="16251361"/>
<dbReference type="DOI" id="10.1091/mbc.E05-05-0402"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="4118" last="4129">
<title>The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.</title>
<authorList>
<person name="Muraoka-Cook R.S."/>
<person name="Sandahl M."/>
<person name="Husted C."/>
<person name="Hunter D."/>
<person name="Miraglia L."/>
<person name="Feng S.M."/>
<person name="Elenius K."/>
<person name="Earp H.S. III"/>
</authorList>
<dbReference type="PubMed" id="16837552"/>
<dbReference type="DOI" id="10.1091/mbc.E06-02-0101"/>
</citation>
<scope>FUNCTION IN DIFFERENTIATION OF MAMMARY EPITHELIUM</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH STAT5A</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Oncol. Res." volume="16" first="179" last="193">
<title>Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.</title>
<authorList>
<person name="Pitfield S.E."/>
<person name="Bryant I."/>
<person name="Penington D.J."/>
<person name="Park G."/>
<person name="Riese D.J. II"/>
</authorList>
<dbReference type="PubMed" id="17120616"/>
</citation>
<scope>MUTAGENESIS OF GLN-646</scope>
<scope>PHOSPHORYLATION AT TYR-1056</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="6582" last="6590">
<title>HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.</title>
<authorList>
<person name="Strunk K.E."/>
<person name="Husted C."/>
<person name="Miraglia L.C."/>
<person name="Sandahl M."/>
<person name="Rearick W.A."/>
<person name="Hunter D.M."/>
<person name="Earp H.S. III"/>
<person name="Muraoka-Cook R.S."/>
</authorList>
<dbReference type="PubMed" id="17638867"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-4145"/>
</citation>
<scope>FUNCTION OF ERBB4 INTRACELLULAR DOMAIN</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION OF ERBB4 INTRACELLULAR DOMAIN</scope>
<scope>MUTAGENESIS OF VAL-675; LYS-751; ARG-992; LEU-995 AND ASP-1000</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Cell. Signal." volume="19" first="466" last="471">
<title>Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.</title>
<authorList>
<person name="Li Z."/>
<person name="Mei Y."/>
<person name="Liu X."/>
<person name="Zhou M."/>
</authorList>
<dbReference type="PubMed" id="16978839"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.07.020"/>
</citation>
<scope>INTERACTION WITH ERBB2</scope>
<scope>MUTAGENESIS OF ASP-843</scope>
<scope>AUTOPHOSPHORYLATION IN TRANS</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="6905" last="6914">
<title>Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.</title>
<authorList>
<person name="Sundvall M."/>
<person name="Peri L."/>
<person name="Maatta J.A."/>
<person name="Tvorogov D."/>
<person name="Paatero I."/>
<person name="Savisalo M."/>
<person name="Silvennoinen O."/>
<person name="Yarden Y."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="17486069"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210501"/>
</citation>
<scope>FUNCTION OF E4ICD</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION OF E4ICD</scope>
<scope>MUTAGENESIS OF LYS-751</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Chem. Biol." volume="15" first="808" last="817">
<title>System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.</title>
<authorList>
<person name="Kaushansky A."/>
<person name="Gordus A."/>
<person name="Budnik B.A."/>
<person name="Lane W.S."/>
<person name="Rush J."/>
<person name="MacBeath G."/>
</authorList>
<dbReference type="PubMed" id="18721752"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2008.07.006"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-875; TYR-1035; TYR-1056; TYR-1150; TYR-1162; TYR-1188; TYR-1202; TYR-1242; TYR-1258 AND TYR-1284</scope>
<scope>INTERACTION WITH PIK3R1 AND STAT1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="FASEB J." volume="23" first="1935" last="1945">
<title>Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.</title>
<authorList>
<person name="Zeng F."/>
<person name="Xu J."/>
<person name="Harris R.C."/>
</authorList>
<dbReference type="PubMed" id="19193720"/>
<dbReference type="DOI" id="10.1096/fj.08-121947"/>
</citation>
<scope>INTERACTION WITH NEDD4</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION OF E4ICD1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5582" last="5591">
<title>Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer.</title>
<authorList>
<person name="Tvorogov D."/>
<person name="Sundvall M."/>
<person name="Kurppa K."/>
<person name="Hollmen M."/>
<person name="Repo S."/>
<person name="Johnson M.S."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="19098003"/>
<dbReference type="DOI" id="10.1074/jbc.M805438200"/>
</citation>
<scope>FUNCTION IN ACTIVATION OF SIGNALING PATHWAYS</scope>
<scope>INTERACTION WITH ERBB2</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION BY ERBB2</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>MUTAGENESIS OF VAL-721; ALA-773; ARG-782; GLU-810; PRO-854; ASP-861; GLU-872 AND THR-926</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="2948" last="2958">
<title>WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.</title>
<authorList>
<person name="Li Y."/>
<person name="Zhou Z."/>
<person name="Alimandi M."/>
<person name="Chen C."/>
</authorList>
<dbReference type="PubMed" id="19561640"/>
<dbReference type="DOI" id="10.1038/onc.2009.162"/>
</citation>
<scope>INTERACTION WITH WWP1</scope>
<scope>MUTAGENESIS OF TYR-1056 AND TYR-1301</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="1388" last="1398">
<title>Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.</title>
<authorList>
<person name="Gilmore-Hebert M."/>
<person name="Ramabhadran R."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="20858735"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-10-0042"/>
</citation>
<scope>INTERACTION WITH TXNL4A; DDX23; MATR3; RBM15; ILF3; TRIM28; U5S1; U2SURP; ITCH; HNRNPU; AP2A1; NULC; LEO1; WWP2; MDM2; HXK1 AND ARS2</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Exp. Cell Res." volume="317" first="1476" last="1489">
<title>Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines.</title>
<authorList>
<person name="Carrasco-Garcia E."/>
<person name="Saceda M."/>
<person name="Grasso S."/>
<person name="Rocamora-Reverte L."/>
<person name="Conde M."/>
<person name="Gomez-Martinez A."/>
<person name="Garcia-Morales P."/>
<person name="Ferragut J.A."/>
<person name="Martinez-Lacaci I."/>
</authorList>
<dbReference type="PubMed" id="21439954"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2011.03.015"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2003" name="Cell Cycle" volume="2" first="555" last="559">
<title>ErbB4 signaling during breast and neural development: novel genetic models reveal unique ErbB4 activities.</title>
<authorList>
<person name="Jones F.E."/>
<person name="Golding J.P."/>
<person name="Gassmann M."/>
</authorList>
<dbReference type="PubMed" id="14504474"/>
</citation>
<scope>REVIEW ON ROLE IN BREAST AND NEURAL DEVELOPMENT</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2005" name="Histol. Histopathol." volume="20" first="1005" last="1015">
<title>The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches.</title>
<authorList>
<person name="Zaczek A."/>
<person name="Brandt B."/>
<person name="Bielawski K.P."/>
</authorList>
<dbReference type="PubMed" id="15944951"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="J. Mammary Gland Biol. Neoplasia" volume="13" first="235" last="246">
<title>ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition.</title>
<authorList>
<person name="Muraoka-Cook R.S."/>
<person name="Feng S.M."/>
<person name="Strunk K.E."/>
<person name="Earp H.S. III"/>
</authorList>
<dbReference type="PubMed" id="18437540"/>
<dbReference type="DOI" id="10.1007/s10911-008-9080-x"/>
</citation>
<scope>REVIEW ON ROLE IN MAMMARY GLAND DEVELOPMENT</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="J. Mammary Gland Biol. Neoplasia" volume="13" first="247" last="258">
<title>HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.</title>
<authorList>
<person name="Jones F.E."/>
</authorList>
<dbReference type="PubMed" id="18473151"/>
<dbReference type="DOI" id="10.1007/s10911-008-9076-6"/>
</citation>
<scope>REVIEW ON ROLE OF THE ERBB4 INTRACELLULAR DOMAIN</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="J. Mammary Gland Biol. Neoplasia" volume="13" first="259" last="268">
<title>Role of ErbB4 in breast cancer.</title>
<authorList>
<person name="Sundvall M."/>
<person name="Iljin K."/>
<person name="Kilpinen S."/>
<person name="Sara H."/>
<person name="Kallioniemi O.P."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="18454307"/>
<dbReference type="DOI" id="10.1007/s10911-008-9079-3"/>
</citation>
<scope>REVIEW ON LIGAND SPECIFICITY AND SIGNALING</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="Adv. Pharmacol." volume="59" first="31" last="51">
<title>Neuregulin-1/ErbB signaling and chronic heart failure.</title>
<authorList>
<person name="Xu Y."/>
<person name="Li X."/>
<person name="Liu X."/>
<person name="Zhou M."/>
</authorList>
<dbReference type="PubMed" id="20933198"/>
<dbReference type="DOI" id="10.1016/S1054-3589(10)59002-1"/>
</citation>
<scope>REVIEW ON ROLE IN NRG1 SIGNALING AND CARDIOVASCULAR HEALTH</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="2647" last="2657">
<title>Function of ERBB4 is determined by alternative splicing.</title>
<authorList>
<person name="Veikkolainen V."/>
<person name="Vaparanta K."/>
<person name="Halkilahti K."/>
<person name="Iljin K."/>
<person name="Sundvall M."/>
<person name="Elenius K."/>
</authorList>
<dbReference type="PubMed" id="21811097"/>
<dbReference type="DOI" id="10.4161/cc.10.16.17194"/>
</citation>
<scope>REVIEW ON ALTERNATIVE SPLICING AND PROTEOLYTIC PROCESSING; TISSUE SPECIFICITY; SIGNALING AND ROLE IN DISEASE</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="15024" last="15029">
<title>The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.</title>
<authorList>
<person name="Bouyain S."/>
<person name="Longo P.A."/>
<person name="Li S."/>
<person name="Ferguson K.M."/>
<person name="Leahy D.J."/>
</authorList>
<dbReference type="PubMed" id="16203964"/>
<dbReference type="DOI" id="10.1073/pnas.0507591102"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 26-641</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-138; ASN-174; ASN-253; ASN-358; ASN-410; ASN-473; ASN-495 AND ASN-576</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2773" last="2778">
<title>6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.</title>
<authorList>
<person name="Wood E.R."/>
<person name="Shewchuk L.M."/>
<person name="Ellis B."/>
<person name="Brignola P."/>
<person name="Brashear R.L."/>
<person name="Caferro T.R."/>
<person name="Dickerson S.H."/>
<person name="Dickson H.D."/>
<person name="Donaldson K.H."/>
<person name="Gaul M."/>
<person name="Griffin R.J."/>
<person name="Hassell A.M."/>
<person name="Keith B."/>
<person name="Mullin R."/>
<person name="Petrov K.G."/>
<person name="Reno M.J."/>
<person name="Rusnak D.W."/>
<person name="Tadepalli S.M."/>
<person name="Ulrich J.C."/>
<person name="Wagner C.D."/>
<person name="Vanderwall D.E."/>
<person name="Waterson A.G."/>
<person name="Williams J.D."/>
<person name="White W.L."/>
<person name="Uehling D.E."/>
</authorList>
<dbReference type="PubMed" id="18287036"/>
<dbReference type="DOI" id="10.1073/pnas.0708281105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 690-999 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LEU-710; MET-766; LEU-864 AND ILE-947</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2008" name="Structure" volume="16" first="460" last="467">
<title>Mechanism of activation and inhibition of the HER4/ErbB4 kinase.</title>
<authorList>
<person name="Qiu C."/>
<person name="Tarrant M.K."/>
<person name="Choi S.H."/>
<person name="Sathyamurthy A."/>
<person name="Bose R."/>
<person name="Banjade S."/>
<person name="Pal A."/>
<person name="Bornmann W.G."/>
<person name="Lemmon M.A."/>
<person name="Cole P.A."/>
<person name="Leahy D.J."/>
</authorList>
<dbReference type="PubMed" id="18334220"/>
<dbReference type="DOI" id="10.1016/j.str.2007.12.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 702-1029 OF APOPROTEIN AND IN COMPLEX WITH LAPATINIB</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ILE-140 AND TYR-303</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2013" name="Am. J. Hum. Genet." volume="93" first="900" last="905">
<title>ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.</title>
<authorList>
<person name="Takahashi Y."/>
<person name="Fukuda Y."/>
<person name="Yoshimura J."/>
<person name="Toyoda A."/>
<person name="Kurppa K."/>
<person name="Moritoyo H."/>
<person name="Belzil V.V."/>
<person name="Dion P.A."/>
<person name="Higasa K."/>
<person name="Doi K."/>
<person name="Ishiura H."/>
<person name="Mitsui J."/>
<person name="Date H."/>
<person name="Ahsan B."/>
<person name="Matsukawa T."/>
<person name="Ichikawa Y."/>
<person name="Moritoyo T."/>
<person name="Ikoma M."/>
<person name="Hashimoto T."/>
<person name="Kimura F."/>
<person name="Murayama S."/>
<person name="Onodera O."/>
<person name="Nishizawa M."/>
<person name="Yoshida M."/>
<person name="Atsuta N."/>
<person name="Sobue G."/>
<person name="Fifita J.A."/>
<person name="Williams K.L."/>
<person name="Blair I.P."/>
<person name="Nicholson G.A."/>
<person name="Gonzalez-Perez P."/>
<person name="Brown R.H. Jr."/>
<person name="Nomoto M."/>
<person name="Elenius K."/>
<person name="Rouleau G.A."/>
<person name="Fujiyama A."/>
<person name="Morishita S."/>
<person name="Goto J."/>
<person name="Tsuji S."/>
<person name="Nakamura R."/>
<person name="Watanabe H."/>
<person name="Izumi Y."/>
<person name="Kaji R."/>
<person name="Morita M."/>
<person name="Ogaki K."/>
<person name="Taniguchi A."/>
<person name="Aiba I."/>
<person name="Mizoguchi K."/>
<person name="Okamoto K."/>
<person name="Hasegawa K."/>
<person name="Aoki M."/>
<person name="Kawata A."/>
<person name="Nakano I."/>
<person name="Abe K."/>
<person name="Oda M."/>
<person name="Konagaya M."/>
<person name="Imai T."/>
<person name="Nakagawa M."/>
<person name="Fujita T."/>
<person name="Sasaki H."/>
<person name="Nishizawa M."/>
</authorList>
<dbReference type="PubMed" id="24119685"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2013.09.008"/>
</citation>
<scope>VARIANTS ALS19 GLN-927 AND TRP-1275</scope>
<scope>CHARACTERIZATION OF VARIANTS ASL19 GLN-927 AND TRP-1275</scope>
</reference>
<comment type="function">
<text evidence="11 12 13 14 17 18 19 20 22 23 26 27 29 33 34 38 41 46 48 49 50 52">Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10 35 36 38 48">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="activity regulation">
<text evidence="18 36 38 42 48">Binding of a cognate ligand leads to dimerization and activation by autophosphorylation on tyrosine residues. In vitro kinase activity is increased by Mg(2+). Inhibited by PD153035, lapatinib, gefitinib (iressa, ZD1839), AG1478 and BIBX1382BS.</text>
</comment>
<comment type="subunit">
<text evidence="7 11 12 13 15 17 20 21 22 24 27 28 29 30 35 36 37 38 39 40 41 44 45 47 48 49 50 51 53 54">Monomer in the absence of bound ligand. Homodimer or heterodimer with another ERBB family member upon ligand binding, thus forming heterotetramers. Interacts with EGFR and ERBB2. Interacts with CBFA2T3 (By similarity). Interacts with DLG2 (via its PDZ domain), DLG3 (via its PDZ domain), DLG4 (via its PDZ domain) and SNTB2 (via its PDZ domain). Interacts with MUC1. Interacts (via its PPxy motifs) with WWOX. Interacts (via the PPxY motif 3 of isoform JM-A CYT-2) with YAP1 (via the WW domain 1 of isoform 1). Interacts (isoform JM-A CYT-1 and isoform JM-B CYT-1) with WWP1. Interacts (via its intracellular domain) with TRIM28. Interacts (via the intracellular domains of both CYT-1 and CYT-2 isoforms) with KAP1; the interaction does not phosphorylate KAP1 but represses ERBB4-mediated transcriptional activity. Interacts with PRPU, DDX23, MATR3, RBM15, ILF3, KAP1, U5S1, U2SURP, ITCH, HNRNPU, AP2A1, NULC, LEO1, WWP2, IGHG1, HXK1, GRB7 AND ARS2. Interacts (phosphorylated isoform JM-A CYT-1 and isoform JM-B CYT-1) with PIK3R1. Interacts with SHC1. Interacts with GRB2. Interacts (soluble intracellular domain) with STAT5A. Interacts (soluble intracellular domain) with BCL2. Interacts (phosphorylated) with STAT1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-358049">
<id>Q13895</id>
<label>BYSL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-80389">
<id>P78352</id>
<label>DLG4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-6672198">
<id>Q96J02-2</id>
<label>ITCH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-2349743">
<id>Q12815</id>
<label>TROAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-80371"/>
<interactant intactId="EBI-1044059">
<id>P46937</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 20 22 26 27 29 33 34 39 41 46 52">Cell membrane</location>
<topology evidence="11 20 22 26 27 29 33 34 39 41 46 52">Single-pass type I membrane protein</topology>
</subcellularLocation>
<text>In response to NRG1 treatment, the activated receptor is internalized.</text>
</comment>
<comment type="subcellular location">
<molecule>ERBB4 intracellular domain</molecule>
<subcellularLocation>
<location evidence="33">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="33">Mitochondrion</location>
</subcellularLocation>
<text>Following proteolytical processing E4ICD (E4ICD1 or E4ICD2 generated from the respective isoforms) is translocated to the nucleus. Significantly more E4ICD2 than E4ICD1 is found in the nucleus. E4ICD2 colocalizes with YAP1 in the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q15303-1</id>
<name>JM-A CYT-1</name>
<sequence type="displayed"/>
<text>Proteolytical processing generates E4ICD1 (s80Cyt1).</text>
</isoform>
<isoform>
<id>Q15303-2</id>
<name>JM-B CYT-1</name>
<sequence type="described" ref="VSP_002895"/>
</isoform>
<isoform>
<id>Q15303-3</id>
<name>JM-A CYT-2</name>
<sequence type="described" ref="VSP_022148"/>
<text>Proteolytical processing generates E4ICD2 (s80Cyt2).</text>
</isoform>
<isoform>
<id>Q15303-4</id>
<name>JM-B CYT-2</name>
<sequence type="described" ref="VSP_002895 VSP_022148"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="12 46 52">Expressed at highest levels in brain, heart, kidney, in addition to skeletal muscle, parathyroid, cerebellum, pituitary, spleen, testis and breast. Lower levels in thymus, lung, salivary gland, and pancreas. Isoform JM-A CYT-1 and isoform JM-B CYT-1 are expressed in cerebellum, but only the isoform JM-B is expressed in the heart.</text>
</comment>
<comment type="PTM">
<text evidence="16 20 23 29 34 52">Isoform JM-A CYT-1 and isoform JM-A CYT-2 are processed by ADAM17. Proteolytic processing in response to ligand or 12-O-tetradecanoylphorbol-13-acetate stimulation results in the production of 120 kDa soluble receptor forms and intermediate membrane-anchored 80 kDa fragments (m80HER4), which are further processed by a presenilin-dependent gamma-secretase to release a cytoplasmic intracellular domain (E4ICD; E4ICD1/s80Cyt1 or E4ICD2/s80Cyt2, depending on the isoform). Membrane-anchored 80 kDa fragments of the processed isoform JM-A CYT-1 are more readily degraded by the proteasome than fragments of isoform JM-A CYT-2, suggesting a prevalence of E4ICD2 over E4ICD1. Isoform JM-B CYT-1 and isoform JM-B CYT-2 lack the ADAM17 cleavage site and are not processed by ADAM17, precluding further processing by gamma-secretase.</text>
</comment>
<comment type="PTM">
<text evidence="26 31 33 37 38 48 50">Autophosphorylated on tyrosine residues in response to ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Ligands trigger phosphorylation at specific tyrosine residues, thereby creating binding sites for scaffold proteins and effectors. Constitutively phosphorylated at a basal level when overexpressed in heterologous systems; ligand binding leads to increased phosphorylation. Phosphorylation at Tyr-1035 is important for interaction with STAT1. Phosphorylation at Tyr-1056 is important for interaction with PIK3R1. Phosphorylation at Tyr-1242 is important for interaction with SHC1. Phosphorylation at Tyr-1188 may also contribute to the interaction with SHC1. Isoform JM-A CYT-2 is constitutively phosphorylated on tyrosine residues in a ligand-independent manner. E4ICD2 but not E4ICD1 is phosphorylated on tyrosine residues.</text>
</comment>
<comment type="PTM">
<text evidence="34 39">Ubiquitinated. During mitosis, the ERBB4 intracellular domain is ubiquitinated by the APC/C complex and targeted to proteasomal degradation. Isoform JM-A CYT-1 and isoform JM-B CYT-1 are ubiquitinated by WWP1. The ERBB4 intracellular domain (E4ICD1) is ubiquitinated, and this involves NEDD4.</text>
</comment>
<comment type="disease" evidence="43">
<disease id="DI-03940">
<name>Amyotrophic lateral sclerosis 19</name>
<acronym>ALS19</acronym>
<description>A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.</description>
<dbReference type="MIM" id="615515"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="9">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="caution">
<text evidence="58">Conflicting reports about the role of ERBB4 in mediating apoptosis, differentiation, or tumor cell proliferation may be explained by the opposite functions of the different isoforms and their intracellular fragments, and by the formation of heterodimers with other EGF receptor family members (PubMed:18454307 and PubMed:21811097). Thus, heterodimer formation of a kinase-dead ERBB4 mutant with ERBB2 is sufficient for the activation of AKT1, MAPK1/ERK2 and MAPK3/ERK1 (PubMed:19098003).</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="L07868">
<property type="protein sequence ID" value="AAB59446.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112199">
<property type="protein sequence ID" value="AAI12200.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143741">
<property type="protein sequence ID" value="AAI43742.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143747">
<property type="protein sequence ID" value="AAI43748.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143749">
<property type="protein sequence ID" value="AAI43750.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209697">
<property type="protein sequence ID" value="BAD92934.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2394.1">
<molecule id="Q15303-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42811.1">
<molecule id="Q15303-3"/>
</dbReference>
<dbReference type="PIR" id="A47253">
<property type="entry name" value="A47253"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001036064.1">
<molecule id="Q15303-3"/>
<property type="nucleotide sequence ID" value="NM_001042599.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005226.1">
<molecule id="Q15303-1"/>
<property type="nucleotide sequence ID" value="NM_005235.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005246433.1">
<molecule id="Q15303-2"/>
<property type="nucleotide sequence ID" value="XM_005246376.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005246434.1">
<molecule id="Q15303-4"/>
<property type="nucleotide sequence ID" value="XM_005246377.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.390729"/>
<dbReference type="PDB" id="2AHX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=26-641"/>
</dbReference>
<dbReference type="PDB" id="2L2T">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=642-685"/>
</dbReference>
<dbReference type="PDB" id="2LCX">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=642-685"/>
</dbReference>
<dbReference type="PDB" id="2R4B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=690-999"/>
</dbReference>
<dbReference type="PDB" id="3BBT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B/D=702-1029"/>
</dbReference>
<dbReference type="PDB" id="3BBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=702-1029"/>
</dbReference>
<dbReference type="PDB" id="3BCE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C=702-1029"/>
</dbReference>
<dbReference type="PDB" id="3U2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A=26-522"/>
</dbReference>
<dbReference type="PDB" id="3U7U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.03"/>
<property type="chains" value="A/B/C/D/E/F=26-640"/>
</dbReference>
<dbReference type="PDB" id="3U9U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="E/F=26-650"/>
</dbReference>
<dbReference type="PDBsum" id="2AHX"/>
<dbReference type="PDBsum" id="2L2T"/>
<dbReference type="PDBsum" id="2LCX"/>
<dbReference type="PDBsum" id="2R4B"/>
<dbReference type="PDBsum" id="3BBT"/>
<dbReference type="PDBsum" id="3BBW"/>
<dbReference type="PDBsum" id="3BCE"/>
<dbReference type="PDBsum" id="3U2P"/>
<dbReference type="PDBsum" id="3U7U"/>
<dbReference type="PDBsum" id="3U9U"/>
<dbReference type="ProteinModelPortal" id="Q15303"/>
<dbReference type="SMR" id="Q15303"/>
<dbReference type="BioGrid" id="108378">
<property type="interactions" value="77"/>
</dbReference>
<dbReference type="DIP" id="DIP-29650N"/>
<dbReference type="ELM" id="Q15303"/>
<dbReference type="IntAct" id="Q15303">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="MINT" id="Q15303"/>
<dbReference type="STRING" id="9606.ENSP00000342235"/>
<dbReference type="BindingDB" id="Q15303"/>
<dbReference type="ChEMBL" id="CHEMBL3009"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1799"/>
<dbReference type="TCDB" id="1.A.87.2.6">
<property type="family name" value="the mechanosensitive calcium channel (mca) family"/>
</dbReference>
<dbReference type="iPTMnet" id="Q15303"/>
<dbReference type="PhosphoSitePlus" id="Q15303"/>
<dbReference type="BioMuta" id="ERBB4"/>
<dbReference type="DMDM" id="3913590"/>
<dbReference type="EPD" id="Q15303"/>
<dbReference type="MaxQB" id="Q15303"/>
<dbReference type="PaxDb" id="Q15303"/>
<dbReference type="PeptideAtlas" id="Q15303"/>
<dbReference type="PRIDE" id="Q15303"/>
<dbReference type="ProteomicsDB" id="60520"/>
<dbReference type="ProteomicsDB" id="60521">
<molecule id="Q15303-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60522">
<molecule id="Q15303-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="60523">
<molecule id="Q15303-4"/>
</dbReference>
<dbReference type="DNASU" id="2066"/>
<dbReference type="Ensembl" id="ENST00000342788">
<molecule id="Q15303-1"/>
<property type="protein sequence ID" value="ENSP00000342235"/>
<property type="gene ID" value="ENSG00000178568"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000436443">
<molecule id="Q15303-3"/>
<property type="protein sequence ID" value="ENSP00000403204"/>
<property type="gene ID" value="ENSG00000178568"/>
</dbReference>
<dbReference type="GeneID" id="2066"/>
<dbReference type="KEGG" id="hsa:2066"/>
<dbReference type="UCSC" id="uc002veg.2">
<molecule id="Q15303-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2066"/>
<dbReference type="DisGeNET" id="2066"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000178568.13"/>
<dbReference type="GeneCards" id="ERBB4"/>
<dbReference type="HGNC" id="HGNC:3432">
<property type="gene designation" value="ERBB4"/>
</dbReference>
<dbReference type="HPA" id="CAB000276"/>
<dbReference type="HPA" id="CAB025522"/>
<dbReference type="HPA" id="HPA012016"/>
<dbReference type="MalaCards" id="ERBB4"/>
<dbReference type="MIM" id="600543">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615515">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15303"/>
<dbReference type="OpenTargets" id="ENSG00000178568"/>
<dbReference type="Orphanet" id="803">
<property type="disease" value="Amyotrophic lateral sclerosis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27847"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000230982"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="Q15303"/>
<dbReference type="KO" id="K05085"/>
<dbReference type="OMA" id="RTRIDSN"/>
<dbReference type="OrthoDB" id="EOG091G00EY"/>
<dbReference type="PhylomeDB" id="Q15303"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250342">
<property type="pathway name" value="PI3K events in ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250347">
<property type="pathway name" value="SHC1 events in ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251985">
<property type="pathway name" value="Nuclear signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1253288">
<property type="pathway name" value="Downregulation of ERBB4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="SignaLink" id="Q15303"/>
<dbReference type="SIGNOR" id="Q15303"/>
<dbReference type="ChiTaRS" id="ERBB4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q15303"/>
<dbReference type="GeneWiki" id="ERBB4"/>
<dbReference type="GenomeRNAi" id="2066"/>
<dbReference type="PMAP-CutDB" id="Q15303"/>
<dbReference type="PRO" id="PR:Q15303"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000178568">
<property type="expression patterns" value="Expressed in 168 organ(s), highest expression level in oviduct epithelium"/>
</dbReference>
<dbReference type="CleanEx" id="HS_ERBB4"/>
<dbReference type="ExpressionAtlas" id="Q15303">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15303">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0098982">
<property type="term" value="C:GABA-ergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099061">
<property type="term" value="C:integral component of postsynaptic density membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099056">
<property type="term" value="C:integral component of presynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005154">
<property type="term" value="F:epidermal growth factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061026">
<property type="term" value="P:cardiac muscle tissue regeneration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045165">
<property type="term" value="P:cell fate commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021551">
<property type="term" value="P:central nervous system morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009880">
<property type="term" value="P:embryonic pattern specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007595">
<property type="term" value="P:lactation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060749">
<property type="term" value="P:mammary gland alveolus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060644">
<property type="term" value="P:mammary gland epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043653">
<property type="term" value="P:mitochondrial fragmentation involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001223">
<property type="term" value="P:negative regulation of neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001755">
<property type="term" value="P:neural crest cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021889">
<property type="term" value="P:olfactory bulb interneuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060045">
<property type="term" value="P:positive regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046427">
<property type="term" value="P:positive regulation of JAK-STAT cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2000010">
<property type="term" value="P:positive regulation of protein localization to cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007416">
<property type="term" value="P:synapse assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00064">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0036">Amyotrophic lateral sclerosis</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0421">Lactation</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Receptor tyrosine-protein kinase erbB-4" id="PRO_0000016674">
<location>
<begin position="26"/>
<end position="1308"/>
</location>
</feature>
<feature type="chain" description="ERBB4 intracellular domain" id="PRO_0000396797" evidence="7">
<location>
<begin position="676"/>
<end position="1308"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="8">
<location>
<begin position="26"/>
<end position="651"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="652"/>
<end position="675"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="676"/>
<end position="1308"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="9">
<location>
<begin position="718"/>
<end position="985"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="724"/>
<end position="732"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="797"/>
<end position="799"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="9">
<location>
<begin position="843"/>
<end position="848"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="676"/>
<end position="684"/>
</location>
</feature>
<feature type="short sequence motif" description="PPxY motif 1">
<location>
<begin position="1032"/>
<end position="1035"/>
</location>
</feature>
<feature type="short sequence motif" description="PPxY motif 2">
<location>
<begin position="1053"/>
<end position="1056"/>
</location>
</feature>
<feature type="short sequence motif" description="PPxY motif 3">
<location>
<begin position="1298"/>
<end position="1301"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding">
<location>
<begin position="1306"/>
<end position="1308"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys-rich">
<location>
<begin position="186"/>
<end position="334"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys-rich">
<location>
<begin position="496"/>
<end position="633"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="9 10">
<location>
<position position="843"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="9">
<location>
<position position="751"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="875"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1035"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="31 37 48">
<location>
<position position="1056"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1150"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1162"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37 48">
<location>
<position position="1188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1202"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37 48">
<location>
<position position="1242"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1258"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37">
<location>
<position position="1284"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="138"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="174"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="181"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="253"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="358"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="410"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="473"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="495"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="548"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="576"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="620"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="29"/>
<end position="56"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="156"/>
<end position="186"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="189"/>
<end position="197"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="193"/>
<end position="205"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="213"/>
<end position="221"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="217"/>
<end position="229"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="230"/>
<end position="238"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="234"/>
<end position="246"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="249"/>
<end position="258"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="262"/>
<end position="289"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="293"/>
<end position="304"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="308"/>
<end position="323"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="326"/>
<end position="330"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="503"/>
<end position="512"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="507"/>
<end position="520"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="523"/>
<end position="532"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="536"/>
<end position="552"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="555"/>
<end position="569"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="559"/>
<end position="577"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="580"/>
<end position="589"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="593"/>
<end position="614"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="617"/>
<end position="625"/>
</location>
</feature>
<feature type="disulfide bond" evidence="25">
<location>
<begin position="621"/>
<end position="633"/>
</location>
</feature>
<feature type="splice variant" description="In isoform JM-B CYT-1 and isoform JM-B CYT-2." id="VSP_002895" evidence="55 56">
<original>NGPTSHDCIYYPWTGHSTLPQHA</original>
<variation>IGSSIEDCIGLMD</variation>
<location>
<begin position="626"/>
<end position="648"/>
</location>
</feature>
<feature type="splice variant" description="In isoform JM-A CYT-2 and isoform JM-B CYT-2." id="VSP_022148" evidence="55 57">
<location>
<begin position="1046"/>
<end position="1061"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation." id="VAR_042113" evidence="32">
<original>T</original>
<variation>I</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung squamous cell carcinoma sample; somatic mutation." id="VAR_042114" evidence="32">
<original>S</original>
<variation>Y</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514262." id="VAR_070810" evidence="43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="927"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514263." id="VAR_070811" evidence="43">
<original>R</original>
<variation>W</variation>
<location>
<position position="1275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="31">
<original>Q</original>
<variation>C</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes proteolytic processing and nuclear localization." evidence="23 34">
<original>V</original>
<variation>A</variation>
<location>
<position position="675"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear localization of the ERBB4 intracellular domain." evidence="22">
<original>KKKR</original>
<variation>EIMG</variation>
<location>
<begin position="681"/>
<end position="684"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation." evidence="35">
<original>L</original>
<variation>N</variation>
<location>
<position position="710"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>V</original>
<variation>I</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity. Abolishes phosphorylation, proteolytic processing and nuclear localization." evidence="19 33 34">
<original>K</original>
<variation>R</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation." evidence="35">
<original>M</original>
<variation>R</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>A</original>
<variation>S</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>R</original>
<variation>Q</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>E</original>
<variation>K</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="30">
<original>D</original>
<variation>N</variation>
<location>
<position position="843"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>P</original>
<variation>Q</variation>
<location>
<position position="854"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="38">
<original>D</original>
<variation>Y</variation>
<location>
<position position="861"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation." evidence="35">
<original>L</original>
<variation>R</variation>
<location>
<position position="864"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>E</original>
<variation>K</variation>
<location>
<position position="872"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="38">
<original>T</original>
<variation>M</variation>
<location>
<position position="926"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively autophosphorylated." evidence="35">
<original>I</original>
<variation>R</variation>
<location>
<position position="947"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes APC/C-mediated degradation; when associated with A-995 and A-1000." evidence="34">
<original>R</original>
<variation>A</variation>
<location>
<position position="992"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes APC/C-mediated degradation; when associated with A-992 and A-1000." evidence="34">
<original>L</original>
<variation>A</variation>
<location>
<position position="995"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes APC/C-mediated degradation; when associated with A-992 and A-995." evidence="34">
<original>D</original>
<variation>A</variation>
<location>
<position position="1000"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1301." evidence="24">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1035"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1." evidence="40">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1056"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with WWP1; when associated with F-1301." evidence="40">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1056"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NEDD4 and impairs ubiquitination." evidence="20 24 40">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1301"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with WWOX. Abolishes interaction with WWOX; when associated with A-1035. Loss of interaction with YAP1 and stimulation of transcription." evidence="20 24 40">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1301"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with WWP1; when associated with F-1056." evidence="20 24 40">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1301"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="42"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="75"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="87"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="144"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="158"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="197"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="221"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="234"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="245"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="257"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="265"/>
<end position="269"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="288"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="303"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="320"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="327"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="353"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="360"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="366"/>
<end position="368"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="370"/>
<end position="374"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="386"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="415"/>
<end position="417"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="432"/>
<end position="438"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="455"/>
<end position="461"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="474"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="479"/>
<end position="482"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="485"/>
<end position="487"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="489"/>
<end position="491"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="493"/>
<end position="497"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="498"/>
<end position="500"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="512"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="519"/>
<end position="528"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="531"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="537"/>
<end position="543"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="545"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="551"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="568"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="576"/>
<end position="585"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="588"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="595"/>
<end position="608"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="612"/>
<end position="616"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="625"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="651"/>
<end position="676"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="715"/>
<end position="717"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="718"/>
<end position="729"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="731"/>
<end position="737"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="740"/>
<end position="743"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="746"/>
<end position="752"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="762"/>
<end position="773"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="778"/>
<end position="780"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="783"/>
<end position="787"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="789"/>
<end position="791"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="793"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="804"/>
<end position="810"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="812"/>
<end position="814"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="817"/>
<end position="836"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="846"/>
<end position="848"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="849"/>
<end position="853"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="856"/>
<end position="859"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="864"/>
<end position="869"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="884"/>
<end position="886"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="889"/>
<end position="893"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="899"/>
<end position="914"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="920"/>
<end position="923"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="926"/>
<end position="928"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="929"/>
<end position="934"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="947"/>
<end position="955"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="961"/>
<end position="963"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="967"/>
<end position="977"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="981"/>
<end position="983"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2AHX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L2T"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2R4B"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BBT"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3U2P"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3U7U"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10348342"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10353604"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358079"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722704"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10725395"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10744726"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10867024"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11178955"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11390655"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12807903"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15534001"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15746097"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16061658"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16203964"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16251361"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16778220"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16815842"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16837552"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16978839"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17120616"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17486069"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17638867"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18287036"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18334220"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18721752"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19098003"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19193720"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19561640"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20858735"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21439954"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24119685"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7689552"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7902537"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8383326"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8570211"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8617750"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9135143"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9168115"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9275162"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9334263"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9419975"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9516479"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9334263"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="58" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19098003"/>
</source>
</evidence>
<sequence length="1308" mass="146808" checksum="5E4AE80985D88761" modified="1996-11-01" version="1" precursor="true">
MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVM
GNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIF
LNYRKDGNFGLQELGLKNLTEILNGGVYVDQNKFLCYADTIHWQDIVRNPWPSNLTLVST
NGSSGCGRCHKSCTGRCWGPTENHCQTLTRTVCAEQCDGRCYGPYVSDCCHRECAGGCSG
PKDTDCFACMNFNDSGACVTQCPQTFVYNPTTFQLEHNFNAKYTYGAFCVKKCPHNFVVD
SSSCVRACPSSKMEVEENGIKMCKPCTDICPKACDGIGTGSLMSAQTVDSSNIDKFINCT
KINGNLIFLVTGIHGDPYNAIEAIDPEKLNVFRTVREITGFLNIQSWPPNMTDFSVFSNL
VTIGGRVLYSGLSLLILKQQGITSLQFQSLKEISAGNIYITDNSNLCYYHTINWTTLFST
INQRIVIRDNRKAENCTAEGMVCNHLCSSDGCWGPGPDQCLSCRRFSRGRICIESCNLYD
GEFREFENGSICVECDPQCEKMEDGLLTCHGPGPDNCTKCSHFKDGPNCVEKCPDGLQGA
NSFIFKYADPDRECHPCHPNCTQGCNGPTSHDCIYYPWTGHSTLPQHARTPLIAAGVIGG
LFILVIVGLTFAVYVRRKSIKKKRALRRFLETELVEPLTPSGTAPNQAQLRILKETELKR
VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL
VRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV
HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ
SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID
ADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAE
EYLVPQAFNIPPPIYTSRARIDSNRSEIGHSPPPAYTPMSGNQFVYRDGGFAAEQGVSVP
YRAPTSTIPEAPVAQGATAEIFDDSCCNGTLRKPVAPHVQEDSSTQRYSADPTVFAPERS
PRGELDEEGYMTPMRDKPKQEYLNPVEENPFVSRRKNGDLQALDNPEYHNASNGPPKAED
EYVNEPLYLNTFANTLGKAEYLKNNILSMPEKAKKAFDNPDYWNHSLPPRSTLQHPDYLQ
EYSTKYFYKQNGRIRPIVAENPEYLSEFSLKPGTVLPPPPYRHRNTVV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>